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Abstract 
Clays and clay minerals (phyllosilicates) have been used for millennia to treat a range 
of human maladies, such as infected wounds and diseases of the skin. The unique 
chemistry of phyllosilicates allows them to support the wound environment and 
encourage healing. Their physicochemical properties can also be utilised to develop 
modified drug-release formulations and also enables their incorporation into polymer 
matrices for the development of advanced wound care materials. By developing novel 
antibacterial phyllosilicate-polymer composite materials it should be possible to 
support wound healing, whilst simultaneously treating infections locally to avoid 
systemic adverse effects and prevent the development of antimicrobial resistance. 
 
In this research project the clay minerals kaolin (KN), refined montmorillonite (rMMT), 
montmorilonite K10 (MMTK10), Laponite® RD (LRD), and Laponite® XL21 (LXL21) were 
investigated for their differing structure and physicochemical properties. Their ability 
to adsorb and desorb the antibacterial agents tetracycline (TC), doxycycline (DC) and 
ciprofloxacin (CIP) was determined through a series of adsorption kinetics and 
isotherm studies. LRD and LXL21 were shown to have the highest drug-carrying 
capacity and were also able to relinquish this drug-load to inhibit the proliferation of 
key wound pathogens; Staphylococcus epidermidis, Propionibacterium acnes, and 
Pseudomonas aeruginosa. XRD and FTIR analyses demonstrated that these drug 
molecules could be adsorbed into the interlayer space and edge groups of the 
Laponite® particles. 
 
   
 
XIV 
 
LXL21-CIP composites were successfully incorporated into alginate polymer matrices 
through interaction of the exposed edge-groups on LXL21 and the hydroxyl groups of 
the alginate to produce novel nanocomposite film and foam materials. Selection of 
candidate materials was initially undertaken qualitatively with the support of a tissue 
viability nurse at the Royal Liverpool and Broadgreen University Hospitals NHS Trust. 
Important properties for wound-dressings such as adsorptive capacity, water vapour 
transmission rate, and keratinocyte compatibility were measured quantitatively and 
compared to materials already used for wound care in the UK. Both the film and foam 
materials were shown to have properties that would be beneficial for wound healing 
and were also able to release CIP in a controlled manner with notable activity against 
S. epidermidis, P. acnes, and P. aeruginosa. 
 
The nanocomposite film formulation developed in this research project showed 
promise for future clinical applications and future work should be undertaken to 
further optimise their manufacture and fully characterise their ability to support the 
healing of infected wounds. Although the nanocomposite foams require further 
research, the work presented in this thesis suggests they could also be promising 
materials for wound care applications.   
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Chapter 1 
Introduction 
 
1.1. A brief history of clay minerals in health 
Clays have been used for health purposes throughout ancient and modern history in 
many forms and applications (Gaskell and Hamilton, 2014). Of note, and possibly the 
oldest application, is their use in the treatment of skin conditions and wounds.  
 
There is tentative evidence that Homo neanderthalensis, and later Homo erectus, 
utilised earths for the treatment of wounds and the management of skin irritations 
(Carretero, 2002; Dawson and Oreffo, 2013). It has been postulated that these early 
humans learned this behaviour from other primates who are still observed applying 
muds and clays to their skin. In modern science it is well noted that many animals 
ingest clays for numerous perceived health benefits (Newton, 1991; Slamova et al., 
2011; Williams and Haydel, 2010). This geophagy was also practiced widely amongst 
human populations across the globe and even though its popularity has diminished 
within modern healthcare it still remains a traditional therapy within various cultures 
(Kikouama and Balde, 2010; Vermeer and Ferrell, 1985).  
 
Some of the most ancient uses of clay are believed to have taken place in 
Mesopotamia over 4000 years ago (Carretero, 2002; Gomes and Silva, 2007; Rytwo, 
2008). During the spread of mankind across the globe the practice of using clays, muds, 
and earths in the treatment of skin conditions and wounds continued. The Ancient 
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Egyptians are well known for their interest in complex therapies and it should come as 
no surprise that they developed medicaments and cosmetics from clays and muds 
(Rytwo, 2008). The Papyrus Ebers details a wide range of uses for clays within Egyptian 
healthcare and it has also been documented that Nubian Earth was utilised as an anti-
inflammatory (Bryan, 1930; Carretero, 2002; Gomes and Silva, 2007).  
 
Ancient Greek and Roman civilisations, credited for their scientific and medical 
intuition, also found uses for clays in healthcare (Bunnell et al., 2007; Gomes et al., 
2013). Whilst clays and muds could possibly have been considered a panacea it is 
known that specific applications were developed for the management of wounds. Of 
note are the works of the Greek physician Galen, who in the second century, 
developed terra sigillata; red earth found on the island of Lemnos, which was shaped 
and stamped with the imprint of the Goddess Diana (Dannenfeldt, 2012). The use of 
terra sigillata spread across Europe and was still popular during the sixteenth century. 
This resulted in many countries sourcing clays from local deposits and developing their 
own versions of the terra sigillata and the respective seals, which continued into the 
early seventeenth century (Dannenfeldt, 2012).  
 
The 1618 edition of the Pharmacopoeia Londinensis contained monographs on earths 
from Lemnos and Malta, alongside the later terra Silesiaca [sic]. In the eighteenth 
century there were around thirty of these sealed earths available across Europe but 
their popularity was minimal compared to the original terrae. Paracelsus and 
paracelsian physicians became eager to understand how treatments and medicines 
worked through experimentation, observation, and understanding – something that 
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misaligned to the traditional uses of terra sigillata and terra Silesiaca (Dannenfeldt, 
2012). 
 
During the Renaissance periods the culture of spas and bath houses blossomed and 
their popularity continued well into the nineteenth and twentieth centuries (Gibson, 
1954; Jackson, 1990; Palmer, 1990; van Tubergen and van der Linden, 2002). As well as 
offering visitors the opportunity to bathe in “natural” and “mineral” waters the bath 
houses also offered therapies utilising muds and sediments (Palmer, 1990; van 
Tubergen and van der Linden, 2002). In Britain the popularity of the baths and spas 
declined in the first quarter of the twentieth century until the industry finally collapsed 
when the National Health Service excluded spa therapy as a treatment option (van 
Tubergen and van der Linden, 2002). Pelotherapy, which is the application of matured 
muds and clays to the skin (Carretero and Lagaly, 2007; Carretero, 2002; Gomes et al., 
2013; Tateo and Summa, 2007; Tateo et al., 2009; Viseras et al., 2007), developed as a 
discipline during the twentieth century but has been viewed mainly as a cosmetic 
investment rather than a clinical intervention. Regardless of this, the demand for 
health spas and their respective therapies has increased over the past twenty-five 
years and it has developed into a successful industry once more. One study into the 
use of mud packs in rheumatoid arthritis (Sukenik et al., 1990) produced inconclusive 
results and more robust trials are needed before the value of such therapies are truly 
determined. 
 
Regardless of this lack of evidence clays continue to be utilised in the formulation of 
modern medicines and are detailed within early pharmacopoeia and pharmaceutical 
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codexes (Pharmaceutical Society of Great Britain, 1911, 1907), where they are still 
listed for modern use. Calamine lotion, containing bentonite (British Pharmacopoeia 
Commission, 2017a), and Kaolin Poultice (British Pharmacopoeia Commission, 2017b) 
for example, still remain within the current British Pharmacopoeia but for the most 
part clays are used as excipients within oral formulations as swelling agents, 
disintegrating agents, and lubricants (Carretero, 2002; Carretero and Pozo, 2009; 
Rodrigues et al., 2013; Viseras et al., 2010).  
 
Academic research of clays and clay-minerals has grown in recent years and a small 
number of teams are looking at the antimicrobial and healing properties of clays, with 
others investigating the possible application of clays and clay minerals for wound care. 
Knowledge of the physicochemical properties of clay-minerals is vital for 
understanding their potential application in the management of infected wounds and 
skin and skin-structure infections.  
 
1.2. The physicochemical properties of clay minerals 
1.2.1. Structure and chemistry of clay mineral layers 
Phyllosilicates are layered materials with a unique structure and chemistry. Each 
individual layer is formed of characteristic sheets that can be categorised into two 
distinct types: tetrahedral silicon oxide sheets and octahedral metal hydroxide sheets 
(Bergaya and Lagaly, 2013; Brigatti et al., 2013). 
 
The tetrahedral sheet is generally made of silicon oxide arranged in a tetrahedral 
formation (figure 1.1 A). The tetrahedra arrange themselves by joining at the corners 
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to share basal oxygen atoms with their neighbouring tetrahedra. When six of these 
tetrahedra come together they form a distinct hexagonal-ring pattern. These rings can 
be seen throughout the continuous silicon oxide sheet, as represented in figure 1.1 B 
(Brigatti et al., 2013). The second type of sheet within the phyllosilicate layers is the 
metal hydroxide octahedral sheet. The individual units of this sheet comprise a 
multivalent metal ion in coordination with six hydroxyl groups, in octahedral formation 
(figure 1.1 C). This central metal ion is commonly Mg2+, Fe2+, Fe3+ or Al3+. The individual 
units align alongside each other and undergo edge oxygen sharing to form a tight, 
continuous, octahedral sheet as depicted in figure 1.1 D (Brigatti et al., 2013).  
 
 
 
Figure 1.1. Diagrams representing the atomic arrangements within phyllosilicates, rather than the 
individual bonds present. Individual silicon oxide tetrahedra (A) arrange via corner-sharing in ring-like 
arrangements to form a continuous tetrahedral sheet (B). The individual metal hydroxide octahedra (C) 
align through edge-sharing to form a continuous octahedral sheet (D). 
 
(A) (B) 
(C) (D) 
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The valence of the cations within the octahedral sheet plays a very important role in its 
chemistry and structure; dictating whether the sheet is classified as trioctahedral or 
dioctahedral. If the valence is equivalent to II (e.g. Mg2+ or Fe2+) then the sheet will 
assume a trioctahedral formation, whereby every position in the sheet is occupied by a 
complete octahedron with central cation. However, if the valency of the cations within 
the sheet is equivalent to III (e.g. Fe3+ or Al3+) then the overall sheet will become 
dioctahedral. For every two fully occupied octahedra within a dioctahedral sheet, one 
position will not have a central cation (Swartzen-Allen and Matijevic, 1974). This does 
not affect the overall structure of the sheet, when considering the arrangement of 
oxygen atoms, but has a profound effect on the overall charge of the sheet, and thus 
the phyllosilicate layer. 
 
In order for the phyllosilicate layers to be formed these two sheets need to join 
together and they do so through a condensation reaction and thus further oxygen 
sharing. The apical oxygen atoms of the tetrahedra are thusly shared with the 
corresponding points on the octahedral sheet, so that the basal oxygen atoms become 
the outward facing surface (Bergaya and Lagaly, 2013). If any of the oxygen atoms 
within the octahedral sheet are not shared with the tetrahedral sheet they can present 
themselves as hydroxyl groups instead. Positions where this is likely to occur are in the 
centre of the tetrahedral ditrigonal ring structure, at the edges of the sheet, and where 
the octahedral sheet only binds to one tetrahedral sheet. 
 
If a layer consists of only one tetrahedral sheet bound to one octahedral sheet this 
phyllosilicate structure is known as a 1:1 layer (figure 1.2 A). However, it is possible for 
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two tetrahedral sheets to sandwich an octahedral sheet, which is referred to as a 2:1 
layer (figure 1.2 B) (Konta, 1995). These layers often form disc-like shapes and their 
size can also be highly variable. For example, the synthetic clay mineral Laponite® is 
classified as a nano-material as the diameter of the layers is around 20-30 nm (Avery 
and Ramsay, 1986; Daniel et al., 2008; Pálková et al., 2010). This is in contrast to the 
natural clay minerals kaolin and montmorillonite, which can have a layer-diameter 
greater than 200 nm (Aochi and Farmer, 2011; Paineau et al., 2011b; Poli et al., 2008).  
 
The differences between the chemistry of 1:1 and 2:1 layers is particularly interesting 
and can have a profound effect on the overall behaviour of the clay mineral that they 
form. When considering the structure of the individual sheets and layers, the most 
important property the chemistry affects is the charge of the layer. 
 
 
Figure 1.2. Artistic representation of a 1:1 clay mineral particle (A) and a 2:1 clay mineral particle (B). 
The magnifications show how the tetrahedral sheets (brown triangles) and octahedral sheets (green 
continuous layer) condense to form the phyllosilicate layers. 
(A) (B) 
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The process of isomorphic substitution can take place in both the tetrahedral and 
octahedral sheets, causing a charge deficiency across the phyllosilicate layer 
(Swartzen-Allen and Matijevic, 1974). Within the tetrahedral sheet the Si4+ atoms are 
able to be substituted for cations of lower charge. This process is more common within 
the octahedral sheet where Fe3+ or Al3+ cations may be substituted for cations of lower 
valence, such as Fe2+ or Mg2+. These substitutions lead to what is described as a charge 
deficiency across the phyllosilicate layer, which manifests as a negative charge on the 
faces of the layers (Aochi and Farmer, 2011; Czímerová et al., 2006; Madejova, 2003). 
The 1:1 clays are generally neutral in nature, or have a very minimal surface charge. 
The 2:1 clays on the other hand may exhibit high degrees of surface charge. This is not 
the only mechanism by which a negative charge can be formed; missing cations from 
trioctahedral sheets can also lead to an increased negative charge at the layer surface 
(Brigatti et al., 2013).  
 
The edges of clay-mineral particles are characterised by exposed hydroxyl groups from 
the metal-hydroxide sheet, but also the formation of SiOH groups where the silicate 
sheet discontinues (Czímerová et al., 2006; Daniel et al., 2008; Swartzen-Allen and 
Matijevic, 1974). These edge groups are important as their charge is pH dependant, 
with their pKa determined by the wider clay-mineral structure. For example, the edge 
groups on Laponite® are generally positively charged below pH 9 (Daniel et al., 2008) 
and become increasingly negatively charged above this pH. It is this mix of negatively 
charged surfaces and positively charged edges that give phyllosilicate materials their 
unique surface and colloidal properties (section 1.2.3). 
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Not all phyllosilicate layers form into disc-like shapes or form particles. One example of 
such minerals is palygorskite, which is termed a modulated clay mineral. Instead of 
forming disc-like structures, these modulated clay minerals, display regular inversions 
of the phyllosilicate layer, which leads to the development of ribbon-like structures 
(Lopez-Galindo et al., 2007; C Viseras et al., 2007; White and Hem, 1983). These 
modulated phyllosilicates are sometimes referred to as fibrous clay minerals (Tateo 
and Summa, 2007). Halloysite is another phyllosilicate that does not form disk-like 
structures but forms tubular structures with a lumen in the nanometre scale (Aguzzi et 
al., 2007; Konta, 1995). These nanotubes have received much attention in recent years 
for a number of applications including drug delivery.  
 
1.2.2. Layer arrangement and particle formation 
Clay mineral layers do not remain in isolation in dry powder (as described here) or 
when in aqueous dispersion (see section 1.2.3), but instead form associations with 
each other. 
 
The 1:1 layers form direct associations with each other through hydrogen bonding 
between the tetrahedral sheet of one layer and the octahedral sheet of an adjacent 
layer (Miranda-Trevino and Coles, 2003). This strong association results in very small 
gallery heights, which is also termed the interlayer space (figure 1.3 A). Measurements 
of the interlayer space of 1:1 clay minerals, such as kaolin, have shown the gallery 
height to be as small as 7Å (Konta, 1995). 
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In contrast to this, the 2:1 phyllosilicate layers have a tendency to repel each other due 
to the negative charge of both layer surfaces. To overcome this repulsion inorganic 
cations (e.g. Na+ and Ca2+) present in the interlayer space counterbalance the negative 
charge (figure 1.3 B) (Konta, 1995; Madejova, 2003). The abundance of these cations is 
determined by the charge distribution across the layer surfaces and the contents of 
the phyllosilicate layers. Isomorphic substitution within the tetrahedral and octahedral 
sheets is able to alter the species of the cations present within the interlayer space 
(Brigatti et al., 2013). Counterbalancing cations present within the interlayer space of 
2:1 clay minerals allow the phyllosilicate layers to form stacks, and therefore particles. 
They increase the size of the interlayer space, which has been reported as 10Å (Konta, 
1995). It is also important to note that these interlayer cations may be either hydrated 
or dehydrated, dependant on the clay mineral, its surrounding environment, and the 
nature of the cations themselves. Cations with a hydrated shell, such as Na+ and Ca+, 
can take up more space and have been shown to increase the interlayer space 
between phyllosilicate layers to 15Å (Konta, 1995). 
 
These interlayer, counterbalancing, cations play an important role in clay mineral 
properties, having an effect on their swelling capacity and electrochemistry. It is also 
possible for these endogenous cations to be exchanged for exogenous inorganic and 
organic cations. This is known as the cation exchange capacity (CEC) of clay minerals 
and is quantified as milliequivilents per unit mass of clay mineral (generally mEq/100g).  
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Figure 1.3. Artistic representation of the layer arrangement within a 1:1 clay mineral particle (A) and a 
2:1 clay mineral particle (B). The magnifications demonstrate the differences in interlayer space 
between these clay mineral species, with the teal circles representing the counterbalancing cations 
within the 2:1 clay mineral interlayer space. 
 
One species of 2:1 clay mineral that has a slightly different interlayer chemistry are the 
chlorites. Instead of having individual inorganic cations to balance the negative surface 
charge of the phyllosilicate layer, the chlorites have a single octahedral metal 
hydroxide sheet within the interlayer space, which counterbalances the phyllosilicate 
layer charge (Konta, 1995). The metal within this hydroxide sheet is generally 
magnesium. Because of this unique structure chlorites are sometimes defined as 2:1:1 
clay minerals. 
 
It is also possible to obtain clay minerals that contain a mixture of phyllosilicate layers, 
which are termed interstratified clay minerals, and are common in nature (Drits, 2003). 
These interstratified minerals may contain mixtures of just 2:1 layers, or may contain 
(A) (B) 
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mixtures of 1:1 and 2:1 layers. One example is the 1-1 montmorillonite-kaolinite 
interstratified clay mineral, which contains equal proportions of montmorillonite (2:1) 
layers and kaolinite (1:1) layers (Plancon, 2001). As can be expected, differing 
proportions of each clay mineral are possible and their distribution throughout the 
mineral may not be uniform – all of which can affect the properties of an interstratified 
clay (Drits, 2003). 
 
As figure 1.4 shows, phyllosilicate particles (of both 1:1 and 2:1 clay minerals) are able 
to associate with other phyllosilicate particles to form aggregates. Dependant on the 
arrangement of these particles it is possible for small interparticulate spaces to be 
formed. More particles may interact with these aggregates and, in turn, aggregates 
can associate with each other to form an assembly of aggregates resulting in visible 
particles that can be seen with the naked eye.  
 
 
 
Figure 1.4. Artistic representation of how individual phyllosilicate layers come together to form particles, 
which further associate to form aggregates and then assemblies. 
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Larger gaps can occur between these associated aggregates to form interaggregate 
spaces, which are more commonly known as pores. It is possible to break up these 
assemblies into smaller aggregates through milling and sieving; a process regularly 
used by clay scientists to obtain particle sizes smaller than 2 m for further 
characterisation. 
 
The phyllosilicate sheet and layer structures are crystalline in nature, and this often 
leads to them being termed as microcrystalline minerals. This crystallinity and the 
relative regularity of layer stacking within a particle, leads to indicative peaks on an X-
ray diffractogram (XRD). However, as shown in figure 1.4, the subsequent association 
of these particles into aggregates is often random, leading to an overall irregular 
structure. Whilst peaks present on XRD diffractograms can be used to determine layer 
type and interlayer spacing, these peaks are not representative of a fully crystalline 
material, and indeed produce diffractograms reminiscent of amorphous materials. 
 
1.2.3. Behaviour in dispersion 
The behaviour of clay minerals in aqueous environments has intrigued scientists for 
generations and has been the main drawing point for their use across history. 
Regardless of their structure, all clay minerals are considered hydrophilic. 
 
The 1:1 clay minerals, due to the way their layers interact, do not swell readily and 
therefore do not disperse fully. For this reason their surface area is restricted to the 
outside of the particles. This lack of dispersion also means that 1:1 clay mineral 
particles will quickly sediment out of dilute dispersions without continuous agitation. 
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Fibrous and modulated clay minerals swell but not in the same way as the layered 2:1 
particles because of a reduced reliance on the interlayer cations. In aqueous 
dispersions the fibrous clays interact with each other and form tangles to create a 
complex matrix with interspersed water. This behaviour allows the modulated clay 
minerals to swell to some extent and also create viscous gels. In general, it is the 
layered 2:1 clay minerals that have received the greatest interest from research teams, 
and it is also these clays that demonstrate the most interesting, and complex, 
chemistry in aqueous environments. 
 
Swelling is often initiated through the direct interaction of the clay mineral surface and 
water molecules and also the interaction between the counterbalancing cations and 
water molecules (Hensen and Smit, 2002; Paineau et al., 2011a). Due to the nature of 
the charge distribution across the phyllosilicate layer the adsorption of water onto the 
surface of the clay is highly regular and many of the free-flowing, liquid, properties of 
water are diminished. The interlayer cations also form a hydration shell around 
themselves, thus increasing their overall diameter and the size of the space between 
the phyllosilicate layers. Once this initial process has been completed additional water 
molecules are recruited to the clay mineral surfaces and into the interlayer space, but 
in a less ordered fashion. Indeed, the regularity imposed on the water molecules, by 
the phyllosilicate layers and the counterbalance cations, diminishes the further away 
the water molecules are from these components. These two very different processes 
have led to the swelling of 2:1 clay minerals being described as proceeding with two 
different phases. The first is the crystalline swelling phase, relating to the ordered 
recruitment of water molecules, and the second as osmotic swelling, which relates to 
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the less restrictive recruitment of water molecules by the clay mineral (Hensen and 
Smit, 2002). 
 
Swelling of 2:1 clay minerals exposes their internal surfaces and has a great effect on 
the overall surface area of the clay minerals. Expansion of the clay mineral interlayer 
space allows for the high aspect ratio of the phyllosilicate layers to be fully appreciated 
and minerals such as montmorillonite can display a surface area in the region of 500-
700 m2/g (Chen et al., 1999; Kahr and Madsen, 1995).  
 
The crystal and osmotic swelling phases are also important determinants of the 
electrochemical environment at the clay mineral surface in dispersion. The negatively 
charged surface of the phyllosilicate layer allows for the attraction of positive ions 
towards the surface, including counterbalancing cations and protons (H+) from the 
aqueous environment. This concentration of cations at the surface of the clay mineral 
is often referred to as the stern layer. This is accompanied by a decreasing cation 
concentration gradient as the distance from the phyllosilicate surface increases. This 
phenomenon is often described as the diffuse double layer theory. 
 
However, the concentration of cations at the clay mineral surface does not make it 
impervious to the effects of protons. If the pH of the dispersion is decreased so that it 
is highly acidic (pH < 2) the protons can actually attack the phyllosilicate structure. The 
H+ ions are able to infiltrate the octahedral sheet and hydrolyse the metal-oxide bonds 
present, thus causing dissolution of the metal cations from the octahedral sheet into 
the surrounding environment (Pentrák et al., 2012; Tyagi et al., 2006). Progressive 
Chapter 1                      Introduction 
 
Page 16 of 260 
dissolution of the octahedral layer can result in an amorphous silica sheet as the 
remaining product (Pentrák et al., 2012). 
 
The negatively charged surfaces, the positively charged edges, the diffuse double layer, 
interlayer friction and van der Waals forces all play important roles in how clay 
minerals behave in aqueous dispersions. As the dispersion becomes more dilute the 
osmotic swelling of the clay mineral layers continues until the layers are so far apart 
(greater than 4 nm) they dissociate from each other, a process often called exfoliation.  
 
Initially, swelling clays can form gels as the interactions between the layers are still 
strong enough for a weak structure to be created. This can be achieved through face-
to-edge, face-to-face and edge-to-edge interactions between the clay mineral layers. It 
can also be achieved through a balance between the attractive effects of van der 
Waals forces and the repulsive effects of the diffuse double layer (Paineau et al., 
2011a). Face-to-edge interactions have been recognised as the most likely interactions 
in place when clay minerals form gel-like dispersions at neutral pH. A large network of 
face-to-edge interactions can form a 3D matrix which is referred to in the literature as 
the house of cards formation (Mongondry et al., 2005; Paineau et al., 2011a). These 
gels are often stable for long periods. An interesting, and attractive, property of gels 
formed from 2:1 clays is they often show non-Newtonian flow properties; so that 
when shaken the kinetic energy provided is great enough for the structure of the gel to 
break down and form a free flowing dispersion. Once energy is removed (shaking is 
stopped) the phyllosilicate layers will re-associate and the gel will be reformed as a 
product of time (Carretero and Pozo, 2009; Lopez-Galindo et al., 2007). 
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As the dispersion becomes even more dilute the repulsive forces between the 
phyllosilicate layers (driven by the diffuse double layer) prevent the layers from 
interacting with each other and instead of forming a gel they form a disperse sol 
(Carretero and Pozo, 2009). When phyllosilicate layers exfoliate and disperse in this 
manner they remain in a colloidal dispersion due to thermodynamic balance (Lagaly 
and Ziesmer, 2003).  
 
1.2.4. Interaction with charged molecules 
The presence of permanent and variable charges across the phyllosilicate makes for 
interesting interactions with charged molecules when in dispersion. One of the most 
commonly reported processes involves the interlayer cations and their exchange with 
other cations. For example, a montmorillonite with Na+ as its interlayer cation may 
exchange these sodium cations for other inorganic cations such as Ca2+, Mg2+, Cu2+, 
Zn2+, Ag+, etc. (Swartzen-Allen and Matijevic, 1974; Top and Ülkü, 2004). However, the 
cation exchange process is not only limited to inorganic cations but may also occur if 
organic cations are present within the dispersion (Swartzen-Allen and Matijevic, 1974). 
 
Small organic molecules (including drug molecules) that bear a positive charge are able 
to interact well with the clay mineral surfaces and displace the interlayer cations 
(Chang et al., 2009). It is well documented that clay minerals within soils are able to 
adsorb antibacterial agents from the environment (Figueroa-Diva et al., 2010; Figueroa 
et al., 2004; Kulshrestha et al., 2004). A number of research teams have also reported 
the interaction between clay minerals and amino acids, how this may facilitate their 
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functionality and reactivity (Greenland et al., 1965), and may even have contributed to 
the creation of life on Earth (Brack, 2013). 
 
When cations and cationic molecules interact with the clay mineral surfaces they can 
cause the stern layer to become compressed towards the clay mineral surface. This 
causes the depth of the stern layer, and thus the size of the diffuse double layer, to 
reduce in size. Increased adsorption of cations will eventually lead to the repulsive 
forces produced by the diffuse double layer being smaller than the attractive forces 
brought around by van der Waals forces and inter-layer friction. Once this occurs the 
clay mineral layers attract each other, associate with each other and coagulate within 
the dispersion (Lagaly and Ziesmer, 2003; Swartzen-Allen and Matijevic, 1974). This 
phenomenon is often called the flocculation-point and refers to the cation 
concentration required to cause the clay mineral to overcome thermodynamic stability 
and flocculate out of dispersion. Cations of higher charge have more profound effects 
upon the diffuse double layer and this can be related directly to valance. For example, 
much more Na+ than Ca2+ is needed to flocculate a clay mineral, whereas less Al3+ than 
Ca2+ is needed to flocculate a clay mineral (Lagaly and Dekany, 2013; Swartzen-Allen 
and Matijevic, 1974).  
 
Anionic components also play an important role within clay mineral dispersions, which 
are able to adsorb onto the edges of clay mineral layers. Adsorption of anions onto 
these side groups can result in an overall negative charge across the clay mineral layer, 
thus leading to an increasingly stabilised colloidal dispersion (Lagaly and Ziesmer, 2003; 
Swartzen-Allen and Matijevic, 1974). Anions are also able to interact with the 
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interlayer counterbalancing cations and these contribute to the diffuse double layer 
(Swartzen-Allen and Matijevic, 1974).  
 
It is not just small organic molecules that are able to interact with the clay mineral 
surfaces, as charged groups belonging to larger constructs may also interact with the 
clay mineral surface. For example, clay minerals are able to adsorb proteins onto their 
surfaces (Cai et al., 2006; Cengiz et al., 2012; Greenland et al., 1965), and may 
themselves become adsorbed onto the surface of bacterial cells where they may 
immobilise and inhibit bacterial growth, or indeed enhance the growth of the cells to 
which they are adsorbed (Rong et al., 2008; Williams et al., 2011; Zhao et al., 2012; 
Zhou et al., 2010). As well as cellular proteins clay minerals are able to adsorb free 
moving proteins from dispersions including toxins, enzymes, and waste materials 
(Carretero, 2002; Deng et al., 2010; Sandri et al., 2016). 
 
1.3. Modifying clay minerals 
Section 1.2 discussed how clay mineral layers behave in dispersion, what natural 
phenomena change the structure, chemistry, and colloidal behaviour of the clay 
mineral layers, and also what other components within the dispersion can interact 
with the clay mineral layers. With knowledge of how these natural phenomena can 
affect clay minerals it is possible to purposefully make modifications to clay minerals 
for a wide number of applications.  
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1.3.1. Acid activation 
In section 1.2.3 it was noted that high concentrations of H+ within dispersion can have 
detrimental effects on the phyllosilicate layers through dissolution of the octahedral 
sheet. The resultant material is, in general, an amorphous silica sheet (Madejova, 2003) 
but these sheets also display considerable and complex distribution of Brønsted acid 
sites (Komadel, 2003). A number of industrial uses have been found for these acid 
activated clays, including use as catalysts and catalyst supports (Komadel, 2003; 
Pentrák et al., 2012; Tyagi et al., 2006). 
 
The interest in using acidified phyllosilicates as catalysts caused chemists to develop 
methods to control the acid activation process. There are a number of reported 
methods for acid activating clay minerals, and the most frequent mineral chosen is 
montmorillonite (Zhao et al., 2013). During this process the clay particles do not fully 
swell and therefore the dissolution of the particle occurs from the outside surfaces 
inwards. This causes swelling and distortion of the edges of the layers, which can 
inhibit further swelling of the clay mineral particles. A number of acid activated 
montmorillonites have been developed for various industrial applications, with the 
“Montmorillonite K-n” series (where n is 10, 20, 30 or 40) of materials being one of the 
most commonly used (Zhao et al., 2013).  
 
1.3.2. Modification with organic compounds 
Due to their chemistry clay minerals are highly hydrophilic, allowing them to wet easily 
and form stable dispersions and suspensions without the need of additives. However, 
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this makes the interaction between clay mineral particles and lipophilic molecules 
difficult. 
 
In recent years much research has been published focusing on modifying clay minerals 
to ensure they become lipophilic. The most common method for achieving this is 
exploiting the natural cationic exchange properties of clay minerals by replacing the 
endogenous counterbalancing cations with cationic alkylammonium molecules. The 
ammonium component of these molecules adsorbs onto to the phyllosilicate surface, 
presenting the alkyl chain outwards from the clay mineral surface. These materials 
have thusly been referred to as organoclays. The lipophilic layer on the organoclay is 
able to interact better with organic solvents, and can also enhance the adsorptive 
capacity for other organic molecules including drugs (da Silva et al., 2013; Lee and Kim, 
2002; Murray, 2000; Önal and Sarıkaya, 2008).  
 
Aside from this, interactions between clay minerals and organic molecules are well 
documented across the literature. The adsorption of cationic dyes onto the clay 
mineral surface has been investigated for a number of years and has been a key 
method to determine the true specific surface area (SSA) of clay minerals when in 
dispersion. Methylene blue, for example, is able to freely interact with clay mineral 
surfaces and a number of experimental methods have utilised this process to 
determine the CEC, SSA and charge of many clay minerals (Chen et al., 1999; Hajjaji 
and El Arfaoui, 2009; Poli et al., 2008; Yukselen and Kaya, 2008). 
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Not long after the interaction between clay minerals and dyes had been investigated, a 
small number of researchers became interested in the interaction between clay 
minerals and common antimicrobial compounds. This interest was originally borne 
from wanting to understand how more complex organic molecules interact with 
phyllosilicate surfaces, and also determine the true fate of antimicrobials within soils 
(McGinity and Lach, 1976; Sassman and Lee, 2005; White and Hem, 1983).  
 
1.3.3. Modification with inorganic cations 
The process of inorganic cationic exchange has been tailored for a number of 
applications. This process happens naturally between the counterbalancing cations at 
the phyllosilicate surface and those in the surrounding dispersion. Research teams 
have manipulated this process by using high concentrations of inorganic cations within 
the dispersion to drive adsorption of the desired elements onto the clay mineral 
surface (Swartzen-Allen and Matijevic, 1974; Top and Ülkü, 2004) . 
 
These metal-exchanged clays have been formulated to contain a wide number of 
different elements such as calcium, magnesium, iron, copper, zinc, and silver. Each 
element interacts with the clay mineral surface in a different way and these 
differences have been attributed to the atomic charge and radius. Valence of the 
cations has shown to be one of the most important variables that effects adsorption 
onto the mineral surface (Bhattacharyya and Sen Gupta, 2006; Bonferoni et al., 2007; 
Browne et al., 1980; Girase et al., 2011; Malachová et al., 2011; Özdemir et al., 2010; 
Tong et al., 2005; Zhou et al., 2004). 
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Copper- and silver-exchanged clay minerals have received additional interest for their 
use as antimicrobial agents (Girase et al., 2011; Hu and Xia, 2006; Malachová et al., 
2011; Tong et al., 2005). Much of the antimicrobial killing power of these composites 
has been attributed to the presence, and release, of the exchanged metal ions. Silver 
has been used in the treatment of skin and skin structure infections for many years 
and is incorporated into a number of wound-care products used in current clinical 
practice (Aziz et al., 2012; Bergin and Wraight, 2006; RPS and BMJ, 2017). Copper has 
also received much interest within healthcare research as a possible antimicrobial 
material that could help keep hospitals cleaner and safer (Gorman and Humphreys, 
2012). However, recently published evidence also suggests that the clay mineral itself 
plays a large role in the antimicrobial properties of these metal-exchanged clay mineral 
composites. It is has been shown that the clay mineral is able to adsorb onto the cell 
surface, immobilising the bacterial cell and thus increasing the contact time of the 
metal ions on its surface (Haydel et al., 2008; Williams et al., 2011) 
 
1.3.4. Modification with inorganic anions 
Much of the research laid out above describes the interaction between clay mineral 
surfaces and various cations. However, the positively charged groups at the edge of 
phyllosilicate layers are also key targets for modification. These positive edges are 
thought to be key players in the formation of gels and contribute to the coagulation 
and flocculation of clay mineral dispersions. Thus, changing these edges to be 
negatively charged will alter their colloidal properties (Swartzen-Allen and Matijevic, 
1974). 
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Sodium phosphate, for example, will dissociate in solution and this allows for the 
phosphate ion to interact with the edges of the phyllosilicate layers. This interaction is 
very different to those that occur at the phyllosilicate surface and is known as a ligand-
exchange process whereby the hydroxyls from the exposed silanol and metal-
hydroxide groups are replaced with phosphate (Lagaly and Ziesmer, 2003). This creates 
a permanent negative charge on the edges, which increases the repulsive tendencies 
in edge-to-face interactions and thus increases the colloidal stability of more 
concentrated clay dispersions. For example, Laponite® RD will form gels at around 3% 
w/v yet Laponite® RDS (sol grade) can easily achieve concentrations of 10% w/v due to 
the effects of the pyrophosphate groups at its edges (BYK Additives & Instruments, 
2013; Rockwood Additives, 2012). 
 
1.4. A clinical need for improved antimicrobial stewardship 
Since the dawn of the 20th Century medical and surgical practices have been enhanced 
and made safer through the use of antibacterial agents. Originating with penicillin a 
variety of molecules are now available for a wide range of indications. However, even 
upon receiving his Nobel Prize in Medicine for isolating penicillin, Alexander Fleming, 
warned about the development of protective mechanisms and the future of resistant 
organisms (Fleming, 1945; Fraise, 2006). 
 
Regardless of this, healthcare practitioners are still being accused to this day of poor 
prescribing practises when it comes to antibacterial agents (Anon, 2015; Lawrence, 
2014; Torjesen, 2014). In order to overcome the resistance of organisms against β-
lactam antibacterials (e.g. penicillins and cephalosporins) a number of β-lactamase 
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inhibitors have been developed, such as tazobactam, which are commonly co-
formulated with penicillins, such as piperacillin (Tazocin®, piperacillin-tazobactam) 
(Fast and Sutton, 2013; Liscio et al., 2015; Pfizer Ltd, 2013). However, bacterial cells are 
able to deploy a number of tactics to build resistance to antibacterial agents, such as 
efflux proteins and protective enzymes. Alongside this, acquired resistance can occur 
through the genetic mutations that occur with each generation or through the sharing 
of genetic material between bacterial strains, and even species (Davies, 2013; Jones, 
1999). 
 
Over the course of the 20th Century the pharmaceutical industry and academic 
scientists developed a number of key classes of antibacterial agents. Some are based 
upon the central β-lactam structure found in penicillin, such as the cephalosporins and 
carbapenems. Others are based on completely different structures such as the 
tetracyclines, the quinolones, the macrolides and the aminoglycosides. A number of 
potent antibacterial agents have much more complex structures and are often 
manufactured using biological means, vancomycin is a key example of this (Patrick, 
2005). 
 
Even this wide-ranging arsenal of antimicrobial molecules has not been able to 
overcome the problems caused by bacterial resistance. Widespread resistance is now 
seen across the penicillin class of antibacterials, and increasing concern is being voiced 
about organisms that are also resistant to vancomycin, macrolides and carbapenems 
(Davies, 2013; World Health Organization, 2014, 2012). Healthcare professionals are 
becoming increasingly aware of the need to treat infections correctly as a failure to do 
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so can result in the pathogen becoming resistant not only to the drug being used, but 
possibly to other antibacterial agents (Costelloe et al., 2010; Public Health England, 
2015; RCP HAIWP, 2011). For example, it is now well known that failure to destroy 
certain bacterial strains with erythromycin may also induce resistance to clindamycin 
(Nathwani et al., 2008; Stevens, 2009).  
 
Since the turn of the 21st Century the emphasis on managing antibacterial resistance 
has become more prominent and much focus has been paid to multiple-drug-resistant, 
and highly virulent, strains such as methicillin resistant Staphylococcus aureus (MRSA), 
Clostridium difficile (often referred to as C diff), and multiple-drug-resistant 
Mycobacterium tuberculosis (MDR-TB) (World Health Organization, 2014, 2012). 
Hospitals in the UK, and indeed worldwide, have deployed a number of stewardship 
programmes to prevent the development and spread of resistant bacterial strains. 
Infection control procedures such as rigorous hand washing, alcohol gels, and isolation 
rooms are now embedded in everyday practice, and enforced by specialist clinicians. In 
addition to this, medical microbiologists and specialist pharmacists work together to 
develop antimicrobial prescribing guidelines specific to each hospital (Davies, 2013). By 
utilising knowledge of microbiology, pharmacology, infection aetiology, and local 
resistance trends these guidelines are designed to inform prescribing decisions for a 
wide range of infections giving restricted prescribing options based on disease severity 
and patient demographics. All of these efforts combine into what is commonly termed 
‘antimicrobial stewardship’ (Davies, 2013; Public Health England, 2015). 
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However, is it only a matter of time before bacteria overcome these defence 
programmes and develop resistance against the second- and third-line choice of 
antimicrobial agents. Indeed, we are already seeing this happen. In response to this 
the Department of Health’s (DH, part of UK Government) Chief Medical Officer 
published a hard-hitting report into antimicrobial prescribing and resistance, and set 
out a number of suggestions and challenges for the future (Davies, 2013). Around the 
same time, the World Health Organisation (WHO) published its vision for the future of 
antimicrobial stewardship (World Health Organization, 2012), setting out the six 
overarching policy statements shown in figure 1.5. 
 
Figure 1.5. The six overarching policy statements developed by the WHO in 2011 aiming to 
tackle global antimicrobial drug-resistance (World Health Organization, 2012). 
 
Policy statement six concerns the discovery and development of novel antimicrobial 
molecules, which are vital for overcoming resistance to currently available molecules. 
However, it is realised that there are very few novel antibacterial molecules in the 
2011 World Health Day six point policy brief: 
1. Commit to a comprehensive, financed national plan with 
accountability and civil society engagement. 
2. Strengthen surveillance and laboratory capacity. 
3. Ensure uninterrupted access to essential medicines of assured 
quality. 
4. Regulate and promote rational use of medicines including in 
animal husbandry, and ensure proper patient care. 
5. Enhance infection prevention and control. 
6. Foster innovations and research and development for new tools. 
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current research pipelines and it was therefore emphasised that researchers and 
clinicians should also focus on new technologies for delivering, targeting and utilising 
the drugs we already have. This sentiment has also been echoed by the Royal 
Pharmaceutical Society’s Pharmaceutical Science Expert Advisory Panel, which wanted 
to see both new technologies and molecules being developed and such developments 
being incentivised by Government (Royal Pharmaceutical Society, 2014).  
 
In relation to this, there are a number of infections that benefit from topical and 
systemic treatment options, including certain eye and respiratory infections. However, 
problems in achieving efficient drug delivery have hampered the application of locally 
targeted medicines for wound and skin and skin structure infections. For this reason, 
within the UK, very few topical antibacterial formulations are available for use in the 
NHS (National Health Service) due to lack of evidence on effectiveness and patient 
outcomes (Healy and Freedman, 2006; Scottish Intercollegiate Guidelines Network, 
2010; Siddiqui and Bernstein, 2010).  
 
Metronidazole and fusidic acid are available, and often used, but only for strict 
indications. Metronidazole gel is utilised in the treatment of malodorous fungating 
wounds where the causative organism is believed to be an anaerobe (Galderma, 2013). 
Fusidic acid cream is only utilised for mild skin infections caused by aerobic bacteria, 
such as Staphylococcus aureus induced folliculitis (Leo Laboratories Ltd, 2013). 
However, should clinical assessment judge these infections as anything other than mild 
it is often necessary to prescribe a systemic antibacterial agent. This is done to treat 
the infection and prevent what is considered a superficial infection developing into a 
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deep-seated, and potentially fatal, sepsis. This comes at not only a financial price but 
also a clinical price for the patient who may experience a number of adverse effects. 
Systemic treatment with antimicrobials has also been linked to the development of 
infections by Clostridium difficile and other resistant bacteria (Cheer et al., 2009; Healy 
and Freedman, 2006; Kluytmans and Struelens, 2009). 
 
1.5. Aim and objectives of this research project 
It is clear that the development of new formulations for the treatment of infected 
wounds should be a priority for pharmaceutical science research. However, as 
highlighted by the Royal Pharmaceutical Society’s report New Medicines, Better 
Medicines, Better use of medicines the pharmaceutical industry currently has few 
incentives to develop drugs and formulations for such conditions (Royal 
Pharmaceutical Society, 2014). 
 
Clay minerals have been used in the treatment of wounds for hundreds of years and 
their unique chemistry may be utilised in other ways. The complex chemistry of clay 
minerals may enable their use as novel drug-carriers, novel excipients, and as material 
modifiers (Aguzzi et al., 2007; Gomes and Silva, 2007; Lopez-Galindo et al., 2007; 
Viseras et al., 2010). It is exciting that these characteristics could also be used to 
benefit the wound healing process, including the adsorption of wound exudates and 
waste (Dannenfeldt, 2012; Dawson and Oreffo, 2013; Williams et al., 2011). The 
interaction between clay minerals and organic materials such as drugs and polymers 
has been reported across the literature with increasing focus on utilising these 
phyllosilicate-based materials for drug-delivery (Rodrigues et al., 2013). Unfortunately, 
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many of those who have considered using clay minerals for drug-delivery purposes 
have had little clinical input, and therefore little potential clinical impact.  
 
The aim of this project was to develop and evaluate novel antibacterial polymer-
phyllosilicate composite systems for the treatment of infected wounds. The specific 
objectives to address this aim were: 
1. To understand and model the interaction between clay minerals and carefully 
selected antibacterial drugs. 
2. To determine the best conditions and parameters for the development of clay-
drug composites. 
3. To develop candidate antibacterial wound dressing materials utilising 
phyllosilicate materials as a key component. 
4. To evaluate the physical and chemical properties of these candidate materials 
and determine their clinical potential for the management of infected wounds. 
5. To determine the antimicrobial properties of the clay-drug composites and the 
candidate materials. 
 
To ensure scientific and clinical rigour within this project a collaboration was 
developed between academics at the School of Pharmacy and Biomolecular Sciences 
at Liverpool John Moores University (Liverpool, UK), clay mineral scientists at BYK 
Additives Ltd. (Widnes, UK; formerly Rockwood Additives Ltd.), and the nurse-led 
tissue viability team at the Royal Liverpool and Broadgreen University Hospitals NHS 
Foundation Trust (Liverpool, UK).  
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The research presented within this thesis aims to lay the foundations of further 
research into the development of novel phyllosilicate-containing antimicrobial wound 
dressings. In essence, this work acts as a pathfinder project that builds on current 
knowledge, develops new knowledge, and shows the potential application of polymer-
phyllosilicate composite systems within wound care. Chapter 2 investigates the 
interaction between selected clay minerals and tetracycline antibacterial agents; 
establishing what influences the interaction between these compounds and 
determining their antibacterial effects. Chapter 3 applies the knowledge developed in 
chapter 2 to a different antibacterial agent; ciprofloxacin. Finally, Chapter 4 utilises the 
clay-ciprofloxacin composites established in chapter 3 in the development and 
evaluation of candidate materials for the treatment of infected wounds. 
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Chapter 2 
Interaction between phyllosilicates and tetracycline 
antibacterial agents 
 
2.1. Introduction 
The tetracycline class of antibacterial agents is one of the oldest classes after the 
penicillins, with chlortetracycline being isolated as a natural compound in the late 
1940s (Griffin et al., 2010; Varanda et al., 2006). Since this, and the realisation that 
chlortetracycline activity could be modified and enhanced, a number of tetracycline 
molecules have been developed and launched to the market including tetracycline, 
doxycycline, oxytetracycline and minocycline (RPS and BMJ, 2017). Whilst no official 
additions have been made to this class for a number of years it cannot be denied that 
tigecycline, founding member of the glycylcycline class of antibacterial compounds 
designed to overcome resistance against tratracyclines (Fraise, 2006; Grolman, 2007), 
is a further modification of the tetracycline structure.  
 
The chemistry of tetracycline antibacterial agents is highly complex and they can 
undergo a number of reactions in aqueous solution. As shown in figure 2.1 agents 
within this class have a number of groups which are able to undergo protonation or 
deprotonation. The pKa values of doxycycline and tetracycline are very similar, due to 
their similar structure. Minocycline has an additional pKa value due to a second 
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dimethyl-amino group. These acid dissociation constants mean these molecules will 
present a charge at all pH ranges (Sassman and Lee, 2005).  
 
 
 
 
Tetracycline 
pKa1: 3.32 (±0.30)
a,b
, pKa2: 7.78 (±0.05)
a,b
, pKa3: 
9.58 (±0.30)
a,b
 
 
Doxycycline 
pKa1: 3.02 (±0.30)
a
, pKa2: 7.97 (±0.15)
a
, pKa3: 9.15 
(±0.30)
a
 
 
 
 
Minocycline 
pKa1: 2.80
c,d
, pKa2: 5.00
c,d
, pKa3: 7.80
c,d
, pKa4: 
9.50
c,d
 
 
 
 
Tigecycline 
pKa1: 2.80
e
, pKa2: 4.40
e
, pKa3: 7.40
e
, pKa4: 8.90
e
, pKa5: 
9.50
e
 
 
Figure 2.1. Chemical structures (drawn with Chemdraw Chem3D, Perkin Elmer) and related pKa 
constants for tetracycline, doxycycline, minocycline and tigecycline. Acid dissociation constants were 
obtained from the following resources: 
a
 pKa values from Qiang and Adams (2004); 
b
 pKa values from 
Clarkes Analysis of Drugs – Doxycycline (2017); 
c
 pKa values from Clarkes Analysis of Drugs – Minocycline 
(2017); 
d
 Heel RC, Avery GS, in Avery GS (ed.) : Drug Treatment, ed. 2, p. 1212- 1222, Sidney, ADIS, 1980; 
e
 pKa values from Center for Drug Evaluation and Research (2005). 
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The central ring structure allows for the formation of partially conjugated systems and 
the delocalisation of electrons across various parts of the molecule (Sarmah et al., 
2006). Upon deprotonation the resultant negative charge is not fixed to one sole atom 
or group, but can be spread across a number of conjugated atoms and groups (Leeson 
et al., 1963). On one side of the molecule (presented at the top of the molecules in 
figure 2.1) there are a large number of hydroxyl and oxygen groups, which generate a 
negative charge on this region of the molecule. This negative charge is able to attract 
and coordinate with inorganic cations such as calcium, iron, and magnesium ions in 
solution (Jin et al., 2007; Parolo et al., 2010). In turn, this can significantly alter the 
clinical efficacy of these drugs (Griffin et al., 2010).  
 
The tetracycline antibacterial molecules inhibit the development, growth and division 
of bacterial cells through interaction with the 30S subunit of the bacterial ribosome, 
thus causing inhibition and cessation of protein manufacture (Grassi, 1993; Griffin et 
al., 2010). Tetracyclines show activity against both Gram-negative and Gram-positive 
bacteria (Grassi, 1993) but are much more active against Gram-positive bacteria. Their 
chemistry makes them particularly soluble in acidic environments, meaning they still 
maintain their bioavailability when taken orally, and are able to achieve good 
penetration and effective concentrations across many tissues (Grassi, 1993). Their 
wide distribution throughout body tissues, and their broad spectrum antibacterial 
activity, makes these agents useful in the treatment of skin and skin structure 
infections (Dawson and Dellavalle, 2013; Perkins and Heard, 1999; Sandwell and West 
Birmingham Hospitals NHS Trust, 2011; Seaton, 2009; Smith, 2004; Stevens, 2009; The 
Royal Liverpool and Broadgreen University Hospitals NHS Trust, 2012; Unal, 2009a). In 
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addition to active antibacterial treatment, doxycycline is commonly used for malaria 
prophylaxis (Giovagnoli et al., 2010). More recently, the activity of the tetracyclines 
has also been investigated as a possible treatment option for arthritic disease 
(Greenwald, 2011; Griffin et al., 2010), chronic airway disease (Griffin et al., 2010; Joks 
and Durkin, 2011; Raza et al., 2006), and even Alzheimer’s dementia (Costa et al., 2011; 
Griffin et al., 2010). 
 
As mentioned in section 1.4, mismanagement of antibacterial agents has led to the 
development of resistant bacteria and problematic infections. The tetracycline class of 
drugs has been increasingly afflicted by such resistance (Griffin et al., 2010; Varanda et 
al., 2006) thus the development of new, topical, delivery systems for the treatment of 
wound, skin and skin structure infections could avoid resistance developing within 
microbiota located in other parts of the body. The development of a topical delivery 
system for tetracyclines should also reduce the precautions and side effects that need 
to be considered when prescribing these agents. For example, patients would no 
longer need to avoid ingesting milk or other polyvalent metallic cation containing 
products (RPS and BMJ, 2017). It would also be possible to reduce the overall dose 
required to treat wound, skin and skin structure infections by using topical 
formulations, and thus systemic absorption would also be reduced. In turn, this will 
reduce the incidence of general adverse effects such as nausea and vomiting, and 
more specific adverse effects such as hepatic impairment and antibiotic-associated-
diarrhoea from organisms like Clostridium difficile (RPS and BMJ, 2017; Tsankov et al., 
2003). 
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The interactions between tetracycline and clay minerals have previously been 
investigated by a number of researchers in the second half of the twentieth century. 
However, much of this research focused only on the qualitative and quantitative 
analysis of such interactions (Aguzzi et al., 2005; Figueroa et al., 2004; Li et al., 2010; 
Pils and Laird, 2007; Porubcan et al., 1978) and the results used to speculate the fate of 
tetracyclines in soil (Pils and Laird, 2007; Sarmah et al., 2006; Sassman and Lee, 2005). 
More recently this has spurred research teams to determine the applicability of clay 
minerals as adsorbent materials for antibacterial agents in hospital and veterinary 
effluent (Chang et al., 2009a, 2009c).  
 
An increasing body of research (Rodrigues et al., 2013; Viseras et al., 2010) is being 
published on the subject of using clay-minerals to deliver a wide-range of drugs such as 
donepezil (Park et al., 2008), chlorhexidine (Samlíková et al., 2017), ciprofloxacin 
(Hamilton et al., 2014), clindamycin (Porubcan et al., 1978), gentamicin (Rapacz-kmita 
et al., 2017), hydralazine (Sánchez-Martín et al., 1988), ibuprofen (Tan et al., 2014), 
itraconazole (Jung et al., 2008), and ofloxacin (Wang et al., 2014), amongst others. 
However, very little research has looked at utilising phyllosilicate materials as drug-
carriers for tetracycline molecules with the aim of developing novel drug-delivery 
materials (Parolo et al., 2010).  
 
In this chapter the interaction between tetracycline and doxycycline with a range of 
clay minerals will be investigated. The natural clays kaolin, montmorillonite, and the 
latter’s acid activated counterpart, montmorillonite K-10, alongside two synthetic clay 
minerals Laponite® RD and Laponite® XL21, were selected for this work. A more 
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detailed overview of the structure and chemistry of these clay minerals is given in 
section 1.2. Tetracycline and doxycycline have similar structures (figure 2.1) and acid 
dissociation constants. Investigating the adsorption of these drugs onto clay minerals 
will allow the effects of the clay mineral structure and the dispersion environment to 
be characterised. The adsorption kinetics and isotherms are reported here, alongside 
analysis of the interactions between tetracycline and doxycycline and the 
phyllosilicates.   
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2.2. Materials and methods 
2.2.1. Materials 
Kaolin (KN) [empirical formula: Al2Si2O8·H2O (PubChem, 2016)], washed and sieved, 
was obtained from Fisher (UK); and refined montmorillonite (rMMT) [empirical 
formula: Al3.2Mg0.8Si8O20(OH)4·Na0.8 (BYK Additives & Instruments, 2013)], was donated 
by (BYK Additives & Instruments ltd., Widnes, UK). An acid activated montmorillonite, 
montmorillonite K-10 (MMTK10) [empirical formula: Al2Si4O10(OH)2.nH2O (California 
Earth Minerals Inc., 2008)] was obtained from Acros (UK). Two synthetic hectorite-like 
clays, Laponite® RD (LRD) and Laponite® XL21 (LXL21) [empirical formula for Laponite®: 
(Si8Mg5.5Li0.3O20(OH)4)
-0.7·Na+0.7 (BYK Additives & Instruments, 2014)], were donated by 
BYK Additives & Instruments Ltd. (Widnes, UK).  
 
Tetracycline hydrochloride (TC) (>98% by HPLC) was obtained from Sigma Aldrich (UK) 
and doxycycline monohydrate (DC) (>98% by HPLC) was received from Medicis 
Pharmaceutical (UK).  
 
2.2.2. Adsorption of tetracycline and doxycycline 
2.2.2.1. Effect of dispersion pH 
To determine the effect of dispersion pH on drug binding 250 mg of clay mineral was 
dispersed in 15 mL deionised water for 2 hours at 7000 rpm. To these dispersions 10 
mL of a 2.5 mg/mL solution of TC or DC was added and the pH adjusted to between 1.0 
and 12.0 with dilute HCl and NaOH. After 24 hours mixing, aliquots of the dispersions 
were centrifuged (EBA20, Hettich Zentrifugen) at 3000 rpm for 10 minutes to separate 
the clay from the supernatant. Each experiment was undertaken in triplicate. The 
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concentration of drug remaining in supernatant was determined by UV-Visible 
spectrophotometry (Genesys 10UV, Thermo Scientific) scanning wavelengths between 
200 – 400 nm and measured in triplicate. 
 
2.2.2.2. Kinetics of tetracycline and doxycycline adsorption 
Adsorption kinetics were undertaken using dispersions of 500 mg KN, 10 mg rMMT, 
100 mg MMTK10, 10 mg LRD, or 10 mg LXL21 in 90 mL deionised water. After a period 
of 2 hours the clay dispersions was adjusted to pH 2.0, pH 5.0 for TC and pH 5.5 for DC, 
and pH 11.0. Drug was dissolved in deionised water and solutions adjusted to the 
appropriate pH. The drug solution (2 mg in 10 mL) was added to the clay-mineral 
dispersion and 1 mL samples taken at regular time intervals between 0 and 60 minutes, 
then less regularly until 48 hours. The samples were filtered through 0.2 µm filters 
(Minisart, UK) and analysed by UV-Vis spectrophotometry to determine the amount of 
drug remaining in the supernatant. Due to the nano-size of LRD and LXL21 particles 
these samples were forced to flocculate with an equal volume of 10 % w/v NaCl 
solution immediately before filtration. The amount of TC and DC adsorbed over time 
was tested against the first, pseudo-first, second, and pseudo-second orders of kinetics 
to determine which model the adsorption fitted best. Each test was repeated in 
triplicate. 
 
2.2.2.3. Adsorption isotherms for tetracycline and doxycycline 
Adsorption isotherms were obtained by dispersing 250 mg clay in 15 mL deionised 
water for 2 hours. Varying concentrations of drug solution were added to the 
dispersions and a final experiment volume of 25 mL ensured. These experiments were 
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undertaken in triplicate at pH 2.0 and pH 11.0 for both TC and DC, and at pH 5.0 for TC 
and pH 5.5 for DC, to further determine the effect of pH on adsorption. Adsorption 
onto KN was allowed to take place over a 24 hour period, whilst adsorption onto the 
other clays was over a 4-hour period; allowing equilibrium to be reached as confirmed 
by the kinetics studies. Samples were filtered through 0.2 µm filters (Minisart, UK) and 
analysed with UV-Vis spectrophotometry to determine the amount of TC and DC 
remaining in the supernatant. Samples containing LRD and LXL21 were flocculated with 
an equal volume of 10 % w/v NaCl solution immediately before filtration. The amount 
of TC and DC adsorbed onto the clay minerals was tested against the Freundlich, 
Langmuir, and Temkin isotherm models to determine which model of adsorption fitted 
best.  
 
Solid clay-drug composites from the pH-effect and adsorption isotherm experiments 
were collected by centrifugation and freeze-drying (Heto FD 2.5, at -50oC) for further 
analysis. 
 
2.2.3. Mechanism of clay-tetracycline and clay-doxycycline interactions 
To determine whether TC and DC were adsorbed onto the surfaces or the interlayer 
space of the clay minerals X-Ray diffractometry (XRD) was employed. Samples were 
randomly orientated on aluminium discs and scanned between 3 and 20 deg 2θ using a 
Rigaku miniflex with a CuKα1 radiation source. Each sample was scanned five times 
and the individual scans combined to reduce noise and clarify diffractions. The 
interlayer spacing of each sample was calculated from the d001 peak using the internal 
Rigaku miniflex analysis software. 
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The interaction of specific functional groups of the TC and DC molecules with the clay 
mineral surfaces were identified using infrared spectroscopy. Fourier-Transform 
Infrared (FT-IR) analysis was undertaken on a Perkin Elmer Spectrum BX FT-IR 
spectrometer with GladiATR attachment. Thirty-two scans were run between 4000 – 
400 cm-1 with an interval of 1.0 cm-1 and a resolution of 2.0. Spectra for the antibiotics 
at varying pH were used to confirm adsorption shift(s) as a result of charge variation. 
 
2.2.4. Antibacterial activity assessment 
In order to test the antibacterial efficacy of the clay-drug composites zone of inhibition 
experiments were undertaken against Staphylococcus epidermidis (NCTC 13360), 
Propionibacterium acnes (NCTC 737), and Pseudomonas aeruginosa (NCTC 12903).  
Liquid cultures of the bacteria were grown at 37 oC to a turbidity equal to a McFarland 
0.5, which equates to a culture density of approximately 1.5x108 colony forming units 
(CFU) per millilitre (McFarland, 1907). S. epidermidis and P. aeruginosa were grown in 
aerobic conditions in nutrient broth (Oxoid), whereas P. acnes was grown 
anaerobically in brain-heart broth (Oxoid).  
 
Serial 1 in 10 dilutions of the McFarland 0.5 culture were performed and 200 L of 
each resultant culture was spread onto pre-poured nutrient agar (Oxoid) plates. After 
growing at 37 oC for 24 hours, for S. epidermidis and P. aeruginosa, and 48 hours for P. 
acnes the individual colonies were counted on the plates that did not exhibit confluent 
growth. These colony counts were used to back-calculate the CFU/mL in the starting 
McFarland 0.5 culture. For P. acnes brain-heart infusion agar was used and the plates 
were incubated under anaerobic conditions at 37 oC for 48 hours. 
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To undertake the zone of inhibition tests 1 mL of a 1 in 10 dilution of the McFarland 
0.5 culture was used to inoculate 19 mL of molten agar (appropriate to each bacterial 
strain, as indicated above). The inoculated agar was then poured into 80 mm diameter 
agar plates and allowed to set in a fridge for one hour. Wells 5 mm in diameter were 
made in the agar using a sterilised cork-borer. 
 
To demonstrate the efficacy of the unmodified drug 50 L of TC and DC solutions were 
placed into each well, at concentrations ranging between 5 g/mL and 250 g/mL. 
Dispersions of the unmodified clays at 40 mg/mL were tested in the same way. Based 
on the drug load within the clay-drug composites, 40 mg/mL dispersions of selected 
clay-drug composites were formed and 50 L of these injected into the wells. The 
plates were incubated under the appropriate conditions and the zones of inhibition 
measured with digital callipers. Each sample was tested three times and each zone of 
inhibition was measured five times. 
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2.3. Results and discussion 
2.3.1. Effects of dispersion pH on adsorption 
The pH of the dispersion was shown to have a profound effect on the adsorption of TC 
and DC onto the selected clay minerals, with the most obvious changes in adsorption 
behaviour occurring at extremes of pH. The pattern of TC adsorption (data not shown) 
onto each clay mineral over the pH spectrum were very similar to those observed for 
DC (figure 2.2), likely a result of their similar structures and locations of protonation. 
 
Both of these molecules have similar pKa values, indicating that the charge on the TC 
and DC molecule plays an important role on the adsorption onto the clay minerals. 
However, this does not fully explain the changes in TC and DC adsorption observed at 
extremes of pH. 
 
Figure 2.2. Average (mean ±SD, n=3) adsorption of doxycycline onto KN (blue triangles), MMTK10 
(purple circles), rMMT (green squares), LRD (red diamonds), and LXL21 (black crosses) under the 
influence of varying dispersion pH.  
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At a pH of 2 or less both TC and DC are in their mono-positive forms which would 
favour adsorption onto the negatively charged clay mineral surface. However, at these 
pH values a reduction in TC and DC adsorbance was observed across all clays, except 
rMMT, and there are a number of possible reasons for this. As described in section 
1.3.1, clay minerals are known to degrade in acidic solutions, causing a reduction in 
cation exchange capacity (CEC) and altering the structure of the clay mineral. This 
effect is likely the cause of the decrease in TC and DC adsorption onto LRD and LXL21, 
whose physical properties were visually observed to change as the pH was reduced 
below 2. The dispersion of LXL21 and LRD was no longer clear but became opalescent 
and more viscous; a likely effect of metal ion dissolution and remaining amorphous 
silica. A slight decrease in absorbance of TC and DC was also observed on MMTK10 but 
this cannot easily be explained by the effects of protons on the clay mineral structure, 
as this clay mineral has already been through a much more rigorous acidification 
process (Zhao et al., 2013). The increased concentration of protons in the dispersion 
may well be competing with TC and DC cations for exchange sites on the clay surface. 
It is likely that the increase in proton concentration reduced drug adsorbance by 
condensation of the Stern layer, followed by flocculation (Segad et al., 2010; Swartzen-
Allen and Matijevic, 1974), and thus limited access to the interlayer space of the 2:1 
clay minerals. 
 
When the dispersion pH is between pKa2 and pKa3 for TC and DC the dimethyl amino 
group still retains its positive charge, with the negative charges being located across 
the A ring and the high density ketone-hydroxyl system on the molecules (figure 2.1) 
(Parolo et al., 2010). The close proximity of these negative charges to the dimethyl 
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amino group will make repulsion from the clay mineral surface more likely and thus 
reduce the amount of drug adsorption. As the pH of the dispersion is increased above 
the pKa3 the dimethyl amino group deprotonates, resulting in a di-negative species 
with no positive charge (Browne et al., 1980; Chang et al., 2009b). It should also be 
noted that as the pH of the dispersion increases the charge on the edge of the clay 
mineral layers changes from positive to negative, potentially causing further repulsion 
of negatively charged drug particles (Lagaly and Ziesmer, 2003; Swartzen-Allen and 
Matijevic, 1974). The greatly reduced adsorption of TC and DC at pH 11, and no 
adsorption at all for all clays at pH 12, except for MMTK10, shows that a positive 
charge on a drug molecule is required for significant adsorption to occur onto these 
clay minerals. Indeed, the same phenomenon was reported by Porubcan et al. (1978) 
who used XRD to demonstrate diminished adsorbance at pH 11. However, the data 
reported here show MMTK10 has a higher proportion of acid sites on its surface and 
these sites may have retained a positive charge that allowed some drug adsorption to 
occur.  
 
From these data it is clear that a pH between 3.0 and 7.0 is ideal for adsorption of TC 
and DC onto clay minerals, which was also reported by Porubcan et al. (1978) and a 
number of other research groups (Figueroa et al., 2004; Parolo et al., 2013, 2010, 
2008). Indeed, when the pH favours increasing proportions of zwitterionic molecules 
(pH 5.0 for TC and 5.5 for DC) this may favour further adsorption onto the clay mineral 
surface as indicated by the increased adsorption onto KN at this pH. However, this 
phenomenon was not as clearly demonstrated for the other clay minerals tested. More 
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data are presented throughout this chapter to further investigate the effects of 
dispersion pH on TC and DC adsorption. 
 
The type of clay mineral used and the pH of the adsorption environment were shown 
to affect the amount of drug adsorbed. KN adsorbed the least drug compared to all the 
other clay minerals tested. In dispersion the KN layers are not able to dissociate from 
each other and therefore the total surface area available for adsorption is low, 
resulting in low adsorption capacity (Miranda-Trevino and Coles, 2003). This is 
compounded by the fact KN has a minimal CEC. Cation exchange has been proposed as 
the main mechanism of TC adsorption onto clay minerals (Figueroa et al., 2004; Li et al., 
2010; Parolo et al., 2013) and this is discussed further throughout this chapter. Based 
on the theory of surface area and CEC it is unsurprising that rMMT, LXL21, and LRD 
adsorbed much more drug compared to KN. The differences in adsorption behaviour 
between 1:1 and 2:1 clay minerals has been discussed in chapter 1 and these 
differences become evident when the trends in figure 2.2 are compared. Essentially, 
the platelets of these clay minerals are able to dissociate in a water dispersion allowing 
the drug to adsorb onto the internal surfaces of the clay mineral particles. These data 
demonstrate that clay mineral CEC and specific surface area (SSA) values are also 
important factors in the adsorption of drug molecules (Aguzzi et al., 2005). Whilst the 
data presented in this section do not easily discriminate between the adsorption 
capacity of the 2:1 clay minerals used, the data presented in subsequent sections 2.3.2 
and 2.3.3 elucidate these differences. 
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2.3.2. Adsorption kinetics 
The pH of the dispersion media played a crucial role in the rate of TC and DC (figure 2.3) 
adsorption onto the clay minerals. Basic dispersions with a pH of 11 were shown to be 
least favourable for TC and DC adsorption, appearing to have a shallow adsorption 
profile thus indicating slower rate of adsorption.  It should also be noted that the 
quantity of TC and DC adsorbed was also greatly reduced at pH 11 compared to pH 2 
and pH 5.0 for TC or pH 5.5 for DC, the reasons for which are described in detail above. 
At pH 11 there was greater variation in the amount of TC and DC adsorbed (standard 
deviations represented by error bars in figure 2.3), compared to at pH 2 or pH 5.0 for 
TC and pH 5.5 for DC. This is likely a result of the clay mineral surfaces and edges being 
negatively charged; repelling the negative charges that would be present on these 
tetracycline molecules. NaOH was used to adjust the pH to 11 and as described by 
Zhao et al. (2012) the positively charged Na+ ions were likely competing with TC and DC 
for the clay-mineral surfaces, reducing the likelihood of these drugs adsorbing onto the 
clay-minerals and introducing greater variability to these results. Adjusting the 
dispersion pH to 2 or at a level that favours the zwitterionic state of TC (pH 5.0) and DC 
(pH 5.5) were shown to hasten and favour drug adsorption onto the clay minerals as 
observed through the gradient and amplitude of the rate of adsorption graphs given in 
figure 2.3.  
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Figure 2.3. Rate of drug adsorption (mean ±SD, n=3) depicted by amount of DC adsorbed onto (A) KN, (B) 
MMTK10, (C) rMMT, and (D) LXL21 at pH 2 (red squares), pH 5.5 (green triangles), and pH 11 (blue 
diamonds) at defined time points. 
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However, to further investigate and characterise the effect of drug, clay mineral, and 
dispersion pH on the kinetics of drug adsorption the data were applied to first-order 
(equation 2.1), second-order (equation 2.2), pseudo first-order (equation 2.3) and 
pseudo second-order (equation 2.4) adsorption kinetic models (Kammerer et al., 2011; 
Tien and Ramarao, 2014).  
 
Equation 2.1 
∆(𝑞𝑒 −  𝑞𝑡)
∆𝑡
=  −𝑘(𝑞𝑒 −  𝑞𝑡) 
 
Equation 2.2 
∆(𝑞𝑒 −  𝑞𝑡)
∆𝑡
=  −𝑘(𝑞𝑒 −  𝑞𝑡)
2 
 
Where qe (mg/g) is the amount of drug adsorbed at equilibrium and qt (mg/g) is the 
amount of drug adsorbed at time t (seconds) with a rate constant of k (s-1).  
 
 
Equation 2.3 
ln(𝑞𝑒 −  𝑞𝑡) =  𝛽 − 𝑘𝑡 
 
Equation 2.3 is the linearised form of the pseudo first-order model where qe (mg/g) is 
the amount of drug adsorbed at equilibrium and qt (mg/g) is the amount of drug 
adsorbed at time t (s). β and k (the rate constant, s-1) can be found by plotting ln(qe – qt) 
against t, whereby β is the intercept and k is the slope. 
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Equation 2.4 
𝑡
𝑞𝑡
=  
1
𝑘𝑞𝑒2
+  
1
𝑞𝑒
 × 𝑡 
 
Equation 2.4 is the linearised form of the pseudo second-order model where qe (mg/g) 
is the amount of drug adsorbed at equilibrium and qt (mg/g) is the amount of drug 
adsorbed at time t (h). By plotting t/qt versus t the rate constant k (g/mg·h) can be 
obtained from the slope and qe from the intercept. kqe
2 is the initial rate of adsorption 
(mg/g·h) and is found mathematically once k and qe are derived. 
 
When experimental data were plotted against the linearised pseudo first (equation 2.3) 
and pseudo second order (equation 2.4) kinetic models the data fitted better to the 
pseudo second order (figure 2.4 and table 2.1), which suggests that the adsorption of 
TC and DC involves two adsorption sites on the clay mineral surface (Kammerer et al., 
2011).  
 
By utilising the pseudo second order model it was possible to determine the initial rate 
of TC and DC adsorption, derive rate constants, and also estimate the amount of drug 
that can be adsorbed onto the clay mineral at equilibrium (table 2.1). As observed 
from the experimental data (figure 2.3) the structure of the clay mineral and the pH of 
the dispersion environment played an important role in the adsorption rate and 
amount of TC and DC. 
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The initial rate of adsorption differed greatly depending on the structure of the clay 
mineral used. The adsorption rate onto MMTK10 (3262 – 25000 mg/g·h) was one to 
two orders of magnitude faster than that of KN (4.01 – 110.86 mg/g·h). The clay 
minerals that were able to fully swell showed adsorption rates that were a further one 
to two orders of magnitude faster than that calculated for MMTK10. LXL21 and LRD 
demonstrated an ability to adsorb TC and DC at much faster rates than rMMT. In 
dispersion, LRD and LXL21 layers will almost completely dissociate from each other at 
the concentrations used in these studies, resulting in a much greater available surface 
area for interaction with TC and DC (Neumann and Sansom, 1971). It can therefore be 
assumed that there is less competition for available adsorption sites allowing a much 
faster initial rate of adsorption.  
 
 
Figure 2.4. Pseudo first-order kinetics (A) and pseudo second-order kinetics (B) for the adsorption of DC 
onto rMMT at pH 2 (red squares), pH 5.5 (green triangles), and pH 11 (blue diamonds) at defined time 
points (mean ±SD, n=3). 
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Data for TC and DC adsorption onto KN, MMTK10, rMMT, LXL21 indicate that an acidic 
environment is more favourable for the adsorption of these two drugs, which was also 
reported by a number of other teams that solely investigated the adsorption of TC 
onto clay minerals (Chang et al., 2009a; Parolo et al., 2013, 2010). Parolo et al. (2013 
and 2010) suggested that the presence of positive charges on the TC and DC molecules 
allows them to interact readily with the negatively charged clay mineral surface. As the 
pH increases the TC and DC molecules become increasingly negatively charged (Parolo 
et al., 2008) which can lead to repulsion from the clay mineral surface. At pH 11 the TC 
and DC molecules are predominantly negatively charged and the edge charges on the 
clay mineral particles will likely have transitioned from positive to negative. This results 
in a system wherein the individual components repel each other and this explains the 
drop in rate of adsorption observed at this pH (Parolo et al., 2008). This trend did not 
translate to LRD and this might be for a number of reasons. The chemistry of LRD 
allows it to adjust dispersions to around pH 9, whereas LXL21 buffers to a more neutral 
pH. This may result in a more positive charge remaining at edge sites at pH 11, which 
would allow adsorption onto the clay mineral edges. The aspect ratio of Laponite® 
layers is around 1:20 (20 nm diameter, 1 nm thick) so a significant proportion of LRD 
surface area is composed of edge sites. As the electrolyte concentration is increased by 
addition of NaOH it is possible that LRD layers re-associated, using the sodium ions as 
interlayer cations (Perkins et al., 1974). This would contribute to a reduction in the 
availability of clay mineral surface for interaction, resulting in the edge sites being the 
predominant site for interaction. Whilst the re-association of layers was likely to occur 
with other clay minerals, including LXL21, the extent of drug adsorption was adversely 
effected by the edge sites bearing a repulsive negative charge. 
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Table 2.1. Goodness of fit (R
2
) of selected kinetic orders for the adsorption of TC and DC onto selected 
clay minerals at defined pH. Where k is the rate constant, qe is the estimated amount of drug adsorbed. 
Clay 
Mineral 
  Pseudo 1
st
 Order  Pseudo 2
nd
 Order 
Drug pH  (R
2
)   (R
2
) Initial rate 
(mg/g h) 
k 
(g/mg h) 
qe 
(mg/g) 
KN TC 2 0.9432  0.9975 110.86 10.56 3.24 
  5 0.9672  0.9905 40.145 6.25 2.54 
  11 0.1853  0.9156 62.112 412.87 0.39 
 DC 2 0.7762  0.9949 65.36 9.43 2.63 
  5.5 0.6423  0.9957 97.09 7.55 3.59 
  11 0.9021  0.9672 4.01 27.54 0.38 
MMTK10 TC 2 0.9203  0.9999 3,714 6.52 23.88 
  5 0.7860  0.9999 3,262 6.33 22.71 
  11 0.6624  0.9982 228.04 20.50 3.35 
 DC 2 0.8346  1.0000 14,300 37.39 19.55 
  5.5 0.6946  0.9999 25,000 62.93 19.93 
  11 0.9724  0.9998 3,333 14.90 14.96 
rMMT TC 2 0.9393  0.9999 37,593 1.51 157.82 
  5 0.7263  0.9999 45,871 2.97 124.36 
  11 0.0344  0.9987 12,150 16.10 27.47 
 DC 2 0.7898  0.9997 20,000 1.07 136.99 
  5.5 0.6548  0.9996 14,285 0.70 142.86 
  11 0.9495  0.9996 5,000 2.21 47.62 
LRD TC 2 0.5097  0.9999 105,263 3.99 162.48 
  5 0.1938  0.9999 62,893 3.95 126.19 
  11 0.0715  0.9999 208,333 12.08 131.31 
 DC 2 0.7394  0.9999 100,000 4.87 143.27 
  5.5 0.7791  0.9998 20,000 0.93 147.06 
  11 0.3898  0.9998 29,000 1.54 137.60 
LXL21 TC 2 0.2121  0.9998 78,125 6.05 113.67 
  5 0.5563  0.9999 69,444 6.03 107.34 
  11 0.0915  0.9998 90,909 5.97 123.397 
 DC 2 0.4827  0.9997 25,000 1.42 132.80 
  5.5 0.1466  0.9999 100,000 7.08 118.86 
  11 0.1589  0.9997 44,200 39.29 110.42 
 
 
2.3.3. Adsorption isotherms 
Adsorption isotherms are mathematical models that have been utilised for many years 
to describe various adsorption phenomenon of compounds from gaseous or aqueous 
environments onto solid and porous surfaces. The Langmuir model assumes that a 
single layer of molecules will adsorb onto a surface, consisting of identical adsorption 
sites, to form a monolayer without any interactions between adsorbate molecules 
Chapter 2            Interaction between phyllosilicates and tetracycline antibacterial agents 
 
  Page 63 of 260 
(figure 2.5 A). In contrast, the Freundlich model is not limited to the formation of a 
monolayer and also accounts for adsorption surfaces of heterogeneous adsorption 
sites, whereby adsorption occurs at the sites allowing for greatest adsorption intensity 
first (Figure 2.5 B). The Temkin isotherm is specifically designed to derive the energy of 
adsorption, which is expressed as heat of adsorption, by accounting for direct 
interactions between the adsorbate and the adsorbent surface (Figure 2.5 C) (Foo and 
Hameed, 2014; Kammerer et al., 2011). Although originally developed to describe the 
adsorption of gaseous compounds onto solid surfaces (Foo and Hameed, 2014), these 
models have been widely applied to disperse aqueous systems; notably the adsorption 
of organic molecules onto clay mineral surfaces (Chang et al., 2016; Kammerer et al., 
2011; Li et al., 2011; Zhao et al., 2012).  
 
 
 
 
 
Figure 2.5. Artistic representation of the (A) Langmuir, (B) Freundlich, and (C) Temkin adsorption models. 
The brown squares represent sites of adsorption on a surface (different shades represent 
heterogeneous adsorption sites). The orange circles represent the adsorbate, whereby the dashed outer 
ring represents indirect interaction and the solid outer ring represents direct interaction with the 
surface.  
 
Utilising these differing adsorption models allows the interaction between TC and DC 
and the clay mineral surfaces to be described in more detail with regards to the impact 
of clay mineral chemistry and dispersion pH on adsorption capacity, TC and DC 
A B C 
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arrangement at the clay mineral surface, and adsorption energies. By measuring the 
drug concentration remaining within the supernatant and the calculated mass of drug 
adsorbed per gram of clay mineral it was possible to plot adsorption isotherms for 
each of the interactions tested at each pH. Examining this process over a range of DC 
and TC concentrations allowed for more accurate evaluation of the drug adsorption 
capacity of these clay minerals.  
 
 
 
Figure 2.6. Adsorption isotherms (n=3) for the adsorption of (A) TC and (B) DC onto KN at pH 2 (red 
squares), pH 5.0 for TC and pH 5.5 for DC (green triangles), and pH 11 (blue diamonds). 
 
 
Figure 2.6 gives the experimental data and adsorption isotherms obtained for the 
adsorption of TC and DC onto KN, whereas figure 2.7 gives adsorption isotherms for TC 
onto MMTK10. The compiled results for the adsorption of TC and DC onto each clay 
mineral at each defined pH are given in table 2.2 
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The experimental data were plotted against linearised versions of the Langmuir 
(equation 2.5), Freundlich (equation 2.6) and Temkin (equation 2.7) adsorption models 
(Kammerer et al., 2011). 
 
 
Equation 2.5 
1
𝑞𝑒
 =  
1
𝐾𝐿𝐶𝑒
 +  
1
𝑄𝑚𝐿
 
 
Linearised Langmuir equation where qe is the calculated amount of drug adsorbed per 
gram of clay mineral, Ce is the measured concentration of drug remaining in 
supernatant (mg/L) at equilibrium, QmL is the monlayer capacity (mg/g), and KL is the 
Langmuir constant(L/g). The values for QmL and KL can be derived from the intercept 
and gradient when plotting the inverse of qe against the inverse of Ce. 
 
Equation 2.6 
log 𝑞𝑒 = log 𝐾𝐹 + 𝑏𝐹 log 𝐶𝑒 
 
Linearised Freundlich equation where qe is the calculated amount of drug adsorbed per 
gram of clay mineral (mg/g), Ce is the measured concentration of drug remaining in 
supernatant (mg/L) at equilibrium, KF is the Freundlich constant (L/g) and a 
representation of adsorption capacity, and bF is a representation of the adsorption 
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intensity (no units). Values for KF and bF are found from the slope and intercept from 
the plot of log qe against log Ce.  
 
Equation 2.7 
𝑞𝑒 = 𝐵 ln 𝐴 + 𝐵 ln 𝐶𝑒  
 
Linearised Temkin equation where qe is the calculated amount of drug adsorbed per 
gram of clay mineral (mg/g), Ce is the measured concentration of drug remaining in 
supernatant (mg/L), A is the isotherm constant (L/mg), and B is the heat of adsorption 
(J/mol). A and B are derived from plotting qe against lnCe. The isotherm energy 
constant bT (no units) can be determined through equation 2.8. 
 
Equation 2.8 
𝐵 =  
𝑅 𝑇
𝑏𝑇
 
 
Where R is the gas constant and T is the temperature of the system.  
 
Experimental data were plotted against the linearised isotherm models so that the fit 
to each adsorption model could be determined for each experiment at each of the 
dispersion pH tested. Examples of these plots are given in figures 2.7 B, C, and D for 
the adsorption of TC onto MMTK10 (figure 2.7 A) at pH 5. Equations of the line were 
used to directly and indirectly determine certain behaviours expressed during the 
adsorption process (Kammerer et al., 2011). The Langmuir model was used to estimate 
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the amount of drug required to form a monolayer at the clay mineral surface (mg/g), 
the Freundlich model was used to estimate the intensity of the adsorption process (bF, 
dimensionless value), while the Temkin model was used to estimate the heat of 
adsorption (B, J/mol) (Kammerer et al., 2011). Table 2.2 gives the fit of each 
experiment to each of the adsorption models tested, alongside the derived adsorption 
behaviours.  
 
 
 
Figure 2.7. (A) Adsorption isotherms for the adsorption of TC onto MMTK10 at pH 2 (red squares), pH 5 
(green triangles), and pH 11 (blue diamonds). The adsorption measurements at pH 5 were plotted 
against the (B) Langmuir model, (C) Freundlich model, and (D) Temkin model. 
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Table 2.2. Correlation of fit between experimental adsorption data to the Langmuir, Freundlich, and Temkin adsorption isotherm models. Where Sm is the monolayer 
coverage, bF is a dimensionless value for adsorbance intensity, and B is the heat of adsorption. 
Clay Mineral Drug pH Langmuir (R
2
) Freundlich (R
2
) Temkin (R
2
) Sm (mg/g) bF B (J/mol) 
KN TC 2 0.9811 0.9272 0.8472 10.82  1.93 2.27 
  5 0.9719 0.9328 0.9283 25.80 3.10 4.50 
  11 0.9811 0.9529 0.9158 3.84 150.45 1.13 
 DC 2 0.9128 0.9129 0.9181 7.18 1.80 1.95 
  5.5 0.9690 0.8424 0.8246 23.51 1.86 2.87 
  11 0.9514 0.7422 0.6403 2.73 187.71 1.22 
MMTK10 TC 2 0.9443 0.9712 0.9915 94.15 35.62 12.34 
  5 0.9587 0.9119 0.9811 123.72 42.01 20.57 
  11 0.8839 0.8251 0.7228 25.18 4.21 4.59 
 DC 2 0.9557 0.9065 0.9528 94.94 39.69 12.42 
  5.5 0.9958 0.9472 0.9523 106.36 19.93 18.36 
  11 0.9093 0.9678 0.9715 13.03 7.14 11.51 
rMMT TC 2 0.8170 0.9288 0.9016 171.51 79.20 45.84 
  5 0.9648 0.9931 0.8623 130.22 16.96 37.41 
  11 0.6642 0.6015 0.5011 17.31 7.81 2.51 
 DC 2 0.9856 0.9626 0.9918 266.82 59.99 61.06 
  5.5 0.9768 0.9214 0.8308 158.65 12.65 33.95 
  11 0.9516 0.8516 0.6518 31.46 1.63 6.55 
LRD TC 2 0.9899 0.9890 0.9057 266.04 6.79 39.10 
  5 0.6374 0.7138 0.5370 74.33 1.49 84.87 
  11 0.9883 0.9894 0.8939 158.19 7.45 30.43 
 DC 2 0.9816 0.9751 0.9205 189.27 11.27 39.51 
  5.5 0.9897 0.9859 0.9079 308.45 1.60 72.08 
  11 0.9338 0.9190 0.7445 109.04 1.50 25.97 
LXL21 TC 2 0.9947 0.9960 0.8947 227.35 2.27 30.22 
  5 0.9977 0.9940 0.8893 238.12 1.60 36.83 
  11 0.9951 0.9941 0.9048 78.55 2.00 56.93 
 DC 2 0.9784 0.9706 0.8037 215.84 2.79 31.90 
  5.5 0.9943 0.9947 0.8457 290.46 1.40 39.26 
  11 0.9540 0.9747 0.8513 110.34 1.01 36.72 
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The adsorption of TC and DC onto KN was shown to more closely follow the Langmuir 
model than the Freundlich or Temkin models. This indicates that the adsorption of 
these drug molecules onto the surface of KN was a saturable process and a monolayer 
was formed at the surface of the KN particles (Kammerer et al., 2011). As predicted 
from the pH variability studies (section 2.3.1), and also reported by Figuero, et al. 
(2004), the adsorption of TC and DC was more pronounced when the dispersion pH 
favoured zwitterionic drug molecules and this was reflected in the monolayer 
saturation (Sm, mg/g) values obtained at these pH compared to at pH 2 or 11. The 
estimated intensity of adsorption (bF) was found to be far greater at pH 11 compared 
to the lower pH tested. This change in adsorption intensity was not observed for the 
adsorption of TC and DC onto the other clay minerals tested and was therefore 
concluded to be the result of the structure of KN and its behaviour at pH 11. Whereas 
the diffuse double layer and the edge charges change dramatically over the full pH 
range tested, these changes are not likely to occur in 1:1 clays minerals such as KN. In 
turn this could have allowed the negatively charged TC and DC molecules to interact 
with the edges of the KN particles more intensely than the faces of the KN layers.  
 
Results for the adsorption of TC and DC onto MMTK10 followed similar patterns to 
those seen in the initial pH investigations and the study of adsorption kinetics. More 
drug was adsorbed onto the MMTK10 at pH that favoured the zwitterionic form of the 
drug molecules and this in turn resulted in a more concentrated monolayer being 
formed at the clay mineral surface (Figueroa et al., 2004; Porubcan et al., 1978). This 
indicates that inducing the zwitterionic form of TC and DC allows the drug molecules to 
become more tightly packed at the clay mineral surface. The adsorption of TC and DC 
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at pH 2, when the molecules are predominantly positively charged, allowed for good 
adsorption and a concentrated monolayer but interaction between both components 
was less intense than at pH 5 or 5.5. The interaction between the drug molecules and 
MMTK10 was found to be least intense at pH 11, which is reflected in the small 
amounts of drug adsorbed and the less densely packed monolayer estimated through 
the Langmuir model. 
 
The adsorption of TC and DC onto rMMT presented a number of differences when 
compared to the acid activated counterpart, MMTK10. All of the values derived from 
experimentation indicate that the adsorption of the drug molecules onto rMMT is 
more intense at pH 2 compared to higher pH. In turn, this resulted in a large 
adsorption of drug and a more densely packed monolayer being estimated through the 
Langmuir model. The structure and chemistry of rMMT gives it a high surface charge 
and a large CEC when compared to the other clay minerals used in this study. The high 
negative charge surfaces will interact more readily with positively charged molecules, 
explaining the very large adsorption of drug at pH 2. These data also suggest the 
adsorption of TC and DC onto rMMT is predominantly via cation exchange as a 
positively charged molecule will be needed to displace the counterbalancing cations 
from the clay mineral surface (Chang et al., 2009c). 
 
The same pattern in adsorption behaviour was not observed for LRD and LXL21. When 
the adsorption process was undertaken at pH 5.0 for TC and pH 5.5 for DC more drug 
was adsorbed onto the clay mineral surface and the Langmuir model predicted a 
higher concentration of drug within the monolayer. As for the other clay minerals, a 
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dispersion pH of 11 was least favourable for adsorption. Undertaking the adsorption at 
pH 2 was not as favourable as for that favouring zwitterionic charge. The layers of 
LXL21 and LRD are more labile in acidic media than rMMT (Thompson and Butterworth, 
1992), breaking down easily to release structural cations and affecting surface charge 
and CEC. This in turn can reduce the adsorption capacity of the increasingly amorphous 
clay mineral and explains the reduction in drug adsorption observed. However, at pH 2 
the intensity of interaction was determined to be larger than at pH 5.0 or pH 5.5. 
Modification of the LXL21 and LRD layer structure not only reduces the charge 
distribution across the layer but can intensify the acid sites present and it may be 
possible that these sites interact more strongly with the drug molecules. It may also be 
possible that any residual CEC resulted in the strong interactions that were also 
observed for the adsorption of TC and DC onto rMMT. The intensity of adsorption was 
much lower at pH 5 or pH 5.5 and was generally equivalent or lower than the intensity 
derived for adsorption at pH 11 suggesting that cation exchange is not the only process 
by which TC and DC interact with LRD and LXL21 and secondary interactions may also 
play a role (Aguzzi et al., 2005; Parolo et al., 2008). Minimal differences in how well the 
data fitted the Langmuir or Freundlich model were observed, so little distinction 
between the models could be made. There are similarities between the Langmuir and 
Freundlich adsorption models whereby the initial stage of adsorption involving low 
concentrations of adsorbate, depicted by a straight line of increasing surface 
adsorption, is the same for both models. The Langmuir model diverges from the 
Freundlich model when it considers the formation of a monolayer at the sorbent 
surface (Kammerer et al., 2011; Langmuir, 1918). This also supports why no plateau of 
monolayer formation was observed on the LRD and LXL21 adsorption isotherms 
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plotted. Therefore, it may be possible that no distinct monolayer of TC or DC formed at 
the surface of LXL21 or LRD and that drug adsorption under certain circumstances is 
able to continue far beyond the expected monolayer formation value.  
 
The heat of adsorption (B, J/mol) calculated using the Temkin model was low for all of 
the composites examined, indicating that the interaction between DC and TC and the 
clay minerals was by physisorption, such as van der Waals forces, rather than by 
chemisorption, such as covalent bonding, (Itodo and Itodo, 2010; Puttamat and 
Pavarajarn, 2016). The effect of the clay mineral surface charge was observed here as 
the heat of adsorption, and therefore the strength of the physisorption, for DC and TC 
onto KN were generally lower compared to the other clay minerals. These weak 
interactions are necessary, however, to allow the drug molecules to desorb from the 
clay mineral surfaces and impose their effects on bacterial cells (see section 2.3.6) 
 
2.3.4. X-ray diffraction analyses 
The use of X-ray in the elucidation of clay mineral structure is common across the 
literature and is a well-established method for determining the size of the interlayer 
space. A number of other authors have utilised powder XRD to measure structural and 
chemical changes in clay minerals as a result of a wide range of chemical processes, 
including the adsorption of organic molecules (Li et al., 2010; Rives et al., 2014; Xuan et 
al., 2013). 
 
The X-ray diffractograms for the naturally occurring KN and rMMT (figure 2.8 A) show 
many similarities but also a number of key differences. The similarities are borne 
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through the similar molecular contents and arrangements of the phyllosilicate sheets 
and layers. Some differences in the diffraction can be attributed to the extra silicate 
sheet in rMMT. One of the most important differences between these two clay 
minerals’ diffractograms is the position and shape of the d001 peak, located at 9.0 deg 
2θ for KN and 7.4 deg 2θ for rMMT, which is a result of the diffraction caused by the 
inner surfaces of the interlayer space. This d001 diffraction can be used to determine 
the distance between clay mineral layers, utilising Bragg’s Law (equation 2.9), and is a 
useful measure of whether the guest molecules have been integrated into the 
interlayer space of the clay mineral (Datta, 2013; Joshi et al., 2010; Vaiana et al., 2011; 
Zhao et al., 2013).  
 
Equation 2.9 
𝑛𝜆 = 2𝑑 sin 𝜃 
 
Where λ is the wavelength of the X-Ray beam (0.154 nm), θ is the Bragg’s scattering 
angle, and d is the spacing (nm, convertible to Å) between the clay mineral sheets. 
 
The irregularity of clay mineral layer arrangement within aggregates (section 1.2.2) and 
imperfections across the structure of the clay mineral layers (section 1.2.1) means that 
diffractograms for these materials do not strictly obey Bragg’s Law (Drits, 2003). It is 
known that clay mineral layers do not always align perfectly and may contain 
imperfections such as overlapping and bending, which can all affect the regularity of 
the d001 diffraction (Villar et al., 2012). The width and asymmetry of the d001 diffraction 
is greater in rMMT because the layers are not held together in as tight and regular 
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fashion as in KN but are associated by various interlayer cations, which can lead to 
changes in the interlayer spacing (Kaufhold and Dohrmann, 2009). Regardless of these 
limitations XRD analysis is still widely used to determine the location of organic 
molecules adsorbed onto clay minerals (Chang et al., 2009b; Li et al., 2010; Park et al., 
2008; Parolo et al., 2008; Rives et al., 2014; Sánchez-Martín et al., 1988; Xuan et al., 
2013). 
 
The diffractogram of MMTK10 (figure 2.8 A) is presented alongside that of rMMT to 
demonstrate the differences between these, originally similar, clay minerals. The 
overall unremarkable diffractogram for MMTK10 is similar to that recorded by 
Kaygusuz and Erim (2013) and could be a result of the dissolution of ions from the 
metal hydroxide sheet (Kaygusuz and Erim, 2013; Nunes et al., 2007; Tong et al., 2013). 
It is possible that the diffractions at 26.5, 35.0, and 46.0 deg 2θ are caused by silicate 
sheets, as these are present in the same position across KN, rMMT, and MMTK10. The 
diffractograms for LRD and LXL21 have been presented separately (figure 2.8 B) to 
clearly demonstrate the difference in X-ray diffractions caused by these synthetic clay 
minerals in comparison to the natural and processed clay minerals. Diffractions for LRD 
and LXL21 are located at the same positions and are representative of the very similar 
structure and chemical content of these two species (BYK Additives & Instruments, 
2014). Whilst chemically synthesising clay minerals such as LRD and LXL21 leads to a 
material free from impurities (Neumann and Sansom, 1971), which is very attractive 
for pharmaceutical purposes, the diffractograms are indicative of a much more 
amorphous material compared to KN and rMMT. On a molecular level the structure of 
LRD and LXL21 is likely to be more regular and crystalline than for KN and rMMT. 
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Figure 2.8. X-ray diffractograms of kaolin (red), refined montmorillonite (green), and montmorillonite K-
10 (blue) are shown in A. X-ray diffractograms of Laponite® RD (orange) and Laponite® XL21 (purple) are 
shown in B.  
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However, the layer diameter of LRD and LXL21 is much smaller than that of rMMT and 
KN leading to an irregular structure on the macro scale, as layers form particles and 
aggregates (Avery and Ramsay, 1986; Lagaly and Ziesmer, 2003). In turn, this leads to 
wide asymmetric d001 peaks (Janeba et al., 1998) potentially making determination of 
the location of adsorbed TC and DC more difficult. 
 
The diffractograms for TC and DC are presented in figure 2.9 and represent a typical 
XRD pattern for crystalline materials. The diffractions in these two patterns are much 
more clearly defined and symmetric in comparison to the clay mineral diffractograms. 
The high-regularity of the molecular arrangement is also demonstrated through the 
intensity of the peaks, which is far greater than those obtained for any of the clay 
minerals. Whilst the molecular structures of TC and DC are very similar the way they 
interact and arrange in crystal lattices is different and this leads to the differences in 
diffraction patterns obtained. 
 
The layers of KN are held tightly and closely together by hydrogen bonds, which makes 
them hard to separate (Miranda-Trevino and Coles, 2003). The adsorption of TC and 
DC onto KN resulted in no significant change in the shape or position of the d001 peak 
(figure 2.10 A) indicating that neither of these drugs adsorbed into the interlayer space, 
which remained 7.15 Å in distance in all composites tested. TC and DC were more likely 
to be adsorbed onto the outer surfaces of the KN particles (Miranda-Trevino and Coles, 
2003), supporting the overall reasoning for the low adsorption capacity of KN observed 
above. 
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Figure 2.9. X-ray diffractograms of unmodified tetracycline (blue) and doxycycline (red). Inlay is 
expanded region of 3-30 deg 2θ.  
 
The d001 diffraction in MMTK10 also remained at the same position as the amount of 
drug adsorbed increased (figure 2.10 B). This indicates that the structural changes 
brought about by acid activation also inhibit the infiltration of TC and DC into any 
remaining interlayer space. However, this poorly defined d001 peak becomes less 
defined and all but absent in the diffractograms obtained for the highest drug loading 
possible for MMTK10. One explanation for this is adsorption onto the outer surface of 
the MMK10 particles prevented the formation of normal clay mineral aggregates and 
thus the normal pseudo-crystalline structure that creates the d001 diffraction was lost 
(Janeba et al., 1998). 
 
Significant changes in the shape and position of the d001 diffraction were observed as 
TC and DC were increasingly adsorbed onto rMMT (figure 2.10 C), LRD (figure 2.10 D), 
3 8 13 18 23 28
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and LXL21 (data not shown as very similar to LRD). For all three of these clay minerals 
the adsorption of TC and DC caused the d001 diffraction to shift to the left, representing 
an increase in the size of the interlayer space (Chang et al., 2009b; Parolo et al., 2008). 
The increase in interlayer space was shown to be limited for rMMT as the size of the 
interlayer space was shown increase to, but remain at, 16.44 Å even as the DC loading 
increased from 73.71 to 102.95 mg/g. However, as the drug loading onto LRD and 
LXL21 increased further so did the size of the interlayer space. For example, as the TC 
loading onto LRD increased from 8.31 mg/g to 83.14 mg/g then to 154.47 mg/g the 
interlayer space was found to be 12.7 Å, 13.97 Å, and 18.06 Å respectively. The width 
and asymmetry of the LRD and LXL21 d001 diffraction also increased, suggesting that 
large amounts of drug present within the interlayer space is able to push the clay 
mineral layers apart and exfoliate the particle structure (Chang et al., 2009b). The 
ability of Laponite® to continue expanding its interlayer space to the point of 
exfoliation is also seen in water, where it almost completely exfoliates to form a 
colloidal dispersion (Mongondry et al., 2005; Phuoc et al., 2009). 
 
No shift in the d001 diffraction peak was observed for any of the controls and standards 
investigated. No peak shift was observed for any of the clay minerals after they had 
been dispersed in water and dried in the same way as the composite materials, 
indicating that no additional water molecules were recruited by the counterbalancing 
cations that could account for the observed interlayer space increase. Physical mixes of 
the clay mineral and drug powders provided diffractograms containing peaks for both 
the clay minerals and the drug powders alone, but showed no significant peak shifts 
and the d001 diffraction remained intact. This confirms that adsorption of drug 
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molecules onto clay mineral layers is facilitated by dispersion in water. These data 
confirm that swelling clays are able to adsorb drug molecules into their interlayer 
space, which allows the 2:1 swelling clay minerals to adsorb greater amounts of drug 
molecules than the non-swelling 1:1 clay minerals. 
 
 
 
 
Figure 2.10. X-ray diffractions for doxycycline adsorbed onto (A) kaolin, (B) montmorillonite K-10, (C) 
rMMT, and (D) LRD. Colours of the lines represent different concentrations of DC loading (orange > 
purple > green > red > blue) 
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There was a notable lack of TC or DC diffraction peaks in the composite samples and 
the whole diffractogram was comparable to that of the unmodified clay minerals, with 
the exception of diffraction peak shifts caused by interlayer space expansion. This 
indicates that the TC and DC molecules were adsorbed onto the clay mineral surfaces 
in an amorphous arrangement (Ito et al., 2001) and that the surfaces or pores of the 
clay minerals did not act as foci for crystallisation of the drug. 
 
2.3.5. FTIR analyses 
FTIR is a useful technique for identifying functional groups within a compound or 
mixture and is often used to support the elucidation of drug molecule structures. 
Molecules, such as TC and DC have individual and characteristic spectra with the 
majority of absorbance modes being present within the fingerprint region (1500 to 500 
cm-1). Clay minerals also have a number of characteristic modes within this region 
(figure 2.11). The most prominent absorbance around 1000 cm-1 is from the Si-O 
stretch within the tetrahedral sheets. Absorbences lower down the spectra result from 
M-OH bonds within the octahedral sheets; notably Al-OH at 912 cm-1 in KN, 924 cm-1 in 
rMMT, and 897 cm-1 in LXL21 (as a shoulder on the Si-O adsorption); Fe-OH at  802 cm-1 
and 685 cm-1 in rMMT; and Mg-OH at 607 cm-1 in KN, 603 cm-1 in rMMT, and 653 cm-1 
in LXL21 (Madejova, 2003; Tyagi et al., 2006). 
 
There are clear differences in the fingerprint regions between KN and the other clay 
minerals and this is due to the differing structure, content, and bonding within the 1:1 
and 2:1 layer sheets, and potentially the differing interactions between the clay 
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mineral layers (Madejova, 2003). The spectra for rMMT and MMTK10 are presented 
together (figure 2.11 B) to demonstrate how the acid activation process can affect the 
structure of these clay minerals. The loss or reduction of shoulder absorbances at 924 
cm-1 and 802 cm-1 are due to dissolution of Al and Fe from the clay mineral sheets in 
acid environments. A slight shift in the Si-O absorbance is also observed after the acid-
activation process, which is a result of the differing electric and bonding environment 
within the increasingly amorphous silicate sheet (Tyagi et al., 2006). 
 
 
 
Wavenumber (cm
-1
) 
Figure 2.11. Extracts from the FTIR spectra of (A) KN, (B) MMTK10 (red line) and rMMT (green line), and 
(C) LXL21 (LRD showed no distinguishable differences). These spectra extracts show the fingerprint 
region of characteristic clay mineral IR absorbance bands. 
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As the amount of drug adsorbed onto a clay mineral increases the amplitude of the 
absorbances also increases (figure 2.12, see insert). The presence of this fingerprint 
region in the spectra of the composites is useful for proving the presence of drug 
within the composite materials, but can also be used to determine the nature of the 
interaction between drugs and clay minerals (Madejova, 2003; Porubcan et al., 1978). 
To balance the increase of drug within the composite material, the characteristic Si-O 
band reduced in intensity. This is unlikely to be due to a change in clay mineral 
structure as no deformations were observed. Instead this is simply a result of the 
changing ratio of drug:clay within the composite materials.  
 
The TC O-H/N-H stretching mode, which generally appears around 3350 cm-1 is masked 
by the broad O-H band at 3500 cm-1 (Chang et al., 2009c), which decreased in 
amplitude as the amount of drug present within the composites increased. This 
absorbance band is characteristic in clay mineral samples and is generated by water 
molecules (Madejova, 2003). Much of the water within the clay mineral structure, 
especially within the 2:1 swelling minerals, is associated with the counterbalancing 
cations. Thus, a reduction in intensity of this band may indicate a loss of hydratable 
counterbalancing cations and support the conclusion that cation exchange is the 
proposed method of DC and TC adsorption onto the clay mineral surface (Madejova, 
2003; Rapacz-kmita et al., 2017). 
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Wavenumber (cm
-1
) 
Figure 2.12. FTIR spectra of increasing amounts of DC adsorbed onto LRD. The lowest DC adsorption 
(blue line) and highest adsorption (green line) are presented alongside a DC-LRD composite whose DC 
loading is around the monolayer formation point (red line).  
 
 
The interaction between DC and TC onto the clay mineral surfaces was also observed 
via shifting of key absorbances in the spectra.  The absorbance at 1250 cm-1 is a 
characteristic C-N stretching mode whose position is shown to shift as the pH favours 
differing charges on the tertiary amine group of TC and DC (de Sousa et al., 2008; 
Parolo et al., 2010; Zhao et al., 2012). As shown in figure 2.13 this absorbance was 
shown to shift from 1250 cm-1 to 1245 cm-1 when TC was absorbed onto rMMT, 
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indicating an interaction between this positively charged group and the clay mineral 
surface; most likely the negatively charged faces. Similar shifts were seen for TC and 
DC onto all the clay minerals tested (data not shown) except at pH 11, where so little 
drug was adsorbed it was very difficult to interpret the spectra. Indeed, it is expected 
that the tertiary amine group on TC deprotonates above pH 9.6 (pKa3; pH 9.1 for DC) 
so a shift in absorbance may be less easily observed. The absorbance at 1508 cm-1 was 
assigned to the amide II band, with a secondary peak at 1513 cm-1 generally assigned 
to N-H stretch at the amide II group (Caminati et al., 2002; Chang et al., 2009a; Li et al., 
2010; Parolo et al., 2008; Zhao et al., 2012). Figure 2.13 also demonstrates the 1508 
cm-1 absorbance did not change position when in a clay-drug composite, whilst the 
accompanying adsorption at 1513 cm-1 did not appear in the spectra for the clay-TC 
and-DC composites. This could be due to the relative intensities of the absorbance 
reducing the resolution of the peaks, which would suggest there is no interaction 
between the clay-mineral surface and the amide groups. However, the shifting or 
disappearance of the 1513 cm-1 absorbance, resulting in a single absorbance at 1508 
cm-1 could indicate some interaction between this group and the clay mineral surface. 
The amide group and O3 complex holds a negative charge above pKa1 (Parolo et al., 
2008) and it would be plausible to suggest any interaction with this group would be 
with the positively charged edges of the clay mineral, providing the pH of the clay 
dispersion does not favour a negative charge at these edge sites (see section 1.2.3). 
Further evidence for an interaction with the amide groups is presented in figure 2.13, 
which shows the amide C=O absorbance at 1655 cm-1 (Li et al., 2010; Zhao et al., 2012) 
shifting to 1650 cm-1. 
 
Chapter 2            Interaction between phyllosilicates and tetracycline antibacterial agents 
 
  Page 85 of 260 
These spectra demonstrate that FTIR can be used to detect the presence of drug 
molecules within clay-drug composites. Indeed, with further work this analytical 
technique could be quantitative and support the data determined mathematically 
through adsorption isotherms.  
 
   
Figure 2.13. FTIR spectra for TC at pH 5 (grey line) and rMMT-TC composite formed at pH 5 (red line). 
Absorbances are paired via the blue lines, with dotted junctions indicating shifts. 
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The FTIR spectra presented here also demonstrated the structural differences between 
the clay minerals and the effects of an acidic environment on their chemical 
composition. More interestingly, by identifying characteristic peaks within the 
fingerprint region of DC and TC spectra, it was possible to determine that the dimethyl 
amino group was able to interact with the clay mineral face sites, whilst the amide 
group was able to interact with the edge sites. Interaction between TC and DC and the 
face sites could potentially be via a cation exchange process, as the absorbance for 
water molecules within the composites reduced significantly and may be a result of 
hydratable cations being displaced by drug molecules. 
 
2.3.6. Antibacterial activity 
Clay minerals on their own exhibited no zone of inhibition and therefore no discernible 
antibacterial activity (figure 2.14 A). This is in contrast to other studies that showed 
varying inhibitory effects of clay minerals on the growth of bacterial cells (Mpuchane 
et al., 2010; Otto and Haydel, 2013; Williams et al., 2011, 2008; Williams and Haydel, 
2010). Williams, and colleagues, determined that it is likely that the exchangeable ions 
play a leading role in the antibacterial properties of some clay minerals (Williams et al., 
2011). However, it is likely that contact with bacterial cells is required for clay minerals 
to impose their antibacterial effects (Williams and Haydel, 2010). The methods utilised 
in these experiments separated the bacterial cells from the clay minerals to determine 
whether the drug molecules desorbed from the composites and whether they 
remained active. Deionised water was used to disperse the un-modified clay minerals 
so it is unlikely for any interlayer cations to be displaced from the clay minerals into 
the growth medium. Alongside this, the cations held within the interlayer space of the 
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clay minerals tested were predominantly Na+, which has no inherent antibacterial 
activity unlike other metallic cations such as silver, copper and zinc (Magaña et al., 
2008; Malachová et al., 2011). 
 
 
 
 
 
 
Figure 2.14. Examples of S. epidermidis cultures in nutrient agar tested via the well-diffusion method 
against 2 mg LXL21 (A), and composites of LXL-TC containing (B) 10.21 mg/g, (C) 79.19 mg/g, and (D) 
124.15 mg/g of TC. 
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It is equally likely that any zones of inhibition observed from the clay-drug composites 
were caused by diffusion of TC and DC from the composites and into the growth 
medium. As the concentration of the standard solutions of TC and DC increased so did 
the zone of inhibition, proving that this method could discriminate between clay-drug 
composites that released TC and DC on rehydration and those that did not. By plotting 
the zone of inhibition (mm) against the Log10 of drug concentration (mg/mL) standard 
curves with high correlation (r2 > 0.955) were obtained, showing that this methodology 
could reliably detect increasing amounts of TC and DC release through increasing zone 
diameters. 
 
As the concentration of drug increased within each clay-drug composite the zone of 
inhibition also increased in diameter (figure 2.14 B-D), proving that there were 
increasing concentrations of drug within the materials as determined in section 2.3.3 
and this awarded greater antibacterial powers to the composites. Moreover, these 
data prove that the antibacterial effect of the drug molecules is maintained during the 
formation and storage of the clay-drug composites making them important and 
interesting materials for future research and further development. 
 
TC and DC were shown to have antibacterial effects against all the bacterial strains but 
were more effective against the Gram-positive strains due to their mode of action 
(figure 2.15). It is important to note the reduced efficacy of TC and DC against P. 
aeruginosa compared to P. acnes and S. epidermidis. Pseudomonas spp. are Gram-
negative bacteria which have less permeable cell membranes, which can reduce the 
penetration of many antibacterial agents.  
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Figure 2.15. Zones of inhibition (mean ±SD, n=3) formed by clay-TC and clay-DC composites, of varying 
drug loading, against S. epidermidis (A), P. acnes (B), and P. aeruginosa (C). 
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Alongside this P. aeruginosa is able to produce a number of efflux proteins which are 
placed within the cell membranes to pump out a wide range of antibacterial drugs 
including the tetracycline class. In addition to this innate resistance P. aeruginosa is 
able to acquire and develop further resistance even during a course of anti-
pseudomonal treatment (Chatterjee et al., 2016; Kobayashi et al., 2009; Lister et al., 
2009; Potron et al., 2015).  
 
Whilst the majority of skin and skin structure infections (SSSIs) are caused by Gram-
positive organisms such as S. epidermidis, S. aureus, P. acnes, and Streptococcus 
species, the prevelance of P. aeruginosa causing and complicating infections and 
diseases, including SSSIs, is increasingly being reported (Dryden, 2009). Many Gram-
negative bacteria, including P. aeruginosa, have now been identified as a risk to human 
health in the same way as MRSA and Clostridium difficile (Dryden, 2009; World Health 
Organization, 2012). There is much scope for improving activity of these clay-drug 
composites against P. aeruginosa and it is possible that another antibacterial agent 
with better activity against Gram-negative bacteria, such as a fluoroquinolone (Unal, 
2009b), could overcome the problem and this will be investigated in chapter 3. 
 
Across the clay-drug composites tested the difference in diameter of the zone-of-
inhibition was much greater between the low and medium loaded materials, 
compared to the difference in diameter induced between the medium and highly 
loaded composites (figure 2.15). However, this perceived reduction in efficacy is not 
actually directly relatable to the potency of the materials formed. As the diameter of 
the zone of inhibition increases the area of effect increases more than is initially 
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perceived. Thus, small increases in the diameter of a larger circle in fact account for a 
larger increase in area of effect than changes in diameter of a smaller circle would.  
 
The diameters for the zones of inhibition were converted into areas of effect 
(excluding the central-well) to give a true expression of the efficacy. By using the 
McFarland 0.5 measurements it was possible to calculate the number of bacterial cells 
per square millimetre of agar, which could be further used to determine the average 
number of cells affected (table 2.3). The calculated efficacy of preventing bacterial-cell 
growth increased by a smaller proportion when the drug-load increased from medium 
to high than it did when the drug-load increased from low to medium. This 
complements the trends observed in the zone of inhibition measurements, suggesting 
that diffusion through increasing volumes of agar was not solely responsible for this 
phenomenon. This assumption is further supported when the chemistry of each clay 
mineral is considered. 
 
Composites formed from KN were shown to create zones of inhibition that were 
comparable to those formed by other composites, which is interesting as KN-TC and 
KN-DC composites contained much less drug than many of the other composites 
tested. This suggests that the KN-TC and KN-DC composites are able to release their 
drug load more freely. KN is a 1:1 clay-mineral with minimal surface charge (Kahr and 
Madsen, 1995) and may therefore hold onto TC and DC molecules less strongly than 
the highly charged 2:1 clay minerals (rMMT and Laponites®) used in this study (see 
section 1.2). 
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The composites with low drug binding had not formed a monolayer and therefore the 
drugs were interacting directly with the surface of the clay minerals through strong 
interactions. As the drug loading increased to ‘medium’ and ‘high’ a monolayer had 
likely formed and additional drug would have adsorbed through secondary weaker 
interactions. However, these secondary interactions did not result in the drug 
molecules being able to dissociate more easily away from the clay mineral surface.  
 
Table 2.3. Calculated mean average number of bacterial cells that were prevented from growing by drug 
molecules which had diffused from clay-TC and clay-DC composites of different drug load. 
  Average number of bacterial cells inhibited (x10
5
) 
Composite Drug Load 
(mg/g) 
S. epidermidis P. acnes P. aeruginosa 
KN-TC 4.75 1.88 2.01 - 
 14.97 2.75 4.00 2.53 
 29.92 3.29 4.51 3.82 
MMTK10-TC 10.30 0.58 1.00 - 
 98.19 2.90 3.95 - 
 148.69 3.71 5.13 4.77 
rMMT-TC 10.01 0.24 1.25 - 
 111.15 1.42 3.24 1.45 
 158.06 1.86 4.71 5.99 
LRD-TC 9.82 0.59 0.21 - 
 129.71 2.07 2.99 - 
 199.75 2.61 3.65 - 
LXL21-TC 10.21 0.48 1.86 - 
 79.19 1.58 4.47 0.54 
 124.15 2.38 5.80 7.24 
KN-DC 3.71 0.65 2.55 - 
 9.83 1.40 5.06 - 
 16.23 1.75 5.58 - 
MMTK10-DC 9.97 0.59 3.02 - 
 114.81 2.07 5.18 3.64 
 146.77 2.55 5.90 15.65 
rMMT-DC 9.71 0.54 1.98 - 
 92.88 1.59 3.96 - 
 133.70 2.10 4.97 5.05 
LRD-DC 7.00 0.31 1.67 - 
 112.72 1.54 4.56 0.37 
 175.36 1.90 5.55 4.81 
LXL21-DC 5.92 0.78 3.27 - 
 82.96 1.58 4.78 - 
 132.33 2.04 5.46 2.79 
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One limitation of the method used to test the antibacterial activities of these 
composites is they are time-limited in a number of ways, which could have affected 
the zones of inhibition obtained. Firstly, the drug needs to dissociate from the 
composite and diffuse through the surrounding agar, whilst bacterial cells proliferate. 
The zone of inhibition is formed at a boundary where the antibacterial concentration 
in the agar is strong enough to prevent bacterial growth, and those areas where it is 
not. Such bacteriostatic and bactericidal concentrations take time to develop, during 
which time the bacterial cells outside of the effective concentration continue to grow 
and replicate. Any bacterial colonies that are able to replicate to sufficient densities to 
be visible before TC and DC reach effective concentrations will still be visible after cell-
death. Therefore, drug may continue to diffuse through the agar but the true extent of 
drug release cannot be measured.  
 
Secondly, the drug molecules can only desorb from the composite when it is hydrated. 
These bacteriological studies were carried out at body temperature, which facilitated 
gradual evaporation of water from the composite dispersions to such an extent that 
these were dry at 24-hours incubation time. This could also mask the true extent of 
drug release from these composite materials especially if modified release properties 
are present, as has been reported by a number of other teams (Park et al., 2008; 
Rodrigues et al., 2013).  
 
Regardless of these limitations the results are important as they show the clay-drug 
composites formed are able to relinquish their drug load and have a significant 
antibacterial effect, especially as the drug-load increases.   
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2.4. Conclusions 
In this series of experiments TC and DC were successfully adsorbed onto KN, MMTK10, 
rMMT, LRD and LXL21 under various conditions. It was found that the adsorption of TC 
and DC onto the clay minerals was rapid and followed pseudo-second order kinetics. 
Adsorption isotherms fitted the Langmuir model, indicating that these drug molecules 
could form a monolayer on the clay mineral surfaces. The data also indicates that once 
this monolayer is formed at the clay mineral surface, further adsorption takes place via 
weaker secondary interactions between the adsorbed drug molecules. The pH of the 
dispersions was shown to be the most important parameter for optimising TC and DC 
adsorption onto the clay mineral surfaces. A pH that favoured the formation of the 
zwitterionic state was shown to allow for the greatest amount of TC and DC to be 
adsorbed onto the clay minerals. Not only this, but this pH (5.0 for TC and 5.5 for DC) 
was unlikely to affect the structure of the clay minerals. 
 
Through XRD and FTIR it was determined that these drug molecules adsorbed into the 
interlayer space of swelling 2:1 clay minerals (rMMT, LRD, and LXL21) but probably 
only adsorbed onto the outer surfaces of KN. It is likely that positively charged amino 
groups within these drug molecules allowed for direct interaction with the negatively 
charged clay-mineral surfaces. It is also possible that negatively charged amide groups 
on the drug molecules could adsorb onto the positively charged edge-sites of the clay 
mineral layers. Indeed, a dispersion pH that favoured negatively charged drug 
molecules resulted in almost negligible drug adsorption – likely a result of clay-mineral 
edge-sites becoming negatively charged creating an overwhelming repulsion between 
the clay-mineral layers and the drug molecules. 
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The clay-drug composites formed were shown to be active against three strains of 
bacteria that are commonly implicated in skin and skin structure infections; S. 
epidermidis, P. acnes and P. aeruginosa. However, very little activity was seen against P. 
aeruginosa and this is likely due to the mode of action of TC and DC and the biological 
structure of these species of bacteria. Increasing drug-load within the composites 
resulted in greater antibacterial effect. The chemistry of the clay-minerals was also 
shown to influence desorption of drug molecules from the composites. Under the 
conditions tested, KN, which has weak surface forces, was shown to relinquish its drug 
load much more easily than highly charged clays such as LRD and LXL21. 
 
These results are promising and will inform further experiments into the adsorption of 
drugs onto clay mineral surfaces and their onward use within wound dressing 
materials. It is unknown whether these findings are specific to TC and DC or whether 
they can be applied to other drug molecules. Therefore, chapter 3 will set out to 
determine whether these findings can be applied to another antibacterial agent with 
differing chemistry and better activity against P. aeruginosa.  
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Chapter 3 
Interaction between phyllosilicates and ciprofloxacin 
 
3.1. Introduction 
Chapter 2 demonstrated that clay minerals adsorb tetracycline antibacterial agents 
onto their surfaces and subsequently release these molecules into their surrounding 
environment for activity against a range of bacterial strains commonly implicated in 
skin and skin structure infections. However, the poor activity of tetracycline (TC) and 
doxycycline (DC) against Gram-negative bacteria, such as Pseudomonas aeruginosa, is 
limited by their mode of action (Chatterjee et al., 2016; Lister et al., 2009) therefore 
other agents such as antipseudomonal penicillins or quinolones may be more clinically 
appropriate (Unal, 2009). 
 
Ciprofloxacin (CIP) is an antibacterial agent in the quinolone class and is commonly 
used in UK healthcare for a range of infections, including skin and skin structure 
infections (Healy and Freedman, 2006; Sandwell and West Birmingham Hospitals NHS 
Trust, 2011; The Royal Liverpool and Broadgreen University Hospitals NHS Trust, 2012). 
CIP exhibits broad spectrum activity having greatest effect against Gram-negative 
bacteria, including P. aeruginosa, and some activity against Gram-positive species 
(Eboka and Okeri, 2005; Phillips et al., 1990; Vance-Bryan et al., 1990; Wispelwey, 
2005). Pharmacologically, it is a concentration-dependant agent with a significant post-
antibiotic effect (Athamna et al., 2004) that induces bacterial cell death through 
inhibition of DNA-gyrase and topoisomerase-IV (Mackenzie and Gould, 1993; Vance-
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Bryan et al., 1990). CIP also has an attractive pharmacokinetic profile allowing it to 
distribute throughout the body and achieving adequate concentrations within 
peripheral tissues (such as the dermis and epidermis) when given orally and 
parenterally (Vance-Bryan et al., 1990). However, CIP, like other fluoroquinolones, has 
significant drawbacks when used systemically. In addition to adverse drug reactions 
such as Achilles tendonitis and QT prolongation (Prabhakar and Krahn, 2004; Vance-
Bryan et al., 1990), the quinolone class of antibacterials have a close association with 
the development of secondary Clostridium difficile superinfections (Dingle et al., 2017). 
Therefore, delivering CIP topically for skin and skin structure infections could 
overcome these risks as systemic concentrations will be much lower than in current 
practice. 
 
CIP has two dissociation constants of 6.1 (pKa1) and 8.7 (pKa2). In acidic environments 
CIP exists predominantly as a cation with dissociation of hydrogen from the carboxylic 
acid group increasing above pH 4 to form zwitterionic species (figure 3.1) that 
dominate between pH 6.1 and 8.7. Maximum zwitterionic species exists around pH 7.2 
(isoelectric point, pI), above which the proportion of zwitterionic species decreases as a 
second hydrogen dissociates from the heterocyclic amine group to form an anionic 
species, which completely dominates above pH 10 (Vasudevan et al., 2009; Wang et al., 
2011). 
 
A number of teams have reported the interaction between CIP and a range of clay-
minerals, determining the mechanism of these interactions and how the properties of 
the dispersion can affect the nature of the interaction (Wang et al., 2011, 2010; Wu et 
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al., 2010). Whilst this portfolio of work is much smaller than that for tetracyclines (see 
section 2.1), Wang and colleagues have undertaken considerable research 
investigating the mechanism of CIP adsorption onto clay-mineral particles and 
proposed a molecular arrangement within the interlayer space (Wang et al., 2011, 
2010).  
 
The findings presented in this chapter, published early 2014 (Hamilton et al., 2014), is 
the only known study investigating CIP-clay composites as antibacterial materials for 
the treatment of infections. The differing structure and chemistry of CIP, compared to 
the tetracyclines, makes it an interesting drug to investigate and determine whether 
the findings and theories regarding drug adsorption developed in chapter 2 are 
transferable to other molecules.  Its broader spectrum of activity also makes CIP an 
important drug to investigate to determine whether it can be used in the formulation 
of phyllosilicate-polymer wound-care products. For this reason, the clay-CIP 
composites formed were tested against the same common skin and skin structure 
pathogens Staphylococcus epidermidis, Propionibacterium acnes, and Pseudomonas 
aeruginosa.  
 
Figure 3.1. Chemical structure of ciprofloxacin in its zwitterionic form (drawn with Chemdraw Chem3D, 
Perkin Elmer) 
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The chemical and structural properties of clay-minerals was shown to play a significant 
role in TC and DC adsorption, so three were chosen for studying the adsorption of CIP 
based on their chemical and physical properties; kaolin (KN) as a 1:1 clay mineral with 
minimal surface area, low surface charge, and low CEC; Laponite® RD (LRD) as a 2:1 
clay mineral with large surface area, moderate surface charge, large CEC, and 
attractive dispersion properties; and montmorillonite K-10 (MMTK10), which is an 
acid-activated 2:1 montmorillonite clay mineral, with moderate surface area, high 
surface charge, moderate CEC, and reduced dispersion potential (see chapters 1 and 2 
for more information).  
 
 
  
Chapter 3                             Interaction between phyllosilicates and ciprofloxacin 
Page 108 of 260 
3.2. Materials and methods 
3.2.1. Materials 
Kaolin (KN), Laponite RD (LRD) and montmorillonite K-10 (MMTK10) were sourced as 
described in section 2.2.1.  Ciprofloxacin (>98% by HPLC), hereafter CIP, was obtained 
from Sigma Aldrich UK. 
 
3.2.2. Adsorption of ciprofloxacin 
3.2.2.1. Effect of dispersion pH 
One gram of clay mineral was dispersed in 80 mL of deionised water for 2 h at 7000 
rpm. After this initial dispersion period the pH was adjusted to between 1 and 12 using 
dilute NaOH or HCl.  A 12.5 mg/mL CIP solution was made by dissolving CIP in dilute 
HCl to produce the more soluble hydrochloride form, which was then adjusted to the 
relevant pH and left to stand for 30 minutes to ensure solubility (Roca Jalil et al., 2015; 
Varanda et al., 2006). The CIP solution was then added to the clay mineral dispersion 
of corresponding pH. After confirming the pH of the dispersion the adsorption was 
continued for 24 h and each experiment was undertaken in triplicate.  
 
Aliquots of the dispersions were centrifuged and the amount of CIP remaining in 
supernatant determined with UV-Visible spectrophotometry (Genesys 10V, Thermo 
Scientific), scanning between 200-400 nm. Standard curves (R2 => 0.998) of UV-vis 
absorption against CIP concentration were obtained at different pH to account for 
λmax shifts occurring at different pH (275 nm and 315 nm at pH 1 to 4, 275 nm and 
320 nm at pH 5 to 8.7, then 270 nm and 320 nm at pH 9 to 12). Measurements were 
performed in triplicate.  
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3.2.2.2. Adsorption kinetics and isotherms 
Methods from sections 2.2.2.2 and 2.2.2.3 were modified for studying CIP adsorption 
kinetics and adsorption isotherms. For adsorption kinetics the concentration of clay 
mineral used was 500 mg/100 mL KN, 100 mg/100 mL MMTK10, or 10 mg/100 mL LRD 
with 2 mg/100 mL of CIP. For adsorption isotherms the concentration of each clay 
mineral used was 250 mg/25 mL with a range of CIP concentrations between 0.5 and 
10.0 mg/mL. All dispersions were adjusted to pH 7.2 before and after adding CIP, and 
were repeated in triplicate. 
 
3.2.3. Mechanism of clay-ciprofloxacin interactions 
X-ray diffractograms were obtained on a Rigaku miniflex (CuKα1 radiation source) and 
FTIR spectra were obtained on a Perkin Elmer Spectrum BX FT-IR spectrometer 
(GladiATR attachment). The specifics of these analytical methods used are given in 
section 2.2.3. 
 
3.2.4. Antibacterial activity assessment 
Zone of inhibition testing was undertaken in triplicate as per section 2.2.4. The 
concentration range of CIP standards was 5 µg/mL to 250 µg/mL, which were slightly 
acidified with HCl to enable dissolution. Blank wells containing acidified water were 
assessed to ensure the HCl was not contributing to the antibacterial effects of the CIP 
standard solutions. 
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3.3. Results and discussion 
3.3.1. Effects of dispersion pH on ciprofloxacin adsorption 
For all three clay minerals tested the dispersion pH played an important role in 
determining drug adsorption onto the clay mineral surface (figure 3.2). A dispersion pH 
of 7.2 was shown to allow the greatest amount of CIP adsorption onto the surface of 
all three clay minerals tested and corroborates published literature that showed 
maximum adsorption occurs when CIP is in the zwitterionic form (Gu and Karthikeyan, 
2005; Wang et al., 2010; Wu et al., 2010). These findings also support the theory 
developed in chapter 2 that inducing a zwitterionic state in a drug molecule may 
enhance its interaction with a clay mineral surface. 
 
 
Figure 3.2. The effects of dispersion pH on the adsorption (mean ±SD, n=3) of ciprofloxacin onto KN 
(blue triangles), MMTK10 (red circles), and LRD (green squares). 
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In chapter 2 the improved affinity for TC and DC in the zwitterionic form was 
postulated to be due to the attraction of the positive group and the repulsion of the 
negative groups from the clay mineral surface, leading to a more favourable 
arrangement of drug molecules at the clay mineral surface. In CIP these charged 
groups are positioned at opposite ends of the molecule (figure 3.1), unlike in TC and 
DC (figure 2.1), which may have significant impact on its arrangement at the clay 
mineral surface. It may be possible for CIP to take on an almost vertical arrangement at 
the clay mineral surface (Carrasquillo et al., 2008; Rivera et al., 2016), minimising the 
surface area of the clay mineral occupied by the adsorbed molecules, thus allowing 
more molecules to be adsorbed per unit of available clay mineral surface area.  
 
When the dispersion pH is below 6.1 CIP will increasingly be in its mono-cationic form, 
which still allows for interactions with the negatively charged clay mineral surfaces 
(Wang et al., 2010). However, as the dispersion became more acidic the amount of CIP 
adsorbed decreased. Whilst the positive charge is favourable for interactions with the 
clay mineral surface, the lack of negative charge at the apical end of the molecule may 
result in a less than ideal arrangement of CIP at the clay mineral surface. The highly 
acidic environment may also have caused significant changes to the clay mineral 
structure through dissolution of the metallic tetrahedral sheet (Komadel, 2003; 
Madejova, 2003) resulting in a reduced affinity between the remaining silica mass and 
the CIP molecules in dispersion.  
 
As the dispersion pH increased above 8.7 the adsorption of CIP onto all the clay 
minerals used was also greatly reduced. CIP will be in the mono-anionic form at high 
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pH and these data show this is not favourable for interaction with clay minerals. It is 
possible that anionic CIP molecules interact with the positive groups exposed at the 
edge of the clay mineral particles (Wang et al., 2010). However, as the pH of the 
dispersion increased beyond pH 9 the edge groups on the clay mineral layers 
deprotonate to become negatively charged (Lagaly and Ziesmer, 2003; Thomas et al., 
1999) and are likely to repel any negatively charged CIP molecules. Yet at pH 11 and 12 
the adsorption of CIP onto MMTK10 and KN was not insignificant. The mono-negative 
CIP molecules should be repelled from the negatively charged clay layers so the 
adsorption detected in these experiments may be due to alternative interactions such 
as van der Waals forces (Carrasquillo et al., 2008) and hydrogen bonding (Wang et al., 
2010).  
 
Differences in CIP adsorption patterns were observed between KN and MMTK10. The 
low adsorption onto KN can be anticipated by its small surface area, low charge, and 
small CEC (Kahr and Madsen, 1995) but, surprisingly, the difference in the amount of 
CIP adsorbed at pH 7.2 was not significantly different between the three clay minerals 
used. Given the chemistry of KN, MMTK10, and LRD it would be expected that KN 
would adsorb a smaller amount of CIP whereas LRD would adsorb the most (Kahr and 
Madsen, 1995; Thompson and Butterworth, 1992). The similar amounts of adsorption 
observed at the isoelectric point could indicate that equilibrium was reached in the 
MMK10 and LRD experiments and the methodology used would not distinguish 
adsorption capacity (Parfitt and Rochester, 1983; Wang et al., 2010). These data could 
also indicate that CIP adsorption at pH 7.2 also involves secondary adsorption 
pathways other than CEC and direct surface interactions, allowing significantly more 
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adsorption onto KN (Carrasquillo et al., 2008; Wang et al., 2010; Wu et al., 2010). 
Studies designed to specifically investigate the kinetics and isotherms of adsorption 
were undertaken to better understand the adsorption of CIP onto clay minerals at pH 
7.2. 
 
3.3.2. Adsorption kinetics 
The majority of CIP adsorption onto KN, MMTK10 and LRD took place within the first 
ten minutes (figure 3.3). The adsorption of CIP onto all three clay minerals was shown 
to fit the pseudo-second order model (table 3.1). 
 
Even though KN adsorbed CIP at the lowest rate the system reached equilibrium after 
1 hour, after which no change in the concentration of CIP remaining in the supernatant 
was detected (figure 3.3 A). The amount of CIP adsorbed onto each clay mineral was 
calculated by UV-Vis spectrophotometry of the supernatant and compared to the 
estimated amount adsorbed (qe, see table 3.1). The percentage difference between 
these values was small for each clay mineral tested, supporting the conclusion that the 
adsorption followed pseudo-second order kinetics. 
 
As for the adsorption kinetics of TC and DC onto clay minerals, large differences in CIP 
adsorption were observed as a result of the clay mineral chemistry, structure, and 
properties (see chapter 2). As expected, KN had the slowest initial rate of adsorption 
and the lowest amount of drug adsorption over the time tested. Both of which can be 
explained by its negligible charge and small surface area (Miranda-Trevino and Coles, 
2003).  
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Figure 3.3. Amount of CIP adsorbed (mean ±SD, n=3) onto (A) KN, (B) MMTK10 and (C) LRD at pH 7.2 at 
defined time-points. Figure D gives pseudo-second order adsorption kinetics (mean ±SD, n=3) and 
goodness of fit (R
2
) for CIP onto KN (blue squares), MMTK10 (red diamonds) and LRD (green triangle).  
 
 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
0 20 40 60
C
IP
 a
d
so
rb
ed
 (
m
g/
g)
 
Time (minutes) 
0
5
10
15
20
25
0 20 40 60
C
IP
 a
d
so
rb
ed
 (
m
g/
g)
 
Time (minutes) 
0
25
50
75
100
125
150
175
200
225
0 20 40 60
C
IP
 a
d
so
rb
ed
 (
m
g/
g)
 
Time (minutes) 
R² = 0.9999 
R² = 1.0000 
R² = 0.9993 
0
0.05
0.1
0.15
0.2
0.25
0.3
0 0.5 1
t/
Q
t 
Time (hours) 
A B 
C D 
Chapter 3                             Interaction between phyllosilicates and ciprofloxacin 
Page 115 of 260 
Table 3.1. Goodness of fit (R
2
) of pseudo-first and pseudo-second order kinetic models for the 
adsorption of CIP onto the selected clay minerals at pH 7.2. Where K is the rate constant, qe is the 
estimated amount of drug adsorbed, and %diff qe is the difference between the estimated CIP adsorbed 
and that measured. 
 
Clay 
Mineral 
Pseudo 1
st
 Order  Pseudo 2
nd
 Order 
  
(R
2
) 
  
 (R
2
) 
Initial rate 
(mg/g h) 
K  
(g/mg h) 
qe 
(mg/g) 
 
%diff qe 
KN 0.4097  0.9999 523.56 31.92   4.05 1.92 
MMTK10 0.4969  0.9999 8333.33 19.66 20.59 0.78 
LRD 0.0765  0.9982 ∞ ∞ 175.44 1.84 
 
 
LRD adsorbed CIP at a much faster rate than MMTK10, and was able to adsorb more 
onto its very large surface area. All the clay minerals were dispersed in water before 
the adsorption experiments were undertaken, which would have allowed the LRD 
layers to separate from each other, greatly increasing the surfaces available for CIP 
adsorption (Mongondry et al., 2005). MMTK10 is not able to swell or exfoliate to the 
same extent as LRD because the acid activation process can lock the layers of 
montmorillonite together through the formation of amorphous silica (Madejova, 2003). 
The effects of this dispersion process can be seen by comparing the initial rates of CIP 
adsorption onto MMTK10 and LRD. Due to the extremely rapid adsorption onto LRD 
the rate was immeasurable (∞ mg/g h, see table 3.1).  
 
When Wang et al. (2011) compared the adsorption of CIP onto three different clay 
minerals they found that montmorillonite had the fastest initial adsorption rate 
compared to rectorite and illite. As montmorillonite is a swelling clay this supports the 
conclusion that clay mineral swelling and exfoliation allows for rapid adsorption of CIP 
(Wang et al., 2011). The initial rate of adsorption of CIP onto all three clay minerals 
used in these experiments (KN, MMTK10, and LRD) was much greater than that for the 
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adsorption of TC and DC (table 2.1). This finding has also been reported by other 
research teams (Wang et al., 2011; Wu et al., 2010) who also found the estimated qe 
was much higher for CIP than for TC.  
 
3.3.3. Adsorption isotherms 
The CIP adsorption isotherms for each clay mineral were related to their structure and 
chemistry. For example, KN has the smallest surface area and charge, so little CIP was 
needed to form a monolayer on its surface (figure 3.4 A). Due to their increased CEC 
and SSA much more CIP could be adsorbed onto MMTK10 and LRD (Miranda-Trevino 
and Coles, 2003).  
 
Monolayer coverage was directly observable for KN and MMT10, but not for LRD 
which appeared to continue adsorbing CIP (figure 3.4 C). Therefore, more CIP would 
need to be added to the system to directly detect monolayer formation. However, due 
to the acidity of concentrated CIP solutions it was impossible to add such high 
quantities of CIP without causing dissolution of metal ions from the LRD structure, or 
causing subsequent precipitation of CIP when the concentrated dispersions were 
adjusted to pH 7.2. 
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Figure 3.4. Adsorption isotherms (n=3) for the adsorption of CIP onto (A) KN, (B) MMTK10, and (C) LRD 
at pH 7.2. 
 
 
The adsorption isotherms for KN and MMTK10 were typical Langmuir isotherms, 
whereas the isotherm for LRD resembled that of a Freundlich isotherm (Parfitt and 
Rochester, 1983). This was proven mathematically when the adsorption isotherms for 
KN and MMKT10 showed better fit to the Langmuir model and LRD showed better fit 
to the Freundlich model (table 3.2). These results may be due to a monolayer not 
being achieved or detected by the LRD experiments. The first section of a Langmuir-
like adsorption isotherm (i.e. the initial steep incline) generally fits the Freundlich 
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model, so it could be possible that the isotherm obtained for the adsorption of CIP 
onto LRD was actually the initial, Freundlich-like, section of a Langmuir-like adsorption 
isotherm (Parfitt and Rochester, 1983). However, as the Freundlich isotherm describes 
reversible multilayer adsorption (Chen, 2015) it is likely that these results prove LRD 
can adsorb many layers of CIP. 
 
 
Table 3.2. Correlation of fit between experimental adsorption data to the Langmuir, Freundlich, and 
Tempkin adsorption isotherm models. Where Sm is the monolayer coverage, bF is a dimensionless value 
for adsorption intensity, and B is the energy of adsorption. 
 
Clay Mineral Langmuir Model Freundlich Model Tempkin Model 
 Fit (R
2
) Qml (mg/g) Fit (R
2
) bF Fit (R
2
) B (J/mol) 
KN 0.942 39.84 0.690 0.393 0.841 2.09 
MMTK10 0.959 123.47 0.845 0.260 0.882 14.52 
LRD 0.834 714.29 0.989 1.005 0.818 390.81 
 
 
Significantly less CIP was required to form a monolayer on KN compared to MMTK10, 
which was significantly less than that for LRD. KN has a very small SSA and CEC giving it 
less capacity to adsorb CIP, compared to LRD, which has a vastly greater SSA and CEC. 
Literature correlates with these findings and suggest that although SSA is an important 
property to consider, CEC may have a greater role to play in determining adsorption 
capacity (Wang et al., 2010).  
 
The intensity of adsorption (bF) was greatest for CIP adsorbing onto LRD than for the 
other two clays, which may be explained by the large surface charge that LRD particles 
carry (Pálková et al., 2010). However, this does not hold true for the adsorption of CIP 
onto MMTK10 as the intensity of adsorption was lower than calculated for KN. 
Adsorption intensity has been shown to change over the pH range (section 2.3.3) and it 
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may be possible that pH 7.2 does not allow for intense interactions between CIP and 
MMTK10. Another explanation may be that the CIP molecules do not interact well with 
the areas that have undergone acid-activation and the Brønsted-acid sites present do 
not favour CIP adsorption (Komadel, 2003). 
 
Whilst the isotherm data does not fit the Tempkin model as well as the Langmuir or 
Fruendlich models (table 3.2) it is still possible to derive assumptions about the heat of 
adsorption (B, J/mol) within these adsorption processes. Overall, the heat of 
adsorption indicates that CIP adsorbs onto the clay minerals via physisorption rather 
than chemisorption (Itodo and Itodo, 2010; Puttamat and Pavarajarn, 2016). The 
higher heat of adsorption of CIP onto LRD indicates greater surface coverage and may 
also suggest there is greater CIP-CIP interaction taking place than in the other systems 
(Dada et al., 2012). This is further supported by the work of Wu et al (2010), who 
reported that cation exchange is not the only mechanism of CIP adsorption onto clay 
minerals and other forms of interaction can contribute. 
 
3.3.4. XRD analysis 
The interlayer spacing for the clay minerals alone, physical blends of the clay minerals 
with CIP, and selected clay mineral-CIP composites was determined through the d001 
value as previously described (see section 2.3.4). 
 
As expected, the interlayer space of KN was found be to be smaller than the MMTK10 
and LRD due to its 1:1 structure and tight junctions between its layers (Miranda-
Trevino and Coles, 2003). Non-significant changes in the d001 value were observed 
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when CIP was adsorbed onto KN and it can be assumed that no change in the size of 
the interlayer space occurred (table 3.3). It is therefore likely that the CIP adsorbed 
onto the external surfaces of KN only (Miranda-Trevino and Coles, 2003). This supports 
the data obtained from the adsorption studies above, whereby the low amount of CIP 
adsorption was attributed to a small surface area. 
 
Interestingly, the d001 peak for MMTK10 was observed to shift to the left, indicating an 
increase in the interlayer space (figure 3.5) (Chang et al., 2009; Parolo et al., 2008). No 
difference in the size of the interlayer space was observed between the pure MMTK10 
sample and the physical blend of MMTK10 and CIP. However, increases in the 
interlayer space were seen as the amount of CIP adsorbed increased (table 3.3). 
 
 
Table 3.3. Interlayer spacing measured by pXRD for the clay minerals alone, physical blends with CIP, 
and selected clay-CIP composites of increasing drug-loading. 
Clay mineral Sample CIP Concentration  
(mg/g) 
Interlayer Space  
(Å) 
KN Control (non-modified) - 7.19 
 Physical blend 50.00 7.19 
 KN-CIP (low concentration) 4.79 7.15 
 KN-CIP (mid concentration) 27.54 7.15 
 KN-CIP (high concentration) 81.53 7.16 
MMTK10 Control (non-modified) - 9.94 
 Physical blend 100.00 9.95 
 MMTK10-CIP (low concentration) 49.76 14.00 
 MMTK10-CIP (mid concentration) 90.70 17.28 
 MMTK10-CIP (high concentration) 117.02 16.75 
LRD Control (non-modified) - 13.57 
 Physical blend 100.00 13.67 
 LRD-CIP (low concentration) 15.85 12.71 
 LRD-CIP (mid concentration) 104.31 13.84 
 LRD-CIP (high concentration) 128.09 13.48 
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A slight decrease in the d001 value was observed for the sample with the highest drug 
loading but this may not necessarily be due to a reduction in the size of the interlayer 
space. As seen in figure 3.5 the d001 peak for the sample with the highest drug load was 
not uniform in shape and was broad in nature. The non-uniformity of the peak 
indicates a loss in regularity of the distance between the clay mineral layers and peak 
broadening is an indication of exfoliation (Chang et al., 2009; Kaufhold and Dohrmann, 
2009; Lee and Kim, 2002).   
 
Theoretically, the exfoliation of MMTK10 and other acid activated clays is difficult. As 
the acidic medium induces the dissolution of the octahedral sheet, to form amorphous 
silica networks, the edges of these particles can become conjoined making it unlikely 
for them to swell and exfoliate (Komadel, 2003; Zhao et al., 2013). However, it cannot 
be denied that a change in the d001 peak was observed for the adsorption of CIP onto 
MMTK10. This shift may have been caused by an increasing distance between particles 
of MMTK10 and not the individual layers. It would be necessary to utilise additional 
imaging methods that can resolve the individual clay layers and the interlayer spacing, 
such as transmission electron microscopy (TEM) (Lee and Kim, 2002). 
 
A change in interlayer space was not observed for the adsorption of CIP onto LRD. It 
was expected that swelling clay minerals, such as LRD, would demonstrate expansion 
of the interlayer space through the adsorption of organic molecules, a small decrease 
in interlayer space was actually observed when a small amount of CIP had been 
adsorbed onto the LRD. 
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Figure 3.5. X-ray diffractions for CIP adsorbed onto MMTK10. Colours of the lines represent different CIP 
concentrations of 49.76 mg/g (red), 90.70 mg/g (blue), and 117.02 mg/g (green). 
 
In solution LRD almost fully disperses into its individual layers and may be flocculated 
by the adsorption of inorganic and organic cations (Ramsay, 1986). The adsorption of 
CIP onto the surface of LRD may have been enough to cause a degree of flocculation, 
and thus shrinkage of the interlayer space. However, the d001 value increased back to 
its original value upon further adsorption of CIP. This may have been caused by the CIP 
molecules forcing the LRD layers apart, or may indicate the initial decrease in 
interlayer spacing was an artefact of the XRD analysis process. Moreover, the initial 
interlayer spacing was quite large and the peak was not well defined on the LRD or 
LRD-CIP blend samples. This could indicate that the interlayer spacing was not regular 
to start with, and due to its colloidal, dispersive, behaviour it is unlikely to display a 
regular interlayer space like montmorillonite and other smectites do. It is likely that CIP 
will bind to the exposed surfaces of the individual LRD layers and have no discernible 
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effect on the relative distances between the LRD layers, and thus no detectable change 
on the XRD traces. 
 
3.3.5. FTIR analysis 
Infrared adsorption for the clays and CIP enabled interpretation of the interaction 
between CIP and the clay mineral surfaces. The spectra for the unmodified clays 
showed the characteristic Si-O stretching band at 900-1100 cm-1 along with metallic-
group (M-OH) absorbance between 600-900 cm-1 (Madejova, 2003). Clear differences 
in the shape and wavenumber of the Si-O absorption were seen between the three 
clay minerals, with MMTK10 having the greatest difference. Muting of the metal 
hydroxide peaks around 800 cm-1 is a clear demonstration of the metal dissolution 
effects of acid activation on the clay mineral structure (Tyagi et al., 2006). No changes 
in the absorbance peaks from the clay minerals were seen in the composite samples 
proving that the adsorption process did not result in further dissolution of metal ions 
from the clay mineral sheets. 
 
The fingerprint region of CIP was clearly defined for the drug alone, and when present 
within physical mixtures and composites. The absorbance peak for the positively 
charged amino group was identified at 1373 cm-1 in the physical blend of CIP and 
MMTK10, but this shifted to 1384 cm-1 when adsorbed onto the surface of MMTK10 
(figure 3.6) This shift indicates an interaction between the positively charged amino 
group on the CIP molecule, and the negatively charged clay mineral surface (Trivedi 
and Vasudevan, 2007; Wang et al., 2011; Wu et al., 2010).  
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Figure 3.6. FTIR spectra CIP (grey line), a physical blend of MMTK10 and CIP (red line) and a MMTK10-
CIP composite (blue line).   
 
 
A shift of the absorbance from 1617 cm-1 in the physical blend to 1631 cm-1 in the 
composite represents an electron withdrawing effect from the ketone group adjacent 
to the carboxyl group (Wu et al., 2010). Other studies utilising FTIR to examine the 
interaction between CIP and clay minerals suggest that this negatively charged region 
can interact with the edge-sites of clay minerals (Wang et al., 2010), interact directly 
with the clay mineral surface (Chang et al., 2016), or the interlayer cations (Rivera et al., 
2016). The shift in absorbance representing electron withdrawal from the ketone 
group suggests that such an interaction could also be taking place here.  
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Therefore, it is likely that CIP remained as a zwitterion during the adsorption process 
and it is possible that both the positive and negatively charged regions are interacting 
with the clay minerals. 
 
3.3.6. Antibacterial properties 
The clay-minerals on their own did not produce any zones of inhibition whereas 
solutions of CIP did create zones of inhibition. As the concentration of the CIP solution 
increased so did the zone of inhibition, proving that any zones of inhibition created by 
the clay-CIP composites was due to desorption and diffusion of CIP from the 
composites. As expected, due to its mode of action (Vance-Bryan et al., 1990; 
Wispelwey, 2005), CIP was active against all three strains of bacteria including P. 
aeruginosa. The zone of inhibition increased in size as the CIP concentration in the 
composite increased (figure 3.7), confirming that increasing amounts of CIP could be 
released from these composite materials as the drug-loading was increased.  
 
Important differences can be seen across the concentrations of drug-loading within 
the composites. As the concentration of CIP in the composites increased from ‘low’ to 
‘medium’ the change in zone of inhibition size was very large. However, the change in 
zone size between the composites marked as ‘medium’ and ‘high’ drug-loading was 
not as impressive. Within the composites marked as ‘low’ the CIP had not formed a 
monolayer and was therefore interacting more strongly with the clay-mineral surface, 
resulting in little desorption of CIP and therefore small zones of inhibition. In the 
composites marked as ‘medium’ and ‘high’ CIP had formed a monolayer at the clay-
mineral surface and any additional absorbed CIP was likely interacting via weaker 
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forces, not related to cation-exchange processes (Parfitt and Rochester, 1983; Wu et 
al., 2010; Yan et al., 2012), and could be more easily desorbed from the composites.  
 
 
 
          
Figure 3.7.  Zones of inhibition (mean ±SD, n=3) formed by clay-CIP composites, of various drug-loading 
(mg/g), against S. epidermidis (A), P. acnes (B), and P. aeruginosa (C).  
 
 
KN-CIP composites with ‘low’ drug loading created much larger zones of inhibition than 
MMTK10-CIP composites with ‘low’ CIP loading. This shows that KN holds onto CIP less 
strongly than MMTK10, probably due to its lower surface charge (Kahr and Madsen, 
1995). The small difference between the size of the zones formed by composites of 
0
5
10
15
20
25
30
4
.7
9
2
7
.5
4
8
1
.5
3
4
9
.7
6
9
0
.7
0
1
1
7
.0
2
1
5
.8
5
1
0
4
.3
1
1
2
8
.0
9
KN-CIP MMTK10-
CIP
LRD-CIP
Zo
n
e 
o
f 
in
h
ib
it
io
n
 (
m
m
) 
4
.7
9
2
7
.5
4
8
1
.5
3
4
9
.7
6
9
0
.7
0
1
1
7
.0
2
1
5
.8
5
1
0
4
.3
1
1
2
8
.0
9
KN-CIP MMTK10-
CIP
LRD-CIP
4
.7
9
2
7
.5
4
8
1
.5
3
4
9
.7
6
9
0
.7
0
1
1
7
.0
2
1
5
.8
5
1
0
4
.3
1
1
2
8
.0
9
KN-CIP MMTK10-
CIP
LRD-CIP
A B C 
Chapter 3                             Interaction between phyllosilicates and ciprofloxacin 
Page 127 of 260 
‘medium’ and ‘high’ drug loading may be attributed to the time-limited nature of the 
experiments which may have prevented all of the available CIP from diffusing into the 
agar. As deionised water was used to disperse the composites it is possible that the 
zones of inhibition observed in these experiments are due to a burst-release of CIP 
from the composites and that further CIP could have been dispersed from the clay 
mineral surface if cations had been present for exchange (Jung et al., 2008; Parolo et 
al., 2010).  
 
These experiments prove that the CIP within the clay-CIP composites remains active 
against these three important wound pathogens, and are therefore interesting and 
exciting materials worthy of further research. However, the behaviour of these 
materials in the wound environment and drug release studies will be needed to gain 
more understanding into the nature of CIP desorption from these materials. 
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3.4. Conclusions 
This research shows that CIP is adsorbed more abundantly onto clay minerals when 
conditions favour the zwitterionic form, which may be explained by the relative 
position of the charges on the CIP molecule that could favour perpendicular 
arrangement and tighter packing at the clay mineral surface. Adsorption was rapid 
onto KN and MMTK10, and immeasurably fast in the case of LRD. Adsorption followed 
pseudo-second order kinetics. Isotherms for KN and MMTK10 best fitted the Langmuir 
model whereas LRD isotherms fitted more closely to the Freundlich model; though this 
may have been due to experimental limitations.  
 
FTIR analyses indicated that both the positively charged amino-group and the 
negatively charged carboxyl-group could interact with the clay minerals. This suggests 
that CIP can interact with both the clay mineral surface and edge groups. Multiple 
mechanisms of adsorption may therefore be possible including cation exchange, direct 
complexation, van der Waals interactions, and even hydrogen bonding. Unfortunately, 
the experiments utilised above were unable to quantify these differing interactions. 
XRD data did prove that CIP can be incorporated into the interlayer space of MMTK10 
and LRD but was limited to the external surfaces of KN. 
 
CIP containing composites were shown to be effective against S. epidermidis, P. acnes 
and P. aeruginosa and unlike composites of TC and DC, which had questionable activity 
against P. aeruginosa (section 2.3.6), clay-CIP composites were proven to have 
promising activity against this organism. However, similar patterns between drug-
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loading and activity were seen between TC, DC and CIP as KN-drug composites more 
easily relinquished their drug load.  
 
These data prove that findings discussed in chapter 2 are not specific to TC and DC, but 
can also be applied to other drug molecules. However, CIP, TC and DC are small 
molecules and investigating the adsorption of larger, more complex, antimicrobials 
currently used to treat bacterial skin and skin-structure infections (SSSIs) such as 
clarithromycin, clindamycin, dalbavancin, and vancomycin (Roberts et al., 2015; Seaton, 
2009; Stevens, 2009; Unal, 2009) will be needed to fully develop a wider theorem 
regarding antimicrobial adsorption onto clay minerals.  
 
The results presented above suggest that clay-CIP composites could be promising 
materials to use in the treatment of SSSIs. However, powders and pastes are not ideal 
materials for use in wounds and SSSIs so a more clinically and patient acceptable 
material needs to be developed (Bennett-Marsden, 2010). Chapter 4 will investigate 
the incorporation of clay-CIP composites into polymeric matrices for the development 
of materials that are appropriate for use on wounds. 
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Chapter 4 
Development and evaluation of antibacterial wound 
dressing materials 
 
4.1. Introduction 
Wound care and the treatment of diseases of the skin are well defined disciplines 
within the NHS in England and patients are often managed by a multidisciplinary team 
of medics, nurses, and pharmacists, amongst others (Bennett-Marsden, 2010; National 
Prescribing Centre, 2012). Regardless of the wound dressing section of the British 
National Formulary being one of the fastest growing sections, there is a noticeable lack 
of topical products that are able to directly treat bacterial skin and skin structure 
infections (Davis and Mclister, 2016; Joint Formulary Committee, 2017; Morgan, 2002). 
Where antibacterial therapy is indicated this is generally in the form of systemic 
treatments given orally, for mild to moderate infections, or parenterally, for severe 
infections (Healy and Freedman, 2006; Siddiqui and Bernstein, 2010).  
 
In this chapter the potential of phyllosilicate containing materials for wound care will 
be explored. However, in order to design a potential wound-care material it is 
important to understand the pathophysiology of wounds and skins and skin-structure 
infections alongside the pharmaceutics and therapeutics of modern wound care 
products 
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4.1.1. An overview of wounds, wound healing, and the role of infection 
Wounds can be described as breaks or disruptions in the normal skin structure or 
function. Acute wounds, such as minor incisions and most abrasions, generally require 
up to 12-weeks for healing to be complete. However, more severe wounds such as 
pressure sores, vascular and diabetic foot ulcers, deep incisions and chronically 
infected wounds can take months, sometimes, years to resolve (Boateng et al., 2008; 
Leaper, 2006; Siddiqui and Bernstein, 2010). While the diameter of a wound may 
initially indicate the severity, the depth of the wound is an important factor to consider 
(Grey et al., 2006). Superficial wounds generally involve the epidermis only whereas 
partial-thickness wounds are the result of damage to both the epidermis and dermis. 
Full-thickness wounds are much deeper and involve the epidermis, dermis, and sub-
dermal layers such as subcutaneous fat, muscle, and even the bone (Boateng et al., 
2008; Cockbill, 2002). The time taken to heal will depend on the width and depth of 
the wound, but will also depend on patient specific factors such as nutrition status and 
any comorbidities (Cockbill, 2002; Hanna and Giacopelli, 1997).  
 
The process of wound healing is often described over four or five overlapping stages 
(Boateng et al., 2008). The initial stage, which occurs within seconds of injury, is 
haemostasis. The primary aim of bleeding is to flush debris and microorganisms from 
the wound and to deliver important components to the wound such as clotting factors 
and platelets. Exposed collagen activates platelets which in turn trigger a number of 
subsequent actions. Activated platelets trigger the clotting cascade, which results in 
the transformation of fibrinogen in the blood to a fibrin mesh that plugs the wound 
(commonly known as a scab) stopping any further blood loss and protecting the wound 
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from external influences such as bacteria. This fibrin-rich clot also supports the 
subsequent stages of wound healing, described below, by providing a scaffold for 
fibroblasts, keratinocytes, and collagen. As well as initiating the clotting process, 
activated platelets also release a number of important cytokines that result in the 
recruitment of fibroblasts, keratinocytes, and neutrophils to the wound and also 
initiate the process of angiogenesis (Boateng et al., 2008; Hanna and Giacopelli, 1997; 
Strodtbeck, 2001; Williamson and Harding, 2004). 
 
The next stage of healing, which often happens simultaneously alongside haemostasis, 
is the inflammatory phase. Recruitment of neutrophils to the environment results in 
further release of cytokines including histamine and serotonin, which results in 
vasodilation and allows for additional white cells such as monocytes to migrate to the 
wound. Neutrophils ingest and destroy bacteria until infection has been eradicated, 
after which the monocytes differentiate into macrophages that destroy dead 
neutrophils, remove dead cell matter, and release nitric oxide to promote wound 
healing. Macrophages remain present within the wound for the duration of the healing 
process, regulating the different processes within the wound bed through the release 
of cytokines (Boateng et al., 2008; Hanna and Giacopelli, 1997; Strodtbeck, 2001; 
Williamson and Harding, 2004).  
 
The third and fourth stages of wound healing are often described together but the 
process of migration is often completed before proliferation. During migration 
keratinocytes move across the wound surface using the fibrin and fibronectin network 
of the clot, the wound bed, and each other as a network. Wound exudate is vital 
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during this process to enable the keratinocytes to move freely across the wound. Dry 
wound environments cause the keratinocytes to burrow until they find moisture to 
support this process, which can lead to scarring in later stages of wound healing. 
Migration of the keratinocytes continues until they meet in the middle and the wound 
surface is enclosed underneath the clot. Not only does this act to create another 
barrier to the proliferating wound-bed but it also generates a hypoxic environment, 
which is key to promoting angiogenesis to support proliferation and healthy wound 
healing (Boateng et al., 2008; Hanna and Giacopelli, 1997; Strodtbeck, 2001; 
Williamson and Harding, 2004).  
 
Occurring alongside the migration of keratinocytes is a stage known as proliferation. 
During this stage, the fibrin network is gradually replaced by hyaluronan and 
fibronectin, which act as supports for cellular growth, protein structures, and 
revascularisation. Fibroblasts utilise the hyaluronan and fibronectin scaffold to lay 
down collagen, which adds additional strength to the wound bed and allows groups of 
fibroblasts to differentiate into myofibroblasts. These myofibroblasts are able to 
contract and pull the edges of the wound inwards, which adds further structural 
support to the proliferating wound bed, reducing the overall size of the wound so that 
migration can be completed more quickly and biochemical requirements are reduced. 
During this stage of healing the fibroblasts and macrophages continue to release 
cytokines that support angiogenesis and proliferation of the lymphatic system 
(Boateng et al., 2008; Cockbill, 2002; Hanna and Giacopelli, 1997; Strodtbeck, 2001). 
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The role of exudate is not limited to easing the migration of keratinocytes but plays an 
important role in the whole of the wound healing process as it prevents desiccation of 
new cells; promotes autolysis and debridement of dead tissue; provides compounds 
necessary for wound healing such as electrolytes, minerals, proteins and saccharides. 
Wound exudate is also vital for the recruitment of leucocytes into the environment, 
which play an important role in removing bacteria and other microorganisms from the 
wound-bed. Excessive exudate, however, can lead to maceration of the surrounding 
healthy tissue, can disrupt and slow down healing, and also promote growth of 
microorganisms (Boateng et al., 2008; Strodtbeck, 2001) 
 
The final stage of wound healing is maturation, which can begin in different locations 
of the wound-bed whilst other areas are still undergoing proliferation. During the 
maturation phase hyaluronan and fibronectin is gradually replaced with different types 
of collagen creating the final structural network which are then cross-linked to add 
more strength to the newly forming tissue. As the necessary dermal and subdermal 
tissues are laid down and mature the number of macrophages, keratinocytes, 
fibroblasts and myofibroblasts diminishes through controlled apoptosis. Overall, 
maturation (also known as remodelling) of a wound can take many months or years to 
finish, depending on the size and depth of the wound (Boateng et al., 2008; Cockbill, 
2002; Hanna and Giacopelli, 1997; Strodtbeck, 2001; Williamson and Harding, 2004). 
 
Wound contamination is ubiquitous but does not necessarily lead to an infection (Grey 
et al., 2006; Healy and Freedman, 2006). A contaminated wound is described as one 
where microorganisms are present but are not replicating at a significant rate and are 
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easily eradicated by the immune cells within the wound. Whereas a colonised wound 
is defined by the presence of microorganisms on a wound surface that are growing and 
replicating. However, such growth in a colonised wound does not cause damage to the 
host cells and is therefore not considered to be an infection. Depending on the wound 
environment, host factors, and the species of microorganism present this colonisation 
may continue until a stage called critical colonisation is reached, which can lead to 
infection (Healy and Freedman, 2006; Siddiqui and Bernstein, 2010). This stage is 
termed critical colonisation because the presence of the microorganisms is such that 
wound healing is interrupted, exudate production increases and the wound bed and 
granulating tissue becomes weaker, which can result in tenderness and pain. Further 
progression of this process and increased microbial bioburden leads to infection, which 
causes proliferation of the wound-bed to cease and new tissues are damaged, exudate 
is overproduced and may become purulent, accompanied by increased warmth and 
swelling of the wound and surrounding tissues (Grey et al., 2006; Healy and Freedman, 
2006; Siddiqui and Bernstein, 2010). Research has also shown that bacteria are able to 
form biofilms within the wound environment, which makes them significantly more 
difficult for the body to eradicate and also makes the bacteria more inherently 
resistant to antimicrobial compounds (Kucera et al., 2014; Lister et al., 2009; Malik et 
al., 2013). This local infection, depending on host and microorganism factors, can 
progress to systemic bacteraemia, which can result in sepsis and even death (Healy 
and Freedman, 2006; Siddiqui and Bernstein, 2010). 
 
Contamination and colonisation are common because bacteria and other organisms 
are translocated from other parts of the body or the environment. Therefore, bacteria 
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implicated in wound colonisation such as Staphylococcus aureus, coagulase negative 
Staphylococcus species (such as Staphylococcus epidermidis), Streptococcus species, 
and Pseudomonas aeruginosa are commonly found within the natural flora of adjacent 
tissues. Other bacteria that form part of the human microbiota that can colonise a 
wound are Propionibacterium acnes, Enterococcus species, Enterobacteriaceae species 
(such as Escherichia coli), and Acinetobacter species (Dryden, 2009; Siddiqui and 
Bernstein, 2010; Török and Conlon, 2005).  
 
Other atypical organisms such as fungi (e.g. Candida species), protozoa (e.g. 
Leishmania species), and arthropods (e.g. Cordylobia anthropophaga) may cause 
chronic wound infections, but their incidence is low (Dryden, 2009; Siddiqui and 
Bernstein, 2010). Bacteria are by far the most commonly implicated organisms within 
infected wounds and cause an increase in morbidity, reduced quality of life, and 
contribute to the increasing pressures being placed on the health service (Grey et al., 
2006). These issues are all being made worse by the increasing problem of 
antibacterial resistance, which was introduced in section 1.4. 
 
4.1.2. An overview of wound care products 
Modern wound care products have been designed to support healing and also protect 
the wound-bed from external influences. Moisture control is a key property of 
dressings, with the aim of ensuring a moist environment for healing is maintained 
whilst preventing maceration or dehydration. To this end, the materials are able to 
maintain a barrier to moisture evaporation but also absorb excessive exudate, which 
contains waste products and autolytic enzymes. Allowing gaseous exchange is 
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important for managing the moisture of the wound but also allowing oxygenation of 
the new tissue. However, it is also important for these dressings to be impervious to 
particles and microorganisms (Davis and Mclister, 2016; Jones et al., 2006; Morgan, 
2002; Williams, 1996).  
 
As well as maintaining an optimal environment for the wound, modern dressings 
provide a number of additional benefits including cushioning or protection from 
further injury, insulating the wound to protect it from external extremes of 
temperature whilst also maintaining a warm wound environment complimentary to 
biological functions. These dressings are designed to have little or no adherence so 
that they do not cause damage to the delicate wound-bed or the surrounding tissue 
when removed and changed. In addition to this, the overall design of the dressing 
should allow for as much time as possible between dressing changes to reduce damage 
to the wound bed, reduce the chance of contamination, reduce costs, and reduce 
impact on the patient’s quality of life (Jones et al., 2006; Morgan, 2002).  
 
Hydrocolloid dressings are available as gel sheets and films formed from 
carboxymethylcellulose, gelatine, or pectin. These dressings are adherent in nature 
and are useful in the management of dry wounds where they are able to adhere to and 
hydrate the eschar or fibrin clot to promote autolysis and debridement. Hydrocolloids 
are not useful in heavily exuding wounds as they do not have a large absorptive 
capacity but they are occasionally used on light to moderately exuding wounds 
whereby they absorb fluid, which in turn allows for increased gaseous exchange 
through the dressing. These dressings are sometimes combined with other materials 
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such as foams or alginates to increase their absorptive capacity (Boateng et al., 2008; 
Hanna and Giacopelli, 1997; Jones et al., 2006; Morgan, 2002). 
 
Alginate dressings are generally formed from the sodium and calcium salts of alginic 
acid, which is a natural polymer made from guluronic and mannuronic acid. Alginates 
are able to absorb large quantities of water and readily form hydrogels when in 
contact with suppurating wounds. Calcium within the wound and the dressings is able 
to cross-link the polymer chains, notably between guluronic acid rich regions (G-G 
blocks), which stabilises the polymer matrix and generates pores within which exudate 
can be held, leading to the generation of a hydrogel (Gacesa, 1988). Dressings rich in 
mannuronic acid will form soft gels whereas those richer in guluronic acid will form 
firmer gels, which are much better at supporting cavitation wounds. This ability to 
absorb large amounts of exudate means alginates should not be used on dry wounds, 
but are more useful in low, moderate and highly exuding wounds. The alginic acid 
polymers are also thought to bring additional benefits to the wound environment and 
have been found to benefit wound inflammation, encourage fibroblast proliferation, 
and even activate macrophages (Boateng et al., 2008; Hanna and Giacopelli, 1997; 
Jones et al., 2006; Morgan, 2002). 
 
Dressings that are readily available with high water content are the hydrogels, which 
are amorphous gels typically formed from a cross-linked polymer matrix of 
poly(methacrylate) or poly(vinylpyrrolidone). As with the alginates the matrices of 
hydrogel dressings trap large amounts of fluid so that approximately 70-90% of their 
mass is water. These hydrogel dressings are useful for dry wounds as they promote 
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hydration, autolysis and debridement. However, due to their ability to donate 
moisture to the wound these dressings are not suitable for suppurating wounds and 
should not be placed on infected wounds, where they can promote growth (Boateng et 
al., 2008; Hanna and Giacopelli, 1997; Jones et al., 2006; Morgan, 2002). 
 
Semi-permeable films are useful for shallow wounds and when dressings are required 
in anatomical flexures such as elbows. Often formulated from nylon or polyurethane 
these semi-permeable films are able to control gaseous exchange into the wound with 
some being utilised for their ability to occlude the wound, create a hypoxic 
environment, and thus stimulate angiogenesis. However, their chemistry and 
formulation means they are poor at absorbing exudate so are not suitable for 
moderately or highly exuding wounds as they cause fluid accumulation that can cause 
tissue maceration and promote infection. As such, semi permeable films are often 
used in combination with other materials such as hydrocolloids or foam-dressings 
(Boateng et al., 2008; Jones et al., 2006; Morgan, 2002). 
 
The final major classification of modern wound dressings is the foams; typically 
formulated from polyurethane. The thickness and porosity of these foams controls the 
amount of exudate they are able to draw up and hold onto, and also dictates their 
ability to protect the wounds and regulate gaseous transfer. Modifying the internal 
structure of these materials allows polyurethane foams to be used on a wide range of 
wounds including dry and heavily exuding. However, the foams can be adherent so 
often have an additional film layer that is in contact with the wound to reduce 
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adherence. Some foams are also co-formulated with a film backing to reduce fluid loss 
(Boateng et al., 2008; Jones et al., 2006; Morgan, 2002). 
 
4.1.3. Polymer-phyllosilicate composites as potential materials for wound care 
Wound healing is a complex process and commercially available dressings are designed 
to support that process but no single dressing is able to cover all eventualities (Jones et 
al., 2006). A review by Gaskell and Hamilton (2014) discusses research regarding the 
development and evaluation of phyllosilicate-polymer composites for wound care 
applications, which is an emerging field and somewhat understudied compared to 
phyllosilicate-polymer research for other industries. 
  
The combination of phyllosilicates and polymers into composites has been found to 
create materials with beneficial characteristics from both the constituents and as such 
the resultant properties are reliant on the chemistry of the individual phyllosilicate and 
polymer as well as their interaction mechanism, any polymeric cross linking, and the 
overall method of composite formation (solution, melt extrusion, or electrospinning 
for example) (Gao, 2004; Ray and Okamoto, 2003). By use of techniques such as X-ray 
diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and transmission 
electron microscopy (TEM) it is possible to characterise the internal structure of these 
composite materials to determine whether they are nanocomposites or 
microcomposites (Alboofetileh et al., 2013; Wang and Rhim, 2015). Microcomposites 
form when the phyllosilicate layers do not separate and the polymer arranges itself 
around the clay-mineral particles, which effectively act as filler within the polymer 
matrix (figure 4.1 A) (Theng, 2012). Nanocomposites form when the phyllosilicate 
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layers separate and the polymer can infiltrate the laminar space. In intercalated 
nanocomposites the clay mineral layers remain associated to each other with 
polymeric chains within the interlayer space (figure 4.1 B). In exfoliated 
nanocomposites the clay mineral layers disassociate from each other and become 
uniformly dispersed throughout the polymeric matrix either in an ordered (figure 4.1 C) 
or disordered fashion (figure 4.1 D) (Theng, 2012).  
 
A number of different phyllosilicate-polymer combinations have been studied for 
wound care applications. Montmorillonite and Laponite® have been widely studied for 
their ability to disperse in water and expose a high specific surface with which it can 
interact with polymers (Bandeira et al., 2012; Gaharwar et al., 2011b, 2010; Joshi et al., 
2010; Paul and Robeson, 2008; Sandri et al., 2016; Viseras et al., 2008). Palygorskite, a 
2:1 fibrous phyllosilicate, has been utilised for its ability to entangle with itself and 
polymer chains to form cross-linked matrices (Ruiz-Hitzky et al., 2013). 
 
Laponites® have been shown to produce nanocomposite materials with improved 
strength, increased elasticity, and greater swelling potential (Ghadiri et al., 2013; 
Shikinaka et al., 2012). A number of synthetic polymers such as polyvinyl alcohol (Ip et 
al., 2011; Kokabi et al., 2007), polyethylene oxide (Gaharwar et al., 2012, 2011a, 2011b; 
Schexnailder et al., 2010; Su and Shen, 2009), polyacrylamide (Li et al., 2009), 
polyethylene glycol (Shikinaka et al., 2012), and polyurethanes (LeBaron et al., 1999; 
Ray and Okamoto, 2003) amongst others have been utilised in research to develop 
useful composites. However, significant interest has been paid to the naturally 
occurring polymers such as chitosan for its low toxicity, biocompatibility, and inherent 
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antimicrobial properties (Aguzzi et al., 2013, 2010; Han et al., 2010; Salcedo et al., 
2013); and alginate for its biocompatibility, current use in wound care products, and its 
high swelling potential (Bandeira et al., 2012; Darder et al., 2016; Ghadiri et al., 2013; 
Gonçalves et al., 2013a; Kaygusuz and Erim, 2013).  
 
 
  
Figure 4.1. Artistic representation of 2:1 phyllosilicates (brown and green plates) interacting with 
polymers (red chains where individual circles indicate monomers) to form microcomposites (a), 
intercalated nanocomposites (b), ordered exfoliated nanocomposites (c), and disordered exfoliated 
nanocomposites (d). 
 
A B 
C D 
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4.1.4. Development and evaluation of novel polymer-phyllosilicate composites for 
wound care applications 
There is a notable lack of products available commercially that directly manage wound 
infections. However, increasing interest is being paid to the utilisation of polymer-
phyllosilicate composites as materials for delivering compounds that will actively 
manage infected wounds such as the inclusion of antimicrobial drug molecules 
including tetracycline (Qi et al., 2013), ofloxacin (Hua et al., 2010), and chlorhexidine 
(Ambrogi et al., 2016). A number of teams have also investigated the inclusion of silver 
(Aguzzi et al., 2013) and copper (Das et al., 2014) ions as antimicrobial agents within 
these composites. The overarching aim of this research project is to produce a wound-
care product that can support wound healing and also treat infections directly at the 
source – thus reducing the need for systemic antimicrobial therapy (see section 1.4). 
 
The research presented here takes the knowledge developed in chapter 2 and applied 
in chapter 3 to design novel composite films and foams that can be further developed 
into candidate wound dressing materials. Kaolin (KN), montmorillonite-K10 (MMTK10) 
and Laponite® XL21 (LXL21) were selected based on their differing physicochemical 
properties. Laponite® XL21 was chosen over Laponite® RD because the latter has a 
tendency to buffer towards pH 9, which would not be acceptable for a wound 
environment. Alginate was utilised as the polymeric compound within the composites 
due to its ability to interact with clay minerals to form composite materials with 
improved properties (Alboofetileh et al., 2013; Pongjanyakul and Suksri, 2010) that 
could be beneficial for wound healing. The drug molecule of choice was ciprofloxacin 
as it has significant activity against common wound pathogens and is also able to 
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successfully absorb and desorb from the clay-mineral surface (as described in chapter 
3).  
 
These composite films and foams were characterised through qualitative and 
quantitative methods to determine certain mechanical and aesthetic properties, such 
as flexibility and transparency. Their ability to support healing of an infected wound 
was evaluated by determining water vapour transmission rate, behaviour in a wound 
environment, drug release, antimicrobial properties, and keratinocyte viability. 
Alongside this FTIR, XRD and thermogravimetric analysis (TGA) were used to determine 
the structure of the composite films and foams, and identify any interactions taking 
place between the individual components. 
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4.2. Materials and methods 
4.2.1. Materials 
Kaolin (KN) was obtained from Fischer (UK) Montmorillonite K-10 (MMTK10) was 
obtained from Acros (UK) and Laponite® XL21 (LXL21) was obtained from BYK Additives 
(UK). Sodium alginate powder was obtained (Sigma Aldrich, UK) as a low viscosity 
alginate (LVAlg, 4-12 cp 1% in water), a moderately viscous alginate (MVAlg, 15-25 cp 1% 
in water), and a high viscosity alginate (HVAlg, >2000 cp 2% in water). The 
commercially available wound dressing products Kaltostat® (ConvaTec Ltd, UK), 
Lyofoam® (Molnlycke Health Care Ltd, UK) and Opsite® (Smith and Nephew Healthcare 
Ltd, UK) were donated by Royal Liverpool and Broadgreen University Hospitals Trust. 
 
4.2.2. Formulation of candidate composites 
4.2.2.1. Pre-formulation studies 
In order to screen a wide range of excipient combinations a process of pre-formulation 
was devised. Throughout the pre-formulation studies 1 g of clay mineral was used, 
whilst the proportion and type of alginate was modified. The proportions of alginate 
tested against set amounts of clay mineral were 0.25 g, 0.5 g, 1 g, 2 g, and 4 g of LVAlg 
or MVAlg; or 0.1 g, 0.25 g, 0.5 g, 1 g, and 2 g of HVAlg. The general methodology for 
obtaining the composite formulations was as follows. 
 
One gram of clay mineral was dispersed in 100 mL deionised water for two hours 
allowing swelling to complete. Alongside this, varying concentrations of alginate 
(indicated above) were swollen in 50 mL deionised water for two hours then placed in 
a sonic bath for 15 minutes to disperse larger air bubbles. The clay mineral dispersion 
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was then stirred at 7000 rpm and the alginate solution slowly added to this in a steady, 
fine, stream. Once all the alginate was added the stirring was reduced to 2000 rpm 
allowing the mixture to become homogenous over a period of 30 minutes.  
 
After this time period 40 mL of mixture was poured into 80 mm diameter plastic 
casting dishes (petri dishes). Films were formed by placing the casting dish, uncovered, 
into a fan-oven set to 40 °C for 24 hours. Foam materials were formed by freezing the 
covered casting dish at -20 °C for 12 hours then drying by lyophilisation (Heto FD 2.5 at 
-50 oC for 72 hours). Each composite formulation was repeated in triplicate and 
assessed as per section 4.2.3. 
 
4.2.2.2. Development of candidate films 
The effect of the drying method was investigated by comparing drying in a fan assisted 
oven at 40 oC for 24 hours to drying in a vacuum oven at 40 oC for 24 hours and drying 
on bench-top at room temperature. Glycerol (225 mg (approximately 0.2 mL) to 2250 
mg (approximately 2 mL)) or polyvinyl alcohol (PVA) (150 mg to 1500 mg) were utilised 
as additives. These were added at the same time as the alginate solutions. The 
composite films were repeated in triplicate and assessed as per section 4.2.3. 
 
4.2.2.3. Formulation of ciprofloxacin-containing composite films 
One gram of LXL21 was dispersed in 80 mL of deionised water at 2000 rpm using a 
magnetic stirrer. After 2 hours the LXL21 dispersion was adjusted to pH 7.4 with dilute 
HCl and a 20 mL solution containing 20 mg, 130 mg or 160 mg CIP (representing 
loading below, at, and above monolayer formation as described in section 3.3) was 
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added and the pH re-adjusted to 7.4 if necessary. This dispersion was protected from 
light and mixed for a further 1 hour to allow CIP adsorption onto LXL21.  
 
Two grams of MVAlg was dispersed in 50 mL deionised water and allowed to swell 
over three hours after which time bubbles were removed by a sonic bath over 15 
minutes. Stirring of the LXL21-CIP dispersion, via magnetic stirrer, was increased to 
7000 rpm and the alginate solution added slowly as a fine stream along with 2.25 g 
glycerol. Once a homogenous mixture was achieved stirring was reduced to 2000 rpm 
for 30 minutes.  
 
Forty millilitres of the formulation mixture was poured into a plastic casting dish (80 
mm diameter) and dried uncovered at 40 oC in a fan oven for 24 hours. This was 
undertaken in triplicate to determine reproducibility. To prevent moisture being 
adsorbed by the foams they were stored in a sealed desiccator containing silica gel 
impregnated with a blue indicator (CoCl2). These composite films were repeated in 
triplicate and assessed as per section 4.2.3. 
 
4.2.2.4. Development of candidate foams 
Once promising composite foams had been identified, glycerol (225 to 2250 mg), CaCl 
(1 mL 0.1 M to 1 mL 1.0 M), NaCl (1 mL 0.1 M to 1 mL 1.0 M), PVA (150 to 1500mg), 
and absolute ethanol (0.2 to 2 mL) were each tested as additives. These additives were 
added to the clay mineral dispersion at the same time as the alginate solution. 
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The effect of the freezing process on the final material obtained was also investigated 
to hasten ice formation, and reduce crystal size. Freezing of the formulations at -20 oC 
over 12-hours was compared to freezing at -80 oC over 12-hours and flash freezing in 
liquid nitrogen. For the liquid nitrogen method, sealed casting dishes wrapped in film 
were completely submerged for 5 to 20 minutes (to determine minimum time 
required), then placed into a -20 oC freezer for 12 hours. All the frozen samples were 
dried in the freeze drier as described above (section 4.2.2.1) over a period of 72 hours. 
The composite foams were repeated in triplicate and assessed as per section 4.2.3. 
 
4.2.2.5. Formulation of ciprofloxacin-containing composite foams 
One gram of LXL21 was dispersed in 80 mL of deionised water at 2000 rpm using a 
magnetic stirrer. After 2 hours the LXL21 dispersion was adjusted to pH 7.4 with dilute 
HCl and a 20 mL solution containing 20mg, 130mg and 160mg CIP (representing 
loading below, at, and above monolayer formation) added then pH re-adjusted to 7.4 if 
necessary. This dispersion was protected from light and mixed for a further 1 hour to 
allow CIP adsorption onto LXL21.  
 
Four grams of LVAlg was dispersed in 50 mL deionised water and allowed to swell over 
three hours after which bubbles were removed by a sonic bath over 15 minutes. 
Stirring of the LXL21-CIP dispersion, via magnetic stirrer, was increased to 7000 rpm 
and the alginate solution added slowly as a fine stream along with 560 mg glycerol. 
Once a homogenous mixture was obtained stirring was reduced to 2000 rpm for 30 
minutes.  
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Forty millilitres of formulation mixture was poured into each casting dish (80 mm 
diameter), the lid placed on and dish wrapped tightly in cling film before submersion 
into a liquid nitrogen bath for 15 minutes. The lids were removed from the frozen 
samples and covered with laboratory film (Parafilm®). After being stored in a -20 oC 
freezer overnight the film covers were pierced and the mixtures dried in a freeze dryer 
for 72 hours. To prevent moisture being adsorbed by the foams they were stored in a 
sealed desiccator containing silica gel impregnated with a blue indicator (CoCl2). The 
composite foams were repeated in triplicate and assessed as per section 4.2.3. 
 
4.2.3. Qualitative analysis of composite materials 
Visually, the samples were described in terms of colour and structural integrity. 
Manually, the materials were described in terms of flexibility, robustness, and texture. 
This was done by one researcher (Ryan Hamilton) to allow for consistent qualitative 
assessment of the visual and malleable properties. 
 
Each composite material that showed promise was reviewed by a tissue viability nurse 
(Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK) to 
qualitatively assess and confirm the desired physical properties (strength, flexibility, 
and texture for example) through manual manipulation and to grade the visual appeal 
(described in terms of colour, transparency, and defects for example). The opinions 
and insights of the tissue viability nurses were pivotal in determining the final 
formulation for the CIP-containing composites.  
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4.2.4. Optical properties of film formulations 
The opacity of the film formulations was assessed with UV-visible spectrophotometry 
(Perkin Elmer Lambda 25 UV-Vis Spectrometer). Each film was cut into rectangles of 
appropriate size to fit into the sample compartment, which was adapted with a smaller 
sample cell-holder that held each film vertically. An empty compartment acted as the 
reference while samples were scanned in triplicate between 200 and 800 nm at a rate 
of 240 nm/min. The absorbance at 600 nm and the thickness (measured by digital 
callipers, WorkZone, UK) of the sample was used to determine the opacity of each film 
using equation 4.1, as described by Tunç and Duman (2010).  
(Tunç and Duman, 2010) 
Equation 4.1 
𝑂𝑝𝑎𝑐𝑖𝑡𝑦 =  
𝐴𝑏𝑠600
𝑋
 
 
Where Abs600 is the absorbance measured at 600 nm and X is the thickness of the film 
(mm). 
 
Foam formulations were not studied as they were opaque and could not be held 
within the spectrophotometer.   
 
4.2.5. Semi-quantitative analysis of the mechanical strength of foam materials 
To differentiate between the physical strength of foam nanocomposites a tablet 
friabilator (Pharma Test model PTFR-A) was utilised as per European Pharmacopoeia 
standard method 2.9.7 (British Pharmacopoeia Commission, 2016). Ten samples of 
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each composite foam, approximately 10 x 10 mm in size, were placed into a Perspex 
drum which was rotated 100 times at a rate of 25 revolutions per minute.  The total 
and average mass for each sample were obtained before and after testing, allowing 
the percentage mass loss to be calculated. The threshold for tablets failing the friability 
test is 1% mass loss. This could not be applied here so the percentage mass loss of 
Lyofoam® and Kaltostat® were used as reference values to which the nanocomposite 
foams were compared. 
 
4.2.6. FTIR analysis of films and foam formulations 
Fourier-Transform Infrared (FT-IR) analysis was undertaken on a Perkin Elmer 
Spectrum BX FT-IR spectrometer with a Pike MIRacle ATR attachment. Thirty-two scans 
were undertaken between 4000-500 cm-1 with an interval of 1.0 cm-1 and a resolution 
of 2.0. 
 
4.2.7. XRD analysis of films and foam formulations 
Samples were scanned between 3 and 20 deg 2θ using a Rigaku miniflex with a CuKα1 
radiation source. Each sample was scanned five times and the individual scans 
combined to reduce baseline noise and clarify diffractions. Samples were clipped into 
place, utilising the baseplate clips, to prevent movement during sample tilting. Foam 
samples required gentle compression before being clipped into place. The interlayer 
spacing of each sample was calculated from the d001 peak using the internal Rigaku 
miniflex analysis software.  
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4.2.8. Thermal analysis of films and foam formulations 
Thermogravimetric analysis (TGA) was undertaken on a TA Instruments TGA Q50. 
Approximate 10 mg of sample (films, foams, and controls) was weighed into the open 
platinum crucible and analysis conducted under a flowing nitrogen atmosphere (60 
mL/min). Temperatures were increased from room temperature to 800 oC at a rate of 
20 oC/min. Analyses were run in triplicate and percentage weight loss determined. 
 
4.2.9. Water vapour permeability of film and foam formulations 
The water vapour transmission rate (WVTR) was measured by adapting the European 
Pharmacopoeia method described by Kokabi et al. (2007). Thirty-millilitre glass sample 
bottles (Supelco) were filled with 25 mL deionised water (100% relative humidity) and 
each film and foam sample was cut to fit over the mouth of each sample bottle. Screw-
top caps with 14 mm diameter aperture were affixed onto the top of each bottle to 
secure the sample, create an air tight seal, and standardise the area (153.94 mm2) for 
vapour exchange.  
 
Sample bottles complete with cap and sample were weighed before being sealed into 
a desiccator containing a solution of concentrated magnesium chloride, creating a 
relative humidity of 32% (Wadso et al., 2009). Desiccator chambers were held at a 
steady temperature of 37 oC in fan assisted ovens. The sample bottles complete with 
cap and sample were weighed after 24 hours of gaseous exchange. Each sample was 
repeated in triplicate and the WVTR for each sample was calculated using equation 4.2. 
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Equation 4.2 
𝑊𝑉𝑇𝑅 (𝑔/𝑚2/ℎ)  =  
𝑊𝑖 −  𝑊𝑓
24 × 𝐴
 × 106 
 
Were Wi is the weight of the unit (bottle, water, sample and cap) before placing in the 
desiccator, Wf is the weight of the unit after 24 hours, and A is the area for vapour 
exchange (mm2). 
 
4.2.10. Behaviour of film and foam formulations in a synthetic wound environment 
The behaviour of film and foam nanocomposites was determined through a synthetic 
wound model. Bacteriological Agar (Agar No 3, Oxoid, Thermo Scientific) was prepared 
to a concentration of 0.5% w/v in a solution 0.02 M CaCl2·2H2O, 0.4 M NaCl, 0.08 M 
Trizma base as a synthetic wound fluid (SWF)(Lindsay et al., 2010; Momoh et al., 2015). 
Bovine serum albumin (BSA) was omitted from the wound model as it denatured 
during the autoclaving process. The utilisation of bacteriological agar rather than 
gelatine (Matthews et al., 2005; Ng and Jumaat, 2014) also allowed for the synthetic 
wound environment to be autoclaved and remain sterile for the 96 hour experiment 
period.  
 
After autoclaving, 200 mL of the molten agar-SWF was poured into square 245 x 245 
mm bioassay dishes (Sigma Aldrich, UK) and allowed to cool and set. This was 
undertaken within an isolator unit so the bioassay dishes could be left partially open to 
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allow water vapour to escape, thus reducing condensation within the bioassay dish 
and also avoiding contamination during the pouring and cooling process.  
 
The resulting gel was soft and moist so as to represent a suppurating wound for testing 
the fluid absorptive capacity of each nanocomposite (section 4.2.10.1). The gel was 
also of sufficient strength to allow the bioassay dishes to stand vertically for adhesion 
studies (section 4.2.10.2). 
 
4.2.10.1. Swelling behaviour of formulations on the synthetic wound surface 
Swelling studies were undertaken on horizontal bioassay dishes so that the effects of 
gravity did not interfere with the movement of fluid on the synthetic wound surface. 
Samples were cut to 10 x 10 mm squares; measured accurately with digital callipers. 
Each sample was weighed before being placed on the synthetic wound surface and 
pressed down gently to ensure optimal contact. Each sample was repeated in triplicate.  
 
Swelling was allowed to take place over a 96 hour period after which each sample was 
measured in four positions with digital callipers and the percentage change in length 
and width calculated. Swollen samples were removed from the surface of the synthetic 
wound environment, blotted with filter paper to remove excess surface water then 
weighed to determine the change in mass. Hydration degree (Gaharwar et al., 2010), 
also termed swelling ratio (Ghadiri et al., 2013), was calculated using equation 4.3. 
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Equation 4.3 
𝐻𝑦𝑑𝑟𝑎𝑡𝑖𝑜𝑛 𝐷𝑒𝑔𝑟𝑒𝑒 =  
𝑀𝑤𝑒𝑡 −  𝑀𝑖𝑛𝑖𝑡
𝑀𝑖𝑛𝑖𝑡
 × 100 
 
Where Mwet is the weight (mg) of the wet formulation (after 96 hrs of swelling) and 
Minit is the initial weight (mg) of the formulation before placing on the wound surface. 
 
4.2.10.2. Adherence of formulations to the wound surface 
A horizontal line was drawn onto the external surface of the base of the bioassay dish 
at a distance of 45 mm from the top. Samples of foams and films (repeated in triplicate) 
were cut to 10 x 10 mm in size and placed along the top of the horizontal line in 
triplicate. Each sample was manually gently pressed onto the synthetic wound surface 
to ensure optimal contact before the bioassay dish was positioned vertically to test the 
adherence of each sample. After 24 and 96 hours the distance travelled by each 
sample was accurately measured using digital callipers and a ruler. 
 
4.2.11. Ciprofloxacin-release profiles from film and foam formulations 
Synthetic wound fluid (SWF), as described by Lindsay et al. (2010), was prepared using 
0.02 M CaCl2·2H2O, 0.4 M NaCl, 0.08 M Trizma base [tris (hydroxymethyl) 
aminomethane], and 2% w/v bovine serum albumin (BSA) in deionised water.  One 
hundred millilitres of this SWF was added to a two-necked round bottom flask and 
stirred at 200 rpm to ensure minimal damage to the materials added to the system, 
but also to allow adequate agitation and mixing of the SWF. A temperature of 37 oC 
was used to mimic that experienced at the wound surface. 
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Once the temperature was stable, 100 mg of each film and foam sample was added to 
the SWF. The release of CIP from these composite materials was compared against 
desorption and release of CIP from a high-load (627.11 mg/g) LXL21-CIP composite, 
generated as per chapter 3, to clearly distinguish between the different phases of drug 
elution from clay-mineral drug composites (Iliescu et al., 2013; Jung et al., 2008; 
Viseras et al., 2010).  
 
At defined time points, 1 mL of release medium was removed and passed through a 
0.2 µm filter to remove any particulate matter. To maintain sink conditions 1 mL of 
fresh SWF was returned to the release studies. Sampling continued for 24-hours as this 
is the minimum amount of time a wound dressing would remain in place clinically. 
 
Alongside the samples, standards containing increasing concentrations of CIP in SWF 
were used to allow semi-quantitative analysis of the CIP content in the actual samples. 
CIP concentrations were measured on an Agilent® 1200 HPLC system fitted with a UV-
Vis diode array detector set at 278 (±8) nm and 227 (±8) nm. The mobile phase was 2% 
acetic acid (AAC) and 100% acetonitrile (ACN) with a flow rate of 1 mL/min. The sample 
injection size was 10 µL into a gradient that commenced at 90:10 and finished at 10:90 
AAC:ACN over ten minutes, with a 5 minute post-run programme returning to the 
starting point. A 10 mm guard column (Crawford Scientific ODS-L 5 micron optimal, 20 
x 4.6 mm, 5 µm) was fitted prior to the 150 x 4.6 mm internal diameter C13 OD-OES 5 
µm column (Crawford Scientific). The guard column was flushed overnight with a 
reverse flow of switching gradients of 100% H2O and 0% ACN to 0% H2O and 100% ACN. 
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Peak areas (mAU) were determined using the built-in integration software (OpenLAB 
CDS Chemstation Edition) allowing the amount of CIP in the samples to be determined. 
The release studies were undertaken in triplicate. 
 
4.2.12. Antimicrobial properties of film and foam formulations 
Preparation of growth media and bacterial cultures was similar to those outlined in 
chapters 2 and 3. As previously, S. epidermidis, P. acnes, and P. aeruginosa were 
utilised as common pathogens in skin and skin-structure infections (SSSI) and infected 
wounds.  The preparation of inoculated agar for pour plates and also spread plates for 
CFU counts were undertaken in the same way as previously described in section 2.2.4. 
 
Discs (5 mm diameter) of each candidate wound dressing material were formed using 
a cork-borer and placed onto the surface of the inoculated agar using aseptic 
technique. Each sample was tested in triplicate. The plates were incubated in their 
respective environments for 24 – 48 hours at 37 oC. After adequate growth, the zones 
of inhibition were measured in five positions using digital callipers and the CFU/mL was 
determined by colony counting the spread plates. 
 
4.2.13. Cytotoxicity (keratinocyte cell viability) studies of film and foam formulations 
Cell viability in the presence of composite materials was measured using an adapted 
colorimetric MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay 
(Mosmann, 1983). A keratinocyte cell line (HaCaT) was obtained at fiftieth passage 
(P50) and cultured (37 oC in 95% humidity and 5% CO2) in 75 cm
2 flasks in Dulbecco’s 
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Modified Eagle Medium (DMEM) enriched with 10% foetal calf serum (FCS). Once 
confluent growth was confirmed through light stage microscopy the cultures were 
passaged using the method below until P53 was obtained. 
 
A single flask of cells was washed with 15 mL phosphate buffered saline (PBS) then 
treated with 1.5 mL ethylene-diamine-tetraacetic acid (EDTA) 0.1 mM for 10 minutes 
at 37 oC. Then 1.5 mL 1% trypsin was added and incubated for a further 3 minutes so 
that the cells could be dispersed in 13 mL complete DMEM. One millilitre of this cell 
dispersion was transferred into cell culturing flasks (75 cm2 for passage, 25 cm2 for 
experimentation) and incubated (37 oC in 95% humidity and 5% CO2) until the desired 
confluence was reached. These flasks were incubated until the cells had adhered to 
the flask surface and a confluence of approximately 40% was achieved.  
 
Samples of film and foam formulations (mass approximately 2 mg) were placed in the 
flasks with 1 mL of PBS. Standards consisted of the constituents of the film and foam 
dressings and were weighed out to be the same mass as would be expected in 2 mg of 
film or foam. Many of these standards were powders or viscous liquids so the 1 mL PBS 
was used to disperse the standards before being pipetted into the cell culture flasks. 
Control flasks were set up, to which 1 mL PBS was added without any further 
treatment. All flasks were incubated at 37 oC for 24 hours and the entire process 
repeated in triplicate. 
 
Once the treatment period was completed the culture medium and treatments were 
removed via vacuum and the flasks gently washed with PBS to remove any residual 
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treatment material. The cells were then treated with DMEM solution containing 0.5 
mg/mL MTT and incubated for 2 hours at 37 oC, after which the MTT solution was 
removed by vacuum and the HaCaT cells lysed with 500 µL isopropanol. Cell debris was 
removed from the solution by centrifugation at 13,000 rpm.  
 
Three 100 µL aliquots of each of test solution was placed into the wells of a 96-well 
ELISA plate (each sample was repeated in triplicate). Standards of 100 µL isopropanol 
were used as the background absorbance. The plates were read on a UV-Vis plate 
reader (CLARIO Star Microplate reader, BMG Labtech, UK) between 540 and 590 nm, 
with λmax observed at 570 nm. Absorbance readings for the control flasks were 
assumed to represent 100% viability, with the relative viability of cells in the test flasks 
calculated by comparing the absorbance of the test solutions to that of the control 
flasks.  
 
4.2.14. Statistical Analysis 
All data was inputted into Microsoft® Excel® for analysis and generation of graphs. 
Mean averages and standard deviations were calculated using the standard 
functionality within Excel®. Statistical significance was calculated by paired t-tests (no 
difference assumed) using the Excel® data analysis extensions available from 
Microsoft®.   
Chapter 4              Development and evaluation of antibacterial wound dressing materials 
Page 164 of 260 
4.3. Results and discussion 
4.3.1. Evaluation and selection of an ideal film formulation 
4.3.1.1. Qualitative analysis of pre-formulation film materials 
Qualitative analysis of the film materials was undertaken to determine their suitability 
as wound dressings in terms of texture, strength, and flexibility. It is important that 
film dressings are smooth and flexible, to prevent damage to the wound bed and 
support the migratory phase of healing, and also conform to the movement of the 
body, especially in anatomical flexures (Boateng et al., 2008; Morgan, 2002). It is also 
ideal that film dressings are transparent to allow the wound to be observed without 
the need to remove the dressing (Jones et al., 2006; Powers et al., 2016). The 
qualitative analyses below describe the appearance, texture, strength and flexibility of 
the different formulations. Collaboration with tissue viability nurses at the Liverpool 
and Broadgreen University Hospitals NHS Trust allowed these interpretations to be 
validated and also enabled relevant health professionals to inform the future direction 
of this research. 
 
When using the clay minerals alone no films were produced, only aggregates of dried 
solid clay mineral that adhered to the surface of the casting dish. Conversely, films 
obtained when casting the alginates with no clay minerals present were thin, 
transparent and smooth. However, they were not flexible enough as they cracked and 
fractured when bent beyond 90o angles (see figure 4.2 A). 
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Figure 4.2. Films formed from (A) 1 g HVAlg, (B) 1 g KN and 1 g HVAlg, (C) 1 g MMTK10 and 1 g HVAlg, (D) 
1 g LXL21 and 0.1 g HVAlg, (E) 1 g LXL21 and 1 g HVAlg, and (F) 1 g LXL21 and 2 g HVAlg. 
 
 
The appearance and properties of the clay-alginate composite films was affected by 
both the type of clay-mineral used and the amount and type of alginate utilised. Visual 
appearance of the films correlated well with the appearance of the clay mineral 
dispersions, in that KN containing films were off-white and opaque (figure 4.2 B), 
MMTK10 were light-brown and opaque (figure 4.2 C), whilst films containing LXL21 
were transparent (figure 4.2 E). 
 
Composites containing KN did not produce acceptable films. Separation of the 
components was apparent by a smooth, shiny upper surface and a matte, rough 
underside. This indicated that KN was unable to form interactions with the alginate 
polymer, allowing natural sedimentation of KN to the bottom of the casting dish during 
A B C 
D E F 
Chapter 4              Development and evaluation of antibacterial wound dressing materials 
Page 166 of 260 
the drying process. This resulted in films that flaked or were brittle, and broke easily 
under gentle manual manipulation (figure 4.2 B).  
 
Films made with MMTK10 and alginates were brittle and broke easily, and phase 
separation was common with the low and medium viscosity alginate containing 
formulations. This is likely due to a lack of interaction between the MMTK10 layers and 
the alginate polymer, which may be attributable to the acid activation process (Section 
1.3.1). Cracking and splitting of the main film, and fraying of the edges, were common 
with these formulations (see figure 4.2 C) and could be caused by the acidic nature of 
MMTK10. Highly acidic environments are known to cause alginate to convert to 
insoluble alginic acid (Qin, 2008) and this may have prevented it from forming 
complete films.  
 
Films formed with LXL21 were clear and transparent and did not contain as many 
inherent defects as the KN and MMTK10 containing films (see figure 4.2 E). Both sides 
of the film had the same texture and no powdery residue was present on the 
underside of the films indicating incorporation of LXL21 into the polymer matrix. This 
proves that the ability of LXL21 to swell and exfoliate in water facilitated its interaction 
with the alginate polymers (Bandeira et al., 2012). Formulations containing 1 g of 
LXL21 and 0.5 to 1 g of HVAlg were found to be promising as they were flexible and 
strong in comparison to the other clay minerals tested. Formulations made from 1 g 
KN or 1 g MMTK10 with 1 g HVAlg contained many imperfections (cracks and holes) 
and tended to be brittle. Like the KN and MMTK10 containing formulations, the films 
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containing LXL21 could not withstand extremes of flexing and bending (greater than 
90o) without breaking.  
 
Across all these initial screening studies involving KN, MMTK10, and LXL21 it became 
clear that the grade and amount of alginate used was important in creating a 
successful film (table 4.1). Having a sufficient amount of polymer in the 40 mL mixture 
was necessary to ensure a complete film was formed in the casting dish upon drying. 
However, it was also shown that having too much alginate in the 40 mL mixture 
resulted in thick films that were warped, hard, and inflexible.  
 
Composite films made with 0.25 to 2.0 g of LVAlg were very thin and contained large 
holes so that a complete film was not formed, whilst those made with 4.0 g of LVAlg 
were thick and warped, making them extremely stiff and brittle. Similar results were 
obtained for materials containing MVAlg, where 0.25 to 1.0 g MVAlg formed films 
containing cracks and frayed edges and 2.0 and 4.0g of MVAlg formed thick, warped 
and brittle films. HVAlg was shown to be the most suitable grade of alginate to use in 
the formation of clay mineral containing films. Using 0.1 to 0.25 g of HVAlg formed 
very thin films with many cracks in the structure (figure 4.2 D) whilst a mass of 0.5 to 1 
g of HVAlg formed continuous films with a fair degree of flexibility and strength (figure 
4.2 E). Increasing the amount of HVAlg to 2.0 g created films that were thick and 
warped with very little flexibility (figure 4.2 F).  
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Table 4.1. Overview of the films made with 1 g of clay mineral and differing concentrations of varying grades 
of alginate. Red fields denote formulations that were not carried forward (N) for further study, and orange 
fields denote formulations that showed potential () and were studied further. 
 LVAlg (g) MVAlg (g) HVAlg (g) 
 0.25 0.5 1 2 4 0.25 0.5 1 2 4 0.1 0.25 0.5 1 2 
KN N N N N N N N N N N N N N N N 
MMTK10 N N N N N N N N N N N N N N N 
LXL21 N N N N N N N N  N N N N  N 
 
 
The low drug loading of KN coupled with its inability to form useful films meant it was 
eliminated from further investigation. Whilst MMTK10 was shown to carry moderate 
amounts of drug its inability to form complete, flexible films alongside the observed 
phase separation was problematic. Therefore, MMKT10 was also not considered for 
further investigation. LXL21 was able to carry large amounts of drug on its surface and 
was not observed to undergo phase separation in the casting process. Therefore, value 
was seen in continuing to develop a formulation utilising LXL21 and alginate but with 
the incorporation of an additive to overcome problems with flexibility. It was also 
evident that using LVALg was not a viable option for the creation of clay mineral 
containing films. For the formulation parameters investigated, 1 g of HVAlg appeared 
to be the best polymer grade and amount to use in further studies. However, it was 
possible that the use of additives to improve flexibility of the films could also allow for 
greater quantities of other grades of alginate to be used. An overview of the 
formulations prepared and the decision on whether they were carried forward for 
further study can be seen in table 4.1. 
 
Altering the drying method had very little effect on the formulation of LXL21-
containing films. Those dried at room temperature created very similar films to those 
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obtained from the 40 oC fan oven however they took over 72-hours to form. Films that 
were dried at 40 oC under vacuum did not dry as fast as those in the fan assisted 40 oC 
oven and formed films that were mottled and non-uniform in appearance, and cracked. 
This was likely caused by the vacuum removing water in an uneven fashion, compared 
to the fan-oven. The hastened drying time in the fan-assisted oven was attributed to 
the circulation of air, removing water from the surface and allowing further 
evaporation to take place at a faster rate than the vacuum oven. 
 
Glycerol and PVA were investigated for their ability to act as plasticisers and softeners 
in film-materials for healthcare applications (Jarray et al., 2016; Momoh et al., 2015; 
Singh et al., 2013; Vieira et al., 2011). Glycerol was found to have beneficial effects on 
the properties of the films produced. Addition of 225 mg to 562.5 mg glycerol had little 
effect on the appearance and flexibility of the films, whilst 1.125 g showed signs of 
improved flexibility. When 1.6875 g or 2.25 g of glycerol was added to the formulation 
containing 1 g HVAlg the films produced were uniform in thickness, clear and 
transparent, soft to touch, and could withstand extremes of bending and even folding 
(figure 4.3). Equally promising results were also seen for films created from 1 g LXL21, 
2 g MVAlg with either 1.6875 g or 2.25 mg glycerol. These films were slightly thicker as 
a result of increased polymer content, but just as flexible as the HVAlg films.  
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Figure 4.3. Images demonstrating the progression of the film formulations produced containing (A) 1 g 
LXL21 and 2 g HVAlg; (B) 1 g LXL21 and 1 g HVAlg; and (C) 1 g LXL21, 1 g HVAlg, and 2.25 g glycerol. The 
QR code can be scanned with mobile and tablet devices and will open a YouTube video demonstrating 
the properties of these materials [url: http://youtu.be/_p0coEiBqaQ].  
 
Tissue viability nurses from The Royal Liverpool and Broadgreen University Hospitals 
NHS Trust independently assessed and critiqued the film dressings prepared. They 
confirmed that formulations without glycerol were not appropriate for wound care as 
their brittle nature would not allow use in body-flexures as any cracking or breaking in 
situ could cause pain and further damage to the wound bed. Of the two possible 
formulations containing glycerol it was decided that the film containing 1 g LXL21 and 
A B 
C 
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2 g MVAlg should be used for the final drug-containing formulations due to its 
increased thickness, which could enhance its exudate adsorbing potential. 
 
4.3.1.2. Qualitative evaluation of ciprofloxacin-containing films 
When 20 mg CIP (0.38% w/w) was included the composite looked identical to the films 
that contained no drug at all. As the concentration of the drug increased, minor 
changes were observed in the appearance of the film materials obtained. At 130 mg 
(2.42% w/w) CIP a complete film with no obvious faults and transparency was obtained. 
At this concentration it can be assumed that a monolayer of CIP will have formed at 
the LXL21 surface (as determined in section 3.3.3). The transparency of the 
formulation indicates that the LXL21 layers had not undergone significant flocculation 
and the equally good material properties suggest that no changes in interaction 
between the clay-drug composites and the alginate chains occurred.  
 
As the drug concentration was further increased beyond the monolayer point a 
number of changes in the materials created was observed. At 160 mg (2.96% w/w) CIP 
the film was complete, soft, and flexible like previous films but a slight opaque 
appearance was observed. This opacity may have been caused by an increase in drug 
concentration but may equally have been as a result of flocculation of the LXL21 layers. 
This opacity was markedly increased and a yellow hue observed as the CIP content was 
increased to 200 mg (3.67% w/w). At this high concentration a number of defects in 
the film structure were also observed in the form of cracks and small holes. This may 
be a result of flocculation of LXL21 before addition of alginate or competition between 
CIP and alginate for interaction sites on the LXL21 layers. These defects may also have 
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been caused by an excess of CIP within the mixture interfering with film formation 
during drying. At this level of CIP content, composite films containing 2 g MVAlg were 
observed to have fewer and smaller defects in their structure when compared to those 
containing 1 g HVAlg. These films were also slightly thicker and softer than the HVAlg 
containing films, which could possibly increase their water adsorption capacity and 
also integrity at the wound surface. Independent evaluation by the tissue viability 
nursing team also confirmed these determinations. 
 
Controls without LXL21 demonstrated that the clay mineral was a vital component. 
When 20 mg CIP was added to the alginate only formulations the film was transparent 
but had taken on a slight yellow hue. However, when the CIP content was increased to 
120 mg and 160 mg the film was no longer clear but white and opaque, with the 
opacity forming rings across the film surface. This was likely caused by the CIP 
precipitating out of solution during the drying process, as the concentration of CIP in 
solution increased beyond its solubility point. No such opacity or precipitation of CIP 
was observed when LXL21 was present in the formulation, indicating that adsorption 
onto the clay mineral surface allows for much greater drug loading within the film. 
 
Thus, the final film formulation selected was 1 g LXL21, 2 g MVAlg, and 2.25 g glycerol. 
It should be noted that glycerol, at the amount used, cannot be considered an additive 
as it makes up a significant proportion of the final formulation. The composite films 
containing 20 mg, 120 mg, and 160 mg CIP were also considered for further analysis.  
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Table 4.2 gives an overview of the composite films that were taken forward for further 
analysis along with a sample code that will be referred to in the analytical sections 
below. 
 
4.3.1.3. Optical properties of film formulations 
Transparency is a desirable property for film dressings as it facilitates accurate 
application on the wound site and allows for the wound environment to be monitored 
whilst the dressing is in place (Boateng et al., 2008; Smith et al., 2016), reducing the 
need to remove the dressing thus reducing the risk of damaging the wound bed. 
Measuring the absorbance and transmittance (figure 4.4) of light through films is a 
recognised way of quantifying film opacity and transparency (Abdollahi et al., 2013; 
Alboofetileh et al., 2013; Shankar et al., 2016).  
 
As shown in figure 4.4 measuring the proportion of visible light transmitted through 
the sample is a useful way to represent the transparency of the film, with higher 
Table 4.2. Composition of the composite films that were taken forward for quantitative analysis. 
Film composition  Sample Code 
KN MMTK10 LXL21 MVAlg GLY CIP   
- - - 2 g - -  MVAlg 
- - - 2 g 2.25 g -  MVAlg-GLY 
1 g - - 2 g - -  MVAlg-KN 
- 1 g - 2 g - -  MVAlg-MMTK10 
- - 1 g 2 g - -  MVAlg-LXL21 
- - 1 g 2 g 2.25 g -  LXL21-MVAlg-LXL21-GLY 
- - - 2 g 2.25 g 20 mg  MVAlg-GLY-20CIP 
- - - 2 g 2.25 g 130 mg  MVAlg-GLY-130CIP 
- - - 2 g 2.25 g 160 mg  MVAlg-GLY-160CIP 
- - 1 g 2 g 2.25 g 20 mg  MVAlg-LXL21-GLY-20CIP 
- - 1 g 2 g 2.25 g 130 mg  MVAlg-LXL21- GLY-130CIP 
- - 1 g 2 g 2.25 g 160 mg  MVAlg-LXL21- GLY-160CIP 
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percentage transmittance indicating greater transparency. By measuring the 
absorbance at 600 nm and accounting for film thickness (see equation 4.1) it is 
possible to obtain a value for film opacity (see table 4.3). 
 
Films containing MMTK10 were shown to be the most opaque as they transmitted no 
light (0%) and had an opacity value of 22.819; the highest obtained for the samples 
tested. Films containing KN were also shown to be transmitters of light and had a 
relatively high opacity of 12.237.  For this reason films containing MMTK10 and KN 
would not be considered optimal clay-minerals for use within these alginate based 
dressings.  
 
 
Figure 4.4. Percentage of light transmitted through films composed of MVAlg (dark blue), MVAlg-KN 
(red), MVAlg-MMTK10 (green), MVAlg-LXL21 (light blue), MVAlg-GLY (purple), and MVAlg-LXL21-GLY 
(orange). 
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Interestingly, LXL21-MVAlg films only transmitted approximately 15% of visible light (at 
600 nm) but this was better than the MMKT10 and KN containing films. LXL21 particles 
are much smaller in size compared to MMTK10 and KN, and are also able to exfoliate 
to a greater extent in water (Mongondry et al., 2005), which may explain why the 
transmittance of these films is higher and the opacity value is lower. 
 
When glycerol is present within the samples the percentage transmittance of LXL21-
MVAlg films is greatly increased and the opacity value is greatly decreased indicating 
this nanocomposite film to be the most transparent of those tested. While the 
percentage of light transmitted by MVAlg-GLY films was perceived to decrease slightly 
compared to the simple MVAlg film, the opacity value of the MVAlg-GLY films indicates 
improved transparency.  
 
The presence of CIP within the films was also shown to affect the optical properties of 
the films; effectively reducing the amount of light transmitted through the sample and 
increasing the opacity of the film as the concentration of CIP increased. 
 
Table 4.3. Opacity values of clay-mineral alginate nanocomposite films 
Sample Abs600 Opacity (±SD) 
MVAlg 0.0467 2.491 (±1.279) 
MVAlg-GLY 0.0795 0.713 (±0.055) 
MVAlg-KN 1.1238 12.237 (±0.558) 
MVAlg-MMTK10 2.8558 22.819 (±2.130) 
MVAlg-LXL21 0.7070 5.165 (±2.407) 
MVAlg-LXL21- GLY 0.0531 0.202 (±0.057) 
MVAlg-GLY-20CIP 0.0866 0.777 (±0.060) 
MVAlg-GLY-130CIP 0.8446 7.576 (±0.582) 
MVAlg-GLY-160CIP 1.4973 13.430 (±1.032) 
MVAlg-LXL21- GLY-20CIP 0.0621 0.236 (±0.066) 
MVAlg-LXL21- GLY-130CIP 0.2880 1.093 (±0.307) 
MVAlg-LXL21- GLY-160CIP 0.3253 1.235 (±0.347) 
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This could also be seen visually by the increased intensity of yellow tones within the 
formulations containing more CIP (as described in section 4.3.1.2). However, these 
optical evaluations demonstrate the effect was significantly (p < 0.001) less 
pronounced in films containing LXL21 (figure 4.5 and table 4.3).  
 
Chapter 3 indicated that when CIP was adsorbed onto clay mineral surfaces it acquired 
an amorphous arrangement and the FTIR and XRD data for these composite materials 
(sections 4.3.3 and 4.3.4, respectively) also suggest that CIP was adsorbed into the 
interlayer space of the LXL21 within the film nanocomposites. Amorphous 
arrangements can affect optical properties of solids, which may account for the 
increased transparency in LXL21 containing films, even at high CIP content. 
 
 
nm 
 
Figure 4.5. Percentage of light transmitted through films composing of MVAlg-GLY-20CIP (dark blue), 
MVAlg-GLY-130CIP (red), MVAlg-GLY-160CIP (green), MVAlg-LXL21- GLY-20CIP (light blue), MVAlg-
LXL21- 130CIP (orange), and MVAlg-LXL21- 160CIP (purple). 
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Conversely, an absence of LXL21 within the films could have resulted in the 
precipitation of CIP during the drying process thus resulting in the presence of CIP 
particles throughout the formulation causing greater opacity. 
 
A serendipitous finding of this experiment was the reduced transmission of ultraviolet 
light (below 400 nm). This reduction in transmission indicates that these 
nanocomposite films may also be able to protect the fragile wound bed from 
ultraviolet radiation, which is known to be harmful to the skin and wound-healing 
(Williams, 1996). Clay minerals are known to absorb UV radiation (Hoang-Minh et al., 
2010), so the reduced transmission in non-clay-mineral containing samples suggests 
that alginate also has a role to play in UV absorption. There was practically no 
transmission of radiation at wavelengths shorter than 325 nm in the CIP containing 
composite (figure 4.5), compared to the non-CIP containing composites that allowed 
much more radiation to be transmitted at wavelengths shorter than 325 nm (figure 
4.4). This shows that CIP was also able to absorb UV light but it is not known whether 
this resulted in degradation of the drug (Phillips et al., 1990), which should be 
investigated in future work to determine whether further UV-protection is required. 
 
Overall, these data prove that LXL21 is a useful additive for alginate films as it is able to 
preserve the transparent properties that are desirable in film dressings. These results 
also support the decision to exclude KN and MMTK10 from ongoing formulation 
studies and that efforts should be made to optimise the properties of the LXL21-
Alginate composite films. Future research is required to determine whether these films 
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can protect the wound environment from UV radiation, and whether this process 
negatively or positively impacts on the stability of CIP. 
 
4.3.2. Evaluation and selection of an ideal foam formulation 
4.3.2.1. Qualitative analysis of pre-formulation foam materials 
Qualitative analysis of the foam-like materials was undertaken to describe their 
texture, strength, flexibility, and plasticity (ability to rebound once compressed). These 
are important properties for foam dressings as they need to be able to cushion and 
protect the wound from further damage, and be flexible enough to be used on the 
curvature and flexures of the human anatomy (Boateng et al., 2008; Powers et al., 
2016). The narrative below describes the appearance, texture, strength and 
cushioning-properties of the different formulations developed. Collaboration with 
tissue viability nurses at the Liverpool and Broadgreen University Hospitals NHS Trust 
allowed these interpretations to be confirmed, and allowed these specialist health 
professionals to inform the future direction of this research. 
 
Unlike the film formulations, the colour of the foams was not significantly affected by 
the clay mineral content. Foams containing KN and LXL21 were off-white in colour, 
whilst those formed with MMTK10 were equally as opaque but were more cream in 
colour. 
 
Separation and flocculation of KN and MMTK10 from the alginate dispersion was 
observed during the formulation of foam materials. This phase separation appeared to 
be more profound in the foam formulations as a large amount of clay mineral powder 
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remained in the casting dish when the foam was lifted out. Using higher amounts of 
high viscosity alginate (4 g MVAlg and 2 g HVAlg) only partially overcame this problem 
and differences in the appearance of the upper and lower surfaces were evident. This 
confirmed that KN and MMTK10 were unable to form physicochemical interactions 
with the alginate polymer chains and were therefore considered inappropriate for 
further study as ingredients in the foam materials. LXL21 performed best out of the 
clay minerals tested. No phase separation was observed and for this reason, and for its 
ability to carry high amounts of CIP, LXL21 was chosen for further study. 
 
Formulations containing low concentrations of all grades of alginate did not result in 
viable foams and instead flaky, fibrous, and particulate materials were obtained. This is 
likely a result of there not being enough polymeric material in the final frozen volume 
to form stable, interlinked, foams. In contrast, high concentrations of more viscous 
alginates (4 g MVAlg and 2 g HVAlg for example) formed foams that were too rigid, 
giving very little of the needed cushioning and flexibility – likely a result of a denser 
internal structure and more interactions between polymeric units. Large amounts of 
LVAlg (4 g) and moderate amounts of MVAlg (2 g) were found to create the most 
promising foam-like materials, especially when formulated with LXL21. These materials 
did not tear easily and had some degree of flexibility and compressibility. For this 
reason composites containing 4 g LVAlg and 2 g MVAlg were carried forward for 
further study. An overview of the foam component combinations studied and their 
potential for further study are outlined in table 4.4. 
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Table 4.4. Overview of the potential of foams made with 1 g of clay mineral and differing concentrations of 
varying grades of alginate. Red fields denote formulations that were not (N) carried forward for further study, 
and orange fields denote formulations that showed potential () and were studied further. 
 LVAlg (g) MVAlg (g) HVAlg (g) 
 0.25 0.5 1 2 4 0.25 0.5 1 2 4 0.1 0.25 0.5 1 2 
KN N N N N N N N N N N N N N N N 
MMTK10 N N N N N N N N N N N N N N N 
LXL21 N N N N  N N N  N N N N N N 
 
 
A number of problems still remained within the promising formulations. It is vital that 
foam wound-dressings are soft and flexible and the two composite foams identified 
above would not provide the necessary cushioning or flexibility required by patients 
and were therefore not fit for purpose. Glycerol was also employed as a plasticiser 
here as it was found to give extremely good properties to the film formulations. Much 
less glycerol, however, was needed to achieve the desired softness for the foams 
compared to the films (562.5 mg vs 2.25 g). This is likely due to the relative density of 
the materials formed as the foam-like materials had much less alginate mass and 
polymer chain interactions per unit volume in comparison to the films. Therefore, less 
glycerol was required to modify the interactions between the polymer chains to 
reduce the rigidity of the material. Using too much glycerol (1.6875 g to 2.25 g) 
resulted in excess glycerol separating from the foam-like materials, resulting in a 
greasy material that would not rebound once compressed. In contrast, materials 
formed using 562.5 mg glycerol would rebound after moderate compression and thus 
had promising cushioning properties (see video in figure 4.6).  
 
Even though the softness of the foam-like materials had been enhanced, the tissue 
viability nursing team from The Royal Liverpool and Broadgreen University hospital still 
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found the materials to be clinically inappropriate. Whilst the materials had cushioning 
properties the integrity of the overall foam was considered unacceptable. This was 
caused by striations of foam and voids throughout the material that resulted in 
structural weaknesses that broke easily on bending. It was likely that these striations 
were caused by arrangements of ice crystals forming during the freezing process and it 
was therefore vital to eliminate ice crystal formation.  
 
A number of compounds known to inhibit the formation of ice crystals (Fink, 2015; 
Giuliani et al., 2012; Inada and Modak, 2006; Soykeabkaew et al., 2015) were studied 
but none of these provided the necessary effects at the concentrations tested. Salts of 
sodium and calcium are employed industrially to prevent the formation of ice crystals, 
or promote melting. However, neither was seen to have significant effects on the 
formation of striations within the composite foams and both were found to increase 
the hardness of the materials obtained. This effect of calcium is well known to increase 
gel strength and structure in alginates as it forms strong bridges between the G-G units 
on the alginate chains (Qin, 2008). Ethanol performed better than the salts, resulting in 
smaller ice crystals that were concentrated at the edges and bottom surface of the 
foam-like materials obtained. However, the striations formed in the materials 
containing ethanol were not reduced enough to provide any remarkable improvement 
in physical strength. 
 
The results above suggest that ice crystals were being formed during the freezing 
process and this was likely to be due to the casting dish, the clay minerals, and alginate 
providing nucleation points for ice-crystal formation. Therefore, hastening of the 
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freezing process was investigated. Speeding up the freezing process using a -80 oC 
freezer did not have much effect on reducing striation (figure 4.6 A). The vast majority 
of striation still occurred at the edges and underside of the foams, proving that the 
casting dish was acting as a nucleation site for ice crystals.  
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Images demonstrating the progression of foam formulations consisting of (A) 1 g LXL21 and 
4g LVALg, frozen at -80 
o
C; (B) 1g LXL21 and 4g LVAlg, frozen in liquid nitrogen; and (C) 1g LXL21 and 4g 
LVAlg with 562.5 mg glycerol, frozen in liquid nitrogen. The QR code can be scanned with mobile and 
tablet devices and will open a YouTube video demonstrating the properties of these materials [url: 
https://youtu.be/nW_61H5ipbw].  
 
 
A B 
C 
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Flash-freezing by submersion in liquid nitrogen allowed the generation of an improved 
foam structure. Submersion into liquid nitrogen caused freezing of the formulation 
mixture from the edges inwards. Short freezing times (5 minutes) resulted in 
incomplete freezing of the sample so that the formulation mixture in the centre of 
sample was still a liquid, which only froze overnight at -20 oC and led to striations and 
weakness at the centre of the foams. Ensuring adequate submersion times (greater 
than 15 minutes) allowed the entire formulation mixture, in the casting dish, to be 
sufficiently frozen. The majority of striation was removed by this freezing process 
(figure 4.6 B) and a more uniform product was obtained that had improved flexibility 
and rebound when glycerol was present (figure 4.6 C). 
 
The formulation selected for further investigation of foam-like materials contained 1 g 
LXL21, 4 g LVAlg and 562.5 mg glycerol prepared by submersing the casting dish in 
liquid nitrogen for 15 minutes, following storage at -20 oC before freeze-drying. As 
shown in figure 4.6 C the foam that was produced was uniform in nature with no 
striation due to water crystal formation. The physical properties were also much 
improved compared to the other pre-formulation samples (see video in figure 4.6), 
having improved flexibility and rebound behaviour. However, the behaviour and 
properties of these materials may change in the wound environment and this was 
further investigated in sections 4.3.7 and 4.3.8. 
 
4.3.2.2. Qualitative evaluation of ciprofloxacin-containing foam materials 
Foams formulated with LXL21 and 20 mg (0.36% w/w) CIP were identical in 
appearance to those without CIP. As the concentration of CIP within the formulation 
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increased to 160 mg (2.80% w/w) the foam took on a yellow hue but no obvious 
structural defects were observed. The incorporation of 200 mg (3.47% w/w) CIP into 
the composite resulted in major defects and a material that was a strong yellow colour 
made of loosely connected flakes and lumps. As for the film formulation, it is likely that 
this high CIP loading caused the LXL21 to flocculate leading to poor interactions 
between the clay mineral layers and the alginate chains. Independent feedback from 
the nursing team confirmed that these foam materials were promising but still needed 
further development. Whilst the foams were soft and responsive to compression they 
could not withstand aggressive folding and bending without breaking or forming 
particulates.  
 
Before further refinement of the foam formulations was considered the potential of 
the composites highlighted above (1 g LXL21, 4 g LVAlg, and 562.5 mg glycerol) were 
investigated as potential carriers for CIP. 
 
Final foam-like formulations were repeated without the inclusion of LXL21 to act as 
comparators. CIP did not precipitate in the formulations containing LXL21 but this is 
not a reliable indication of whether the CIP remained in solution or not. The 
formulation mixtures for clay-free composites were distinctly whiter than those 
containing LXL21, suggesting that CIP precipitated out before or during the casting 
stage. This explains the ring-like patterns observed in the foam, as these patterns 
would have been induced by the drying process. Therefore, it is likely that the CIP did 
not remain solubilised in the foams and was simply dispersed throughout the dressing, 
held in place by the rapid freezing process.  
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Table 4.5. Composition of the composite foams that were taken forward for quantitative analysis. Where LN 
represented the liquid nitrogen freezing technique. 
Sample composition  Sample Code 
Clay mineral 
(1g) 
Alginate Glycerol CIP Freezing 
method 
  
- 4 g LVAlg - - LN  LVAlg 
- 4 g LVAlg 562.5 mg - LN  LVAlg-GLY 
KN 4 g LVAlg - - LN  LVAlg-KN 
MMTK10 4 g LVAlg - - LN  LVAlg-MMTK10 
LXL21 4 g LVAlg - - LN  LVAlg-LXL21 
LXL21 2 g MVAlg - - LN  MVAlg-LXL21 
LXL21 1 g HVAlg - - LN  HVAlg-LXL21 
LXL21 4 g LVAlg 562.5 mg - - 20 
o
C  LVAlg-LXL21- GLY-m20 
LXL21 4 g LVAlg 562.5 mg - - 80 
o
C  LVAlg-LXL21- GLY-m80 
LXL21 4 g LVAlg 562.5 mg - LN  LVAlg-LXL21- GLY-LiqN 
- 4 g LVAlg 562.5 mg 20 mg LN  LVALg-GLY-20CIP 
- 4 g LVAlg 562.5 mg 130 mg LN  LVALg-GLY-130CIP 
- 4 g LVAlg 562.5 mg 160 mg LN  LVALg-GLY-160CIP 
LXL21 4 g LVAlg 562.5 mg 20 mg LN  LVALg-LXL21- GLY-20CIP 
LXL21 4 g LVAlg 562.5 mg 130 mg LN  LVALg-LXL21- GLY-130CIP 
LXL21 4 g LVAlg 562.5 mg 160 mg LN  LVALg-LXL21- GLY-160CIP 
  
 
Table 4.5 gives an overview of the composite files that were taken forward for further 
analysis along with a sample code that will be referred to in the analytical sections 
below. 
 
4.3.2.3. Semi-quantitative analysis of the mechanical strength of foam materials 
Friability testing was utilised to estimate the overall mechanical strength and 
robustness of the foam materials obtained. The results shown in figure 4.7 display the 
percentage weight loss of the foams after tumbling and indicate the effect of each 
ingredient on the structural integrity of the composite material. The commercially 
available dressings Kaltostat® and Lyofoam® did not lose any mass during tumbling, 
which was set as the target weight loss for the composite materials.  
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Figure 4.7. Percentage weight loss (average, based on 10 samples) of selected foam-like materials after 
friability testing, demonstrating the effects of differing clay minerals (orange), alginate grades (green), 
freezing parameters (grey) drug loading (red), and absence of LXL21 from the final formulation (purple). 
Calculated percentage losses are explicitly given for each material. 
 
The type of clay mineral used was shown to have the greatest impact on the friability 
of the foam like materials obtained. KN and MMTK10 were both shown to perform 
extremely poorly and would therefore not be acceptable for the clinical care of 
wounds. As described above it is likely that KN and MMK10 were not able to form 
interactions with the alginate polymer chains, resulting in a fragile structure based on 
alginate-alginate chain interactions only.  
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The grade and mass of alginate used was also shown to be important in the overall 
robustness of the foam materials obtained. Foams of LVAlg, containing no other 
components, were shown to lose only 0.742 % of their mass during testing. In the 
presence of LXL21 the composite foam containing 4 g LVAlg was shown to lose less of 
its overall mass (1.381 %) compared to 2 g MVAlg (1.817 %) and 1 g HVAlg (4.758 %). 
This is likely caused by a higher mass of alginate allowing for increased inter-polymer 
interactions and also increased abundance of interactions with the LXL21 present. It is 
also plausible that using lower concentrations of longer chain polymers (such as 1 g 
HVAlg) allows for the matrix to be more flexible, less dense, and therefore easier to 
break apart during friability testing. 
 
Altering the freezing process of the foams was shown to have a positive effect on the 
strength of the foams. Those frozen at -20 oC lost large amounts of mass (4.25%) 
during testing compared to those frozen at -80 oC (0.01% mass loss). Those frozen in 
liquid nitrogen lost 0.207 % of their mass during testing. These data show that the 
reduced ice-crystal formation and greater visual homogeneity in these rapidly frozen 
samples also awarded the composites more structural integrity compared to those 
frozen in the -20 oC freezer.  
 
The results of the friability testing suggest that addition of non-swelling clay minerals 
(KN and MMTK10) to the alginate polymers creates a less structurally sound composite 
foam when compared to the swelling clay LXL21. This is supported by scientific 
literature showing that the presence of a 2:1 clay mineral within polymeric matrices 
can increase the structural robustness of foam composites (Ray and Okamoto, 2003). 
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These data therefore support the decision to retire KN and MMTK10 from further 
study and to focus on the role of LXL21 within these composite foam materials. 
However, it may be possible that the methodology used here is not sensitive enough 
to fully characterise material strength. Therefore, future work needs to include 
analysis of tensile properties, flexure properties, and compression-rebound properties 
(Boateng et al., 2008; Ray and Okamoto, 2003; Thu et al., 2012). 
 
4.3.3. FTIR analysis of films and foam formulations 
FTIR is extensively used in the evaluation of clay-polymer composites to determine the 
location and nature of clay-polymer interactions (Bandeira et al., 2012). The FTIR 
spectrum for LXL21 is discussed in section 2.3.5 and is provided again in figure 4.8 
below.  
 
As with the spectra for other organic molecules, such as CIP (discussed in section 3.3.5 
and provided again in figure 4.8), the fingerprint for MVAlg and LVAlg can be seen 
between 550 – 1800 cm-1. Characteristic absorbance bands appear in the same 
positions for LVAlg and MVAlg at 3265 cm-1 for the hydroxyl groups, 1596 cm-1 for –
COOH symmetric stretching, 1406 cm-1 for –COOH asymmetric stretching, and 1025 
cm-1  for C-O-C stretching (Benli et al., 2011; Ghadiri et al., 2013; Pongjanyakul, 2009).  
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Figure 4.8. Full FTIR spectra for LXL21 (dark blue), CIP (light grey), LVAlg (orange) and MVAlg (red). 
 
No change in the position of the absorbance peaks were observed when LXL21 was 
physically mixed with the alginates indicating that no chemical or physical interaction 
took place during this process. When formulated into a film without LXL21 or glycerol 
the positions of the absorbance bands for MVAlg remained unchanged when 
compared to the original powder (figure 4.9). This suggests that no change in the 
chemical or physical structure of MVAlg took place during the dispersion, casting, and 
drying processes. When LXL21 was present within the film formulation, the symmetric 
–COOH absorbance shifted to 1602 cm-1 and the asymmetric –COOH absorbance 
shifted to 1410 cm-1. This shift to a higher wavenumber is suggestive of hydrogen 
bonds being formed between the –COOH groups on the alginate polymer chain and 
the LXL21 particles (Bandeira et al., 2012; Benli et al., 2011). In this sample the Si-O-Si 
stretch absorbance, characteristic to LXL21, was shifted to 975 cm-1 and the Si-O 
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bending absorbance was shifted to 625 cm-1, which is suggestive of an interaction 
occurring at the exposed silanols at the clay-mineral edge sites (Bandeira et al., 2012; 
Ghadiri et al., 2013). The presence of glycerol within the film formulations could be 
detected by the double absorbance at 2935 and 2883 cm-1, assigned to the –OH 
vibrations (Calvino-Casilda et al., 2011), and the bands at 1078 and 1028 cm-1, which 
are attributed to the CH2OH vibration (Tan et al., 2016). 
 
 
 
  
Wave number (cm
-1
) 
Figure 4.9. Enlarged sections of the FTIR spectra for MVAlg film (purple), MVAlg-LXL21 film (green), and 
MVAlg-LXL21- GLY film (light blue). 
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When assessing the spectra for films containing MVAlg-GLY-160CIP and LXL21-MVAlg-
GLY-160CIP a number of key observations can be made. The absorbance peaks for 
glycerol appear at the same wavenumber as in the LXL21-MVAlg-GLY film (figure 4.9). 
The characteristic absorbance bands for MVAlg also remained at the same position as 
previously observed above. As discussed by Singh et al. (2013) in their work on 
antibiotic hydrogel wound dressings, glycerol is often used to reduce the 
intermolecular forces between polymer chains but no details are given as to any 
physicochemical interaction that takes place. The academic literature also provides 
little evidence of an interaction between glycerol and alginate chains. Therefore, the 
lack of interaction picked up by FTIR in this research may be truly representative of the 
weak interaction between glycerol and MVAlg. However, a slight shift in the Si-O-Si 
absorbance of LXL21 is observed in the sample of the final formulation. The 
appearance of this peak at 987 cm-1 (appears at 950 cm-1 in unmodified LXL21, and 975 
cm-1 in the LXL21-MVAlg film) in the LXL21-MVAlg-GLY film and the LXL21-MVAlg-GLY-
160CIP film suggests there is an interaction between LXL21 and glycerol. Even though 
the interaction between glycerol and clay mineral surfaces, specifically the interlayer 
space, has been recognised for a number of years it is not well characterised (Lagaly et 
al., 2013; Madsen, 1977; Tan et al., 2017). It may be possible that the ability of glycerol 
to act as a plasticiser is not detectable through FTIR, hence why no absorbance shifts 
are observed here. Given the reported interaction between 2:1 clay minerals and 
glycerol in the literature it may be possible that the shift in the Si-O-Si absorbance is 
suggestive of an interaction between glycerol and LXL21.  
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In section 3.3.5, key absorbance peaks for CIP were shown to shift, indicating an 
interaction between the zwitterionic CIP molecule and the edges and interlayer 
surfaces of the clay mineral particles. However, the absorbance assigned to the 
positively charged amino group appeared in its original position at 1373 cm-1. Other 
characteristic CIP peaks that were previously observed at 1588 and 1617 cm-1 could 
not be detected in these samples as they were masked by the COO– asymmetric 
stretch of MVAlg (figure 4.10).  
 
   
Wave number (cm
-1
) 
Figure 4.10. Enlarged sections of the FTIR spectra for the film containing MVAlg-GLY-160CIP (teal) and 
MVAlg-LXL21- GLY-160CIP (pink). 
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Therefore, it is not possible to determine whether CIP has remained within the LXL21 
laminar space when formulated with MVAlg. It is possible that the appearance of the –
NH2
+ absorbance in its original position means that CIP is not interacting with the 
LXL21 surface (Chang et al., 2016; Wang et al., 2010) and may have been displaced by 
glycerol (figure 4.10). 
 
Similar analyses and cross comparisons were undertaken for the foam formulations 
(figure 4.11). In the samples containing LXL21 the –COOH symmetric and asymmetric 
stretching absorbance peaks were shifted to higher wavenumbers at 1600 and 1410 
cm-1, respectively. The Si-O-Si stretching absorbance was shown to shift significantly to 
985 cm-1 and a smaller shift in the Si-O bending absorbance to 625 cm-1 was also 
observed. The shift in these characteristic bands is indicative of an electrostatic 
interaction between the carboxyl groups of the alginate polymer and the positively 
charged exposed silanols at the LXL21 particle edge sites (Bandeira et al., 2012; Darder 
et al., 2016). Characteristic absorbance bands can be observed when glycerol is 
present within the composites, but the bands are not as well resolved as in the film 
formulations described above. The proportion of glycerol within the foam composites 
was significantly smaller than the film composites, accounting for these low intensity 
bands.  
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Figure 4.11. Enlarged sections of the FTIR spectra for LVAlg powder (orange) and foams containing 
LVALg-LXL21 (green), LVAlg-GLY-160CIP (teal), and LVAlg-LXL21-GLY-160CIP (pink). 
 
None of the characteristic CIP absorbance peaks could be identified in the FTIR spectra 
of the foam composites as the large absorbance bands of LVAlg at 1600 and 1410 cm-1 
were masking the smaller CIP absorbance. Unfortunately this means no accurate 
conclusions can be drawn about the interaction of CIP with LXL21 and LVAlg in these 
foam composites. It may be reasonable, however, to assume that the interactions 
between LXL21, LVAlg, glycerol, and CIP in the foam composites are similar to those 
observed in the film composites. Therefore, CIP is likely adsorbed onto the internal 
surfaces with LVAlg chains interacting with the LXL21 particle edge sites. In the film 
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composites it was proposed that glycerol could compete with, and displace, CIP from 
the LXL21 surface. While it may be possible for the same process to occur in the 
production of the foam composites the degree of CIP displacement may well be lower 
due to the smaller amount of glycerol used within the formulation process. While the 
release-studies and antimicrobial testing discussed below prove that CIP was still 
present in these foam composites pXRD analyses were necessary to determine the 
location of both CIP and glycerol within these composite materials.  
 
4.3.4. XRD analysis of film and foam composites 
X-ray diffraction is a useful technique to determine whether microcomposites, 
intercalated nanocomposites, or exfoliated nanocomposites are formed through clay-
mineral polymer interactions (Alboofetileh et al., 2013; Zhang et al., 2009). The 
diffraction pattern for LXL21 is characteristic of Laponite® as seen in chapters 2 and 3 
with a broad, low intensity, reflection at 6.81 degrees 2θ representing a d001 spacing of 
13.61 Å. The diffractogram for MVAlg powder revealed this product was amorphous in 
nature with a broad diffraction at 6.56 degrees 2θ and a rise in baseline at 18.25 
degrees 2θ onwards, which is characteristically reported in the literature (Alboofetileh 
et al., 2013; Ghadiri et al., 2013; Yang et al., 2012). The physical mixture of these two 
compounds does not cause any alteration of the interlayer space of LXL21 but a muting 
of its diffraction peaks due to the proportion of MVAlg present (figure 4.12 A). 
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Figure 4.12. XRD diffractograms for (A) LXL21 powder (orange), MVAlg powder (grey), and a physical mix 
of LXL21 and MVAlg (dark blue), and (B) MVAlg film (red), MVAlg-LXL21 film (green), and MVAlg-LXL21-
GLY film (purple). 
 
When formulated as a film the MVAlg polymers formed a more ordered structure as 
indicated by the higher intensity peak at 7.95 degrees 2θ. The addition of LXL21 to the 
formulation produced a diffractogram indicative of a structure more ordered than the 
LXL21 powder and MVAlg films (figure 4.12 B). 
 
The initial diffraction at 7.33 degrees 2θ suggests that the d001 spacing of LXL21 was 
reduced to 12.01 Å. While alginate is believed to interact with the interlayer surfaces 
of other swelling minerals such as MMT, the data presented here suggest that does 
not happen with LXL21 as the interlayer space did not increase. A similar conclusion 
was drawn by Ghadiri et al. (2013) who observed an intensification of diffractions but 
no shift in position, indicating increased order within the matrices but no change in 
0
500
1000
1500
2000
2500
3000
3500
3 8 13 18
C
P
S 
0
500
1000
1500
2000
2500
3000
3500
3 8 13 18
Degrees (2θ) 
A B 
Chapter 4              Development and evaluation of antibacterial wound dressing materials 
Page 197 of 260 
Laponite® XLG interlayer spacing. Therefore, it is likely that the negatively charged 
carboxyl groups, and the high density negative charge of the G-G regions, of MVAlg 
were interacting with the positively charged exposed hydroxyl groups at the edge of 
the LXL21 platelets.  
 
The addition of glycerol into MVAlg-LXL21 film system caused significant changes in 
the diffractogram with broad low intensity diffractions appearing at 5.32, 9.58 and 
19.69 degrees 2θ. It is probable that the diffraction at 5.32 degrees 2θ is due to the 
LXL21 with an increased d001 spacing of 16.6 Å due to glycerol adsorption into the 
interlayer space of LXL21. This reduction of order within the diffractogram is 
suggestive of reduced crystallinity (Chang et al., 2009) and order within the films 
containing glycerol, which supports the qualitative analysis that declared glycerol a 
good softener and plasticiser for these films. 
 
The diffraction pattern for LVAlg (figure 4.13) was very similar to that for MVAlg, which 
showed an amorphous structure. The diffractogram for the physical mixture of LXL21 
and LVAlg generated diffractions at 6.81 and 19.67 degrees 2θ indicating that there 
was no separation of the clay mineral layers through the process of creating a physical 
mixture. Although the baseline appears to have shifted upwards on the intensity scale 
a new low-intensity, broad, diffraction can be observed at 13.69 degrees 2θ, which is 
also observed at 13.51 degrees 2θ in the physical mix of LXL21 and MVAlg above. As 
demonstrated by Chang et al., (2009) not all clay-mineral diffractions are detected but 
it is possible to apply Bragg’s Law (equation 2.9) to predict at what angles these 
diffractions should appear. Therefore, it is probable that these new diffractions 
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represent the d002 reflection with the diffractions at 6.81 and 19.67 degrees 2θ 
representing the d001 and d003 reflections, respectively. 
 
Unlike the diffraction pattern for the MVAlg film, which showed increased order 
compared to the powder, the diffraction pattern for the MVAlg foam indicated this 
material was amorphous with no order induced by the casting or freeze-drying 
processes. The addition of LXL21 to the LVAlg foam resulted in increased order within 
the material, as indicated by the reflection at 7.87 degrees 2θ. This shift in d001 
reflection suggests that the interlayer space of LXL21 has decreased to around 11.22 Å.  
 
 
 
Figure 4.13. XRD diffractograms for (A) LXL21 powder (orange), LVAlg powder (grey), and a physical mix 
of LXL21 and LVAlg (dark blue), and (B) LVAlg foam (red), LVAlg-LXL21 foam (green), and LVAlg-LXL21-
GLY foam (purple). 
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Finally, addition of glycerol to the foam formulation did not reduce the order within 
the material as much as was observed in the film formulations, which may have been 
due to the reduced amount of glycerol used within the foam formulations. However, 
the reflections at 5.32, 9.42 and 19.63 degrees 2θ observed in this sample were in 
similar locations to those observed in the LVAlg-LXL21-GLY film. The reflection at 5.32 
degrees 2θ is likely caused by the LXL21 with an increased d001 space of 16.6 Å. As 
proposed above, it is probable that the glycerol was absorbed into the interlayer space 
of LXL21. 
 
4.3.5. Thermal analysis of film and foam formulations 
By examining the thermal behaviour of the individual components, in isolation and 
together, of the final formulations it was also possible to determine the role of each 
component within the film (figure 4.14) and foam nanocomposites (figure 4.15) on the 
thermal stability and cross-linking of the materials formed (Ghadiri et al., 2013; Ray 
and Okamoto, 2003; Shikinaka et al., 2012) 
 
The first loss of mass observed on all the TGA experiments started at approximately 
30oC temperature and was due to the loss of water within the sample. The size of this 
mass loss can be related to the amount of water held within each sample (Matthews et 
al., 2005; Pongjanyakul and Puttipipatkhachorn, 2008). The powder of MVAlg alone 
showed moisture loss between 30 oC and around 105 oC, which was followed by a 
significant loss of mass between 210 – 270 oC and a smaller mass loss between 360 – 
410 oC (figure 4.14). These mass changes were due to the depolymerisation and 
decomposition of the alginate polymer. Subsequent combustion of the alginate 
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polymer residues can be observed between 550 – 710 oC (Ghadiri et al., 2013; Iliescu et 
al., 2013; Pongjanyakul and Puttipipatkhachorn, 2008). When MVAlg was formed into 
a simple film the loss of mass due to unbound, surface, water was approximately 4% 
greater than for the powder form, indicating that even in the dry state the film was 
able to retain a certain degree of water. No change in the initial decomposition of the 
alginate polymer was observed, however the third mass loss was recorded between 
390 – 490 oC. This shift to a higher temperature may be caused by reduced heat 
conduction (Chen et al., 2012) and possible increased thermal stability in the alginate 
film in comparison to the powder form (Bandeira et al., 2012; Tezcan et al., 2012).  This 
shift in thermal stability can also be observed through the final residue combustion 
commencing at 635 oC in the film sample.  
 
The addition of glycerol resulted in marked changes in the thermal properties of the 
MVAlg film. The second mass loss at 140 oC is an indication of glycerol mass loss rather 
than early decomposition of the alginate polymer (Momoh et al., 2015), which was 
seen to follow similar decomposition behaviour to the MVAlg film. The second and 
third mass losses at 390 – 490 oC and 660 oC, respectively, indicate that the enhanced 
thermal stability of the MVAlg film is maintained in the presence of glycerol. 
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Figure 4.14. Mass change (%) of (A) MVAlg powder (green), MVAlg film (black), and MVAlg-GLY film 
(orange), and (B) LXL21 powder (purple), physical mix of LXL21 and MVAlg (red), MVAlg-LXL21 film (dark 
blue), and a MVAlg-LXL21-GLY film (light blue) when heated from room temperature to 800 
o
C. 
 
The thermal behaviour of LXL21 is unique in these set of experiments as its inorganic 
chemistry does not provide for multiple combustible compounds in the same way as 
organic molecules. The two main events in the LXL21 TGA curves (figure 4.14) can be 
explained by evaporation of water from the surface and interlayer spaces of the clay-
mineral between 35 – 90 oC then dehydroxylation of the clay-mineral structure above 
660 oC (Bandeira et al., 2012; Iliescu et al., 2013; Pongjanyakul and Puttipipatkhachorn, 
2008). The physical mixture of LXL21 and MVAlg powders did not demonstrate any 
changes in degradation of alginate at 210 oC, indicating there was no interaction taking 
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place between the LXL21 and MVAlg. However, the latter half of the analyses more 
closely resembled that of LXL21 decomposition with no features of alginate residue 
combustion. Chen et al. (2012) reported that silicates can retard the diffusion of 
organic decomposition products and elevate the char yield as the organic compounds 
experience elongated time at these elevated temperatures. While LXL21 was not 
forming cross links with MVAlg it may have been possible for LXL21 to reduce the 
mobility of MVAlg decomposition products, which could explain the lack of mass loss 
expected at 550 oC.  The final mass loss of the physical mixture, commencing at 660 oC, 
was larger than LXL21 alone, which could indicate the release of MVAlg decomposition 
product as the clay-mineral structure was destroyed.  
 
When LXL21 and MVAlg were formulated into a film the thermal behaviour changed 
significantly (figure 4.14). Whilst the evaporation of water and initiation of MVAlg 
decomposition remained unchanged (commencing at 215 oC) the second mass loss 
from alginate destruction occurred at higher temperature of 425 – 550 oC and the final 
decomposition, expected at 660 oC, was not observed. The above explanation 
regarding immobilisation of alginate combustion products does not fit the data 
presented here and may be explained by an interaction between the LXL21 particles 
and the MVAlg polymer chains. The addition of a clay-mineral to alginate has been 
shown to improve thermal stability by other research teams (Bandeira et al., 2012; 
Benli et al., 2011; Ray and Okamoto, 2003; Tezcan et al., 2012; Yang et al., 2009) and is 
the likely explanation here also.  
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The thermal behaviour of LVAlg powder was almost identical compared to the LVAlg 
foam with no LXL21 or additives (figure 4.15). This is in contrast to what was observed 
when alginate was formulated into a film. The foam formulations are less dense and 
more aerated than the films, which may result in improved heat transfer and 
combustion during the TGA experimental process. When glycerol was added to the 
LVAlg foam formulation a number of changes in its thermal behaviour were observed. 
The initial evaporation of water was more rapid than in the simple LVAlg foam, 
suggesting that water was less tightly bound within the glycerol-containing foam. The 
percentage weight loss at this stage was also slightly larger in the glycerol-containing 
foam, indicating there was around 5.1% more water present (mass loss from water 
13.3% vs 8.2%). The mass losses observed at 190 – 280 oC and 390 – 530 oC are due to 
the depolymerisation and decomposition of the alginate polymer, with the final mass 
loss commencing at 610 oC representing combustion of the alginate residues (Ghadiri 
et al., 2013; Iliescu et al., 2013; Pongjanyakul and Puttipipatkhachorn, 2008).   
 
The thermal behaviour of a physical mix of LVAlg and LXL21 (figure 4.15) produced 
similar results to those obtained for the physical mixture of MVAlg and LXL21 (figure 
4.14). The initial mass loss due to alginate decomposition was observed at the same 
temperatures as the control experiment. However, the second decomposition mass 
loss that appeared at 390 – 530 oC in the control samples was not observed here. As in 
the MVAlg experiments this may have been due to the LXL21 inhibiting the 
mobilisation of alginate combustion products (Chen et al., 2012). This is supported by 
the third mass loss commencing at a cooler temperature of 540 oC which likely 
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represented the combustion and increased mobility of the alginate residues as the 
LXL21 is dehydroxylated and decomposed (Ghadiri et al., 2013). 
 
 
 
  
 
Figure 4.15. Mass change (%) of (A) LVAlg powder (green), LVALg foam (black dashed), and LVALg-GLY  
foam (orange), and (B) LXL21 powder (purple), physical mix of LXL21 and LVAlg (red), LVALg-LXL21 foam 
(dark blue), and a LVAlg-LXL21- GLY foam (light blue) when heated from room temperature to 800 
o
C. 
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The addition of LXL21 into the LVAlg foam formulation resulted in a number of changes 
in the TGA results. The initial loss of water was much greater in this formulation, 
indicating that the LXL21 was able to recruit a significant amount of water to the 
formulation. The loss of water, and therefore the proportion of water within the foam, 
was 6% greater compared to the physical mixture of the components. The first stage of 
alginate decomposition was much larger in the foam sample, compared to the 
powders, suggesting that the porous nature of the foam allowed for better heat 
transference through the sample and greater mobilisation of the combustion products. 
Unlike the film formulations, where the addition of LXL21 was shown to improve 
thermal stability, this effect was not observed in the foam formulations containing 
LXL21. The final combustion of alginate residues was seen to commence at 510 oC (30 
oC cooler than the physical mixture) which may be a result of the diffuse distribution of 
LXL21 throughout the formulation being unable to inhibit the decomposition of 
alginate in the same way it does in a closely-packed film. The addition of glycerol into 
the LVAlg-LXL21 foam formulation did not appear to make any significant impact on 
the thermal behaviour of the resultant formulation. The mass loss recorded between 
410 – 530 oC is unlikely to be a result of earlier combustion of LVAlg but is likely to be a 
mixture of glycerol volatilisation and LVAlg decomposition and combustion (Momoh et 
al., 2015; Shankar et al., 2016). Throughout the TGA of the foam formulations glycerol 
was shown to have less of an effect on the thermal behaviour than in the film 
formulations. This is likely due to the proportions of glycerol in each formulation, 
which are four times greater in the film formulations.  
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The TGA of CIP shows the powder contains less than 0.8 % water and that, after 
melting, almost complete decomposition and combustion occurs between 260 – 500 
oC (Berhane et al., 2016). The decomposition of CIP is difficult to identify in the TGA for 
the films and foams (figure 4.16) due to the small amounts of drug present in the 
formulations in comparison to the amounts of LXL21, alginate, and glycerol. An 
interesting observation was the amount of sample remaining at 800 oC was higher in 
both films and foams that contained more CIP.  
 
Logic dictates that samples containing more CIP would combust to a greater extent 
due to their organic nature, thus leaving less residual mass (Bugatti et al., 2011; Chen 
et al., 2012). However, this was not observed in these experiments. 
 
  
 
Figure 4.16. Mass change (%) of CIP (grey line) containing films (A) and foams (B) made with 20 mg CIP 
(green line), 130 mg CIP (red line), and 160 mg CIP (dark blue line). 
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Whilst it is unlikely that the formulation protects the drug at such extremes of 
temperature it is possible that mobility of these combustion products was reduced, 
thus increasing the char yield (Chen et al., 2012; Ray and Okamoto, 2003). Therefore, 
more CIP in the sample could result in a higher char yield and thus a higher mass 
remaining at the end of the experiments. 
 
4.3.6. Water vapour permeability of film and foam formulations 
Water vapour permeability, expressed as water vapour transfer rate (WVTR, g/m2/h), 
is a vital property of wound care products as it determines a dressing’s ability to 
maintain a moist wound environment and can dictate whether a product can be used 
on low, moderate or highly exudative wounds (Matthews et al., 2005; Thu et al., 2012). 
Maintaining a moist wound environment is important for the healing process as it 
promotes epithelialisation, angiogenesis, debridement, and wound closure as well as 
reducing pain (Jones et al., 2006; Kokabi et al., 2007; Palfreyman et al., 2010; Singh et 
al., 2013). A dressing with WVTR of less than 35 g/m2/h is considered an occlusive 
dressing in medical practice literature (Bolton et al., 1992) and a WVTR of 36 – 56 
g/m2/h is considered, in the scientific literature, to also maintain a moist wound 
environment (Kokabi et al., 2007). However, Thu et al. (2012) describe dressings with a 
WVTR of 79.2 – 241.7 g/m2/h being suitable for low exuding wounds only and higher 
WVTR being required for more suppurating wounds. For this reason a control with no 
dressing was used to represent an open, uncovered, wound and set the baseline WVTR. 
Commercially available dressings were also examined as comparators.  
(Thu et al., 2012) 
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The control system exhibited a WVTR of 48.42 g/m2/h and Opsite® was proven to be 
an occlusive film dressing with a WVTR of 4.91 g/m2/h. KN was shown to significantly 
reduce WVTR (figure 4.17) whereas no significant change was observed when 
MMTK10, LXL21 or glycerol were added to the MVAlg film. KN has poor swelling and 
hydration properties when compared to MMTK10 and LXL21. Therefore the 2:1 clays 
are more likely to adsorb water and hinder the movement of moisture through the 
films compared to KN. However, when LXL21 and glycerol were present together 
within the CIP containing films a significant decrease in the WVTR was observed 
compared to the other samples (except Opsite®) and the control. Depending on the 
system within which it is present glycerol can either increase or decrease the WVTR of 
biocomposite films (Vieira et al., 2011). In this research glycerol was only able to 
induce a reduction in WVTR when CIP was present within the system. As suggested in 
the FTIR and XRD studies (sections 4.3.3 and 4.3.4, respectively), CIP and glycerol may 
be able to compete for the LXL21 surface. Therefore, this could increase the 
proportion of glycerol available not adsorbed onto the LXL21 to affect the 
nanocomposite film structure thus inhibiting water vapour loss through the film (Singh 
et al., 2013), improving its ability to maintain a moist wound environment. 
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Figure 4.17. Water vapour transmission rates (WVTR) for film formulations (mean ±SD, n=3). * Indicates 
no significant difference in WVTR between the preformulation samples. ** Indicates no significant 
difference in WVTR between CIP containing samples that do not contain LXL21. *** Indicates no 
significant difference between the WVTR of the candidate film formulation samples. 
 
All the foam composites tested in this study caused a reduction in the WVTR when 
compared to the control (figure 4.18), suggesting they can promote moisture retention 
at the wound surface. The nanocomposite foams were shown to have similar WVTR to 
Kaltostat®, which is a fibrous non-woven pad made from sodium and calcium alginates 
(Voncina et al., 2015). These data therefore suggest that the nanocomposite foams 
handled water vapour and gaseous exchange in a similar way to the branded 
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equivalent. Lyofoam Max® was able to demonstrably (p <0.001) reduce WVTR when 
compared to Kaltostat® and the nanocomposite foams because of its denser, 
hydrophobic, polyurethane structure (Powers et al., 2016).  
 
  
 
Figure 4.18. Water vapour transmission rates (WVTR) for foam formulations. * Indicates no significant 
difference in WVTR between LVAlg, LVAlg-GLY and LVAlg-KN samples. ** Indicates no significant 
difference in WVTR between CIP containing samples that do not contain LXL21. *** Indicates no 
significant difference between the WVTR of the LXL21-LVAlg-GLY-130CIP film and the other CIP 
containing samples. **** Indicates no significant difference in WVTR between the two groups of CIP 
containing composites. 
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The increased thickness of these foam composites, compared to the film composites 
above, may result in an increase in water vapour diffusion time through the composite 
(Thu et al., 2012), which can explain the difference in WVTR observed. Another 
contrast between the foam and the film composites was that the LVAlg-MMKT10 and 
LVAlg-LXL21 foams reduced the WVTR significantly (p < 0.05) more than the LVAlg-KN 
composite. In the preformulation studies it was noted that KN precipitated out during 
the casting stage and remained in the casting dish after drying. Therefore, it is unlikely 
that there was sufficient KN available to affect WVTR.  
 
The LVAlg-LXL21-GLY foam demonstrated a significantly lower WVTR compared to the 
LVAlg and LVAlg-GLY foams. Vieira et al (2011) discussed how glycerol can both 
increase and decrease the WVTR of a biocomposite film and the data presented here 
suggest glycerol can have varying effects on alginate films and foams depending on the 
physical structure of the composite, the amount of glycerol, and presence of clay 
minerals or drugs. No significant change in the WVTR of the CIP containing 
biocomposites was observed when compared to the non-drug containing composites. 
A small degree of intragroup variability was observed, with the LVAlg-LXL21-GLY 
nanocomposite containing 160 mg CIP having a greater WVTR than the 20 mg 
containing composite.  
 
As described above, the competition between CIP and glycerol for the LXL21 surface 
may increase the amount of glycerol available to alter the nanocomposite structure 
and thus the WVTR (Singh et al., 2013). It should also be noted that high drug loads can 
also affect the structure of LXL21. This effect in surface environment and platelet 
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organisation may result in reduced interactions with water molecules, thus increasing 
the chance and rate of water vapour transmission through the composite.  
 
Both the film and foam nanocomposites containing LXL21 provided a marked 
reduction in WVTR compared to the controls, which suggests they are able to retain 
moisture within the wound and thus promote healing. The wound environment 
(sections 4.3.7 and 4.3.8) and cytotoxicity experiments (section 4.3.11) described 
below will be equally important in determining whether these candidate materials 
show promise for clinical application. 
 
4.3.7. Swelling behaviour of formulations on the wound surface 
Maintaining a moist environment is an important feature of wound dressings, as 
described above, but the ability of a wound care product to absorb excess moisture 
and exudate from a wound is equally important. Whilst a moist environment can 
promote wound healing, too much moisture can promote bacterial growth and also 
maceration of the surrounding healthy tissue. The data presented here demonstrate 
differences between the film and foam formulations that may indicate applications for 
different types of wounds. Both the film and foam dressings were shown to absorb a 
large amount of SWF during the 96 hour testing period. However, the hydration 
degree, and therefore amount of SWF absorbed, by the foam nanocomposites  was 
demonstrably greater (p < 0.001) than for the film composites (table 4.6). This may 
well have been the result of increased porosity within the foam composites, caused by 
the lyophilisation process, allowing for faster and greater SWF uptake. 
 
Chapter 4              Development and evaluation of antibacterial wound dressing materials 
Page 213 of 260 
Table 4.6. Hydration degree of film and foam formulations on the synthetic wound surface. 
Film sample Hydration degree Foam sample Hydration degree 
Opsite® 0.70 (±0.90) Kaltostat® 404.78 (±159.51) 
MVAlg 356.22 (±34.13) Lyofoam® 949.87 (±23.62) 
MVAlg-KN 365.29 (±138.39) LVAlg 907.26 (±111.14) 
MVAlg-MMTK10 285.74 (±29.29) LVAlg-KN 764.21 (±48.52) 
MVAlg-LXL21 414.69 (±40.14) LVAlg-MMTK10 765.18 (±38.93) 
MVAlg-GLY 522.56 (±33.78) LVAlg-LXL2 719.71 (±34.95) 
MVAlg-LXL21-GLY 391.80 (±10.99) LVAlg-GLY 1212.57 (±114.50) 
MVAlg-GLY-20CIP 562.13 (±17.32) LVAlg-LXL21- GLY 980.38 (±70.35) 
MVAlg-GLY-130CIP 495.71 (±21.22) LVAlg-GLY-20CIP 1174.51 (±38.64) 
MVAlg-GLY-160CIP 489.65 (±35.30) LVAlg-GLY-130CIP 1103.87 (±41.83) 
MVAlg-LXL21-GLY-20CIP 357.07 (±20.11) LVAlg-GLY-160CIP 1196.38 (±51.99) 
MVAlg-LXL21-GLY-130CIP 327.32 (±64.87) LVAlg-LXL21- GLY-20CIP 1022.94 (±118.33) 
MVAlg-LXL21-GLY-160CIP 313.73 (±11.98) LVAlg-LXL21- GLY-130CIP 923.22 (±27.95) 
  LVAlg-LXL21- GLY-160CIP 700.80 (±47.26) 
 
 
Over the 96 hour duration, the film samples changed from being transparent to an 
opaque white colour. Whilst the foam samples were opaque at the start of the test, 
the end product was a hydrogel with similar opaque-white tones as the films. This 
change in light transmission is likely the result of calcium ions within the absorbed SWF 
creating cross-links between the G-G blocks of the alginate chains (Davidovich-Pinhas 
and Bianco-Peled, 2010). This effect is also the reason why the alginate film and foam 
samples did not lose structural integrity during the tests, as has been described in 
other examinations of alginate as a wound-dressing material. 
 
The change in size of MVAlg films containing clay-minerals was significantly less (p < 
0.05) compared to the MVAlg with no other additives (figure 4.19). It is well known 
that clay-minerals can act as cross-linkers within a wide range of polymeric materials, 
which is why they have been examined as an additive to these materials (Alboofetileh 
et al., 2013; Ghadiri et al., 2013; Shikinaka et al., 2012; Zhang et al., 2009). 
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As demonstrated by the FTIR analyses (section 4.3.3), LXL21 was able to form hydrogen 
bonds with the MVAlg chains and is therefore likely to be acting as a cross-linker 
between MVAlg chains. This will result in more rigidity within the nanocomposite 
materials and therefore restrict polymer mobility on hydration and result in less 
change in size on SWF absorption. However, the addition of LXL21, KN, and MMTK10 
did not result in a significant change in the hydration degree of these film materials 
(table 4.6), suggesting that the overall ability to absorb fluid from a wound is not 
impeded. Moreover, the absorption of fluid may be supported by the presence of 
LXL21, compared to the other clay-minerals, as its high surface area allows for greater 
interaction with water. 
 
The addition of glycerol to the MVAlg films also resulted in a reduced size change 
compared to the MVAlg film containing no additives. As a plasticiser glycerol reduces 
the interactions between polymeric chains so this effect is unlikely a direct result of 
alginate-glycerol interactions. Glycerol is a hygroscopic compound and has been used 
as an osmolyte, to enhance water absorption (Björklund et al., 2013).  Therefore, it is 
reasonable to suspect that glycerol was able to enhance the absorption of SWF into 
the alginate film so that calcium bridges were formed faster, thus limiting the change 
in size. This enhanced fluid absorption is also demonstrated in table 4.6, which 
demonstrates the significant (p < 0.05) increase in hydration degree of the MVAlg-GLY 
film compared to the MVAlg film. 
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Figure 4.19. Average (mean ±SD, n=3) percentage change in size of nanocomposite films (blue bars) and 
foams (green bars) when on the synthetic wound environment. 
 
 
This effect of glycerol is not seen in the presence of LXL21 as the percentage change in 
size of films containing MVAlg-LXL21-GLY was significantly (p < 0.05) smaller compared 
to those films that did not contain both of these additives.  The hydration degree of 
the MVAlg-LXL21-GLY films was also significantly (p < 0.001) lower compared to the 
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other composite films examined. These results point towards a complex interaction 
between the MVAlg, LXL21, and glycerol and not just a simple restriction in the 
mobility of alginate chains. As described in the FTIR and XRD analyses, glycerol may be 
able to interact with and adsorb onto LXL21. This may have the dual-effect of reducing 
the hygroscopic properties of glycerol, but also reducing the water and electrolyte 
adsorptive capacity of LXL21, resulting in an overall limitation on swelling size change 
and hydration degree. 
 
As shown in figure 4.19 the nanocomposite foams behaved very differently compared 
to the films. The foams had a propensity to shrink or remain a relatively static size and 
expressed a higher degree of inter-sample variation. The shrinkage of these materials 
on absorption of SWF is a result of calcium ions forming bridges between alginate 
strands, especially in the G-G blocks, resulting in a much tighter, contracted, network 
of alginate chains. The effects of glycerol within these composite foams were similar to 
those observed in the composite film materials in that the LVAlg-GLY foam shrank, 
whereas the LVAlg foam with no additives was shown to increase in size. This supports 
the theory that glycerol was able to promote the rapid absorption of SWF into the 
composites, resulting in enhanced calcium-bridge formation. The hygroscopic effects 
of glycerol are also demonstrated through the significant (p < 0.001) increase in 
hydration degree of the LVAlg-GLY foam compared to the LVAlg foam with no additives.  
 
In a similar vein to the films, the addition of glycerol to the LVAlg-LXL21-CIP foam 
composites also lead to a significant drop in hydration degree (p < 0.05, when 
compared as groups) although this effect was much less pronounced in the foam 
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composites; likely due to the reduced amount of glycerol used in formulating the 
foams. The influence of LXL21’s ability to absorb fluid within these nanocomposites is 
demonstrated in the series of foams containing LXL21 and CIP. As the amount of CIP 
absorbed onto the LXL21 was increased the hydration degree decreased due to a 
reduced uptake of fluid, supporting the theory that substrates absorbed onto the 
LXL21 surface will lead to a reduction in SWF uptake.  
 
These results show that both film and foam nanocomposites are able to absorb large 
amounts of wound fluid making them promising candidate materials for use on 
suppurating wounds. These data also prove these materials remain structurally intact 
over a 96 hour period, thus requiring less frequent changing, and the calcium bridges 
formed within the alginate matrix could also prevent particulate matter being 
generated during dressing changes. In particular, the ability of LXL21 to restrict size 
change during fluid absorption, and also contribute to the absorption process, is an 
important finding of this work. It was also proven that glycerol makes multiple 
important contributions to these composite materials. 
 
As well as giving a useful estimation into the swelling behaviour of these composite 
materials, this study has also developed and utilised a novel synthetic wound 
environment not yet reported in the scientific literature. The research presented here 
makes several advances on previously published work that have used over-ripe melon 
(Matthews et al., 2005), simple gelatine gels (Ng and Jumaat, 2014; Thu et al., 2012), 
electrolyte solutions (Momoh et al., 2015; Rezvanain et al., 2017), or water (Kokabi et 
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al., 2007)  to predict the behaviour of polymeric composites, both with and without 
phyllosilicates, in a wound environment. 
 
4.3.8. Adherence of formulations to the wound surface 
Ideally, wound dressings should have low or no adherence to the wound surface so 
that the migratory phase and re-epithelialisation occurs unopposed and that damage is 
not inflicted upon the wound-bed when the dressing is removed or changed 
(Hutchinson, 1990; Morgan, 2002). Non-adherent dressings are of benefit in dry 
wounds, whereas low adherent dressings may be of particular benefit in suppurating 
wounds (Hanna and Giacopelli, 1997; Palfreyman et al., 2010; Scottish Intercollegiate 
Guidelines Network, 2010). As the methodology utilised in this study is essentially a 
semi-quantitative method, adapted from Matthews et al (2005), particular attention 
needs to be paid to how the composite films and foams behave in comparison to the 
readily available commercial products Opsite®, Kaltostat®, and Lyofoam®.  
 
Of the films, Opsite® was shown to be the most adherent as it did not migrate 
throughout the duration of the experiments (Figure 4.20 A). This observation, coupled 
with its negligible hydration degree and low WVTR, fits well to the clinical indication 
for this dressing as it is only intended for lightly exuding wounds (Joint Formulary 
Committee, 2017). These observations may also be extrapolated to suggest that the 
methodologies used in these studies are able to predict the behaviour of the 
composite materials in a wound environment. Therefore, it is reasonable to suggest 
that all the other composite films tested were less adherent to the wound surface and 
therefore may be beneficial in wounds generating a greater amount of exudate.  
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Figure 4.20. Movement of film (A) and foam (B) dressings down the synthetic wound surface over 24 
hours (light brown diamonds) and 96 hours (dark brown squares). Thick lines represent the average 
(mean, n=3) movement of formulations down the wound surface. Standard deviations are given by the 
thin lines (error bars) 
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Composite films containing clay minerals were shown to reside for at least 24 hours 
before migrating, unlike the films of MVAlg, MVAlg-GLY, and MVAlg-GLY-CIP that all 
showed migration within 24 hours. By 96 hours all of the composite films had migrated 
down the synthetic wound surface due to the increasing mass of the composites over 
time as they took on more fluid.  
 
When analysed as groups, the MVAlg-LXL21-GLY-CIP films were significantly (p < 0.05) 
more adherent than the MVAlg-GLY-CIP films, which further proves that LXL21 is able 
to increase adherence to the synthetic wound surface. This phenomenon has also 
been reported in other studies where clay-minerals are proposed to increase 
adherence to the wound surface through i) interactions between the clay-mineral 
surface and important proteins such as fibronectin, and ii) through clay-mineral 
particles acting as a focus for cellular adherence (Gaharwar et al., 2012; Ghadiri et al., 
2013). 
 
Although not statistically significant, the increasing proportion of CIP within the non 
LXL21 containing films appeared to reduce the surface adherence. The adherence 
properties of alginates are known to be derived from the large number of carboxyl and 
hydroxyl groups which are able to form hydrogen bonds with other materials, such as 
agar (Wang and Rhim, 2015), and the protein and polysaccharide rich wound-bed 
(Pongjanyakul and Suksri, 2010). While not detected by FTIR due to masking of 
characteristic absorbance bands, the observations made in this study hint at an 
interaction between CIP and the MVAlg polymer resulting in reduced ability to form 
hydrogen bonds with the synthetic wound surface.  
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Of the commercially available foams Kaltostat® was shown to be significantly (p < 0.05) 
more adherent than Lyofoam®. Broadly speaking, the composite foams expressed 
similar adhesive strength to the composite films and were comparable to the 
adhesiveness of Kaltostat®, except the LVAlg-GLY-CIP composite foams that 
demonstrated greatly reduced surface adhesion that was more comparable to 
Lyofoam® (figure 4.20 B). Therefore, it would be fair to assume that these composite 
foams could be suitable for use on moderately exuding wounds in the same way as  
Kaltostat® and Lyofoam® (Bennett-Marsden, 2010; Joint Formulary Committee, 2017). 
The absence of LXL21 in the CIP containing foams resulted in a significant decrease in 
the surface adherence. This may be explained, as above, by a potential interaction 
between CIP and alginate resulting in a reduced opportunity for the alginate to form 
hydrogen bonds with the synthetic wound surface (Pongjanyakul and Suksri, 2010). 
The absence of LXL21 in these samples also means the ability of a clay-mineral to also 
form interactions with the wound surface is not present, resulting in lower adhesion 
(Ghadiri et al., 2013).  
 
These results are limited by their design and future research into the optimisation and 
clinical application of these materials will need to employ more sensitive methods to 
fully quantify wound-bed (Pongjanyakul and Suksri, 2010; Singh et al., 2013) and 
cellular adhesion (Ghadiri et al., 2013; Qi et al., 2013). However, it is promising that the 
migrations observed were comparable to readily available products suggesting that 
they should not adhere to the wound-bed in a harmful way. 
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4.3.9. Drug-release profiles 
Achieving modified and prolonged release of drugs is often desirable to achieve 
therapeutic benefit, reduce toxicity, and to encourage patient adherence (Rodrigues et 
al., 2013; Viseras et al., 2008). Whereas many modified-release oral preparations aim 
to reduce dosing to once or twice a day, dependant on pharmacokinetics (Qiu and Lee, 
2017), the ideal release profile for a wound dressing should be in the order of days 
(Sandstrom, 2011). This would ensure that sufficient drug is eluted into the tissue 
continuously between dressing changes, which should be as infrequent as possible to 
support wound healing. 
 
Figures 4.21 and 4.22 demonstrate the difference in the release profile of the LXL21-
CIP composite compared to the MVAlg-LXL21-GLY-CIP nanocomposite films and foams. 
Release of CIP from the LXL21-CIP composite showed rapid drug release within the first 
15 minutes, followed by a slower release profile that reduced in rate as time 
progressed – notably between 4 to 6 hours of release. This initial burst release is likely 
related to the presence of CIP on the external surface of the LXL21 particles (Iliescu et 
al., 2013), and would have been plentiful given the large CIP load of this composite. 
The reducing rate of release between 15 minutes and 6 hours is a result of CIP being 
released from the interlayer space of LXL21, initially through swelling of the layers and 
diffusion of the drug, then subsequent release of the CIP adsorbed onto the clay 
mineral surface (Hua et al., 2010; Iliescu et al., 2013). In chapters 2 and 3 it was 
proposed that drug adsorption onto these clay minerals was likely down to cation 
exchange, alongside other interactions. In total, 87.7% of the CIP within the LXL21-CIP 
composite was released over the 24 hour period measured.  
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Figure 4.21. Profiles of ciprofloxacin released (mean average mass of CIP per mg of sample, ±SD, n=3) 
from film formulations containing MVAlg-LXL21-GLY-20CIP (blue diamonds), MVAlg-LXL21-GLY-130CIP 
(red crosses), and MVAlg-LXL21-GLY-160CIP (green triangles), alongside foams containing LVAlg-LXL21-
GLY-20CIP (purple squares), LVAlg-LXL21-GLY-130CIP (grey crosses), LVAlg-LXL21-GLY-160CIP (orange 
rings), and LXL21-CIP (black circles). * and ** indicate significant difference at p < 0.05 and p < 0.001, 
respectively, between highlighted values. 
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The remaining 12.3% (77.12 mg) was less than the calculated monolayer coverage, 
which is suggestive of cation exchange taking place between the CIP and the cations 
(Ca2+ and Na+) within the SWF (Iliescu et al., 2013; Joshi et al., 2009; Pongjanyakul and 
Suksri, 2010) but may also suggest that the remaining CIP was interacting with the 
LXL21 via different mechanisms (Hua et al., 2010; Joshi et al., 2010). Jung et al (2008) 
describe a ‘zipping effect’ that can take place as cations from the release medium 
exchange with the drug molecules on a Laponite® surface. As the inorganic cations are 
much smaller than the organic drug molecules a reduction in interlayer space occurs at 
the edge of clay mineral platelets, essentially zipping the structure together and 
inhibiting drug release from the inner-most regions of the interlayer space. This 
phenomenon may have been taking place in the LXL-CIP composite, resulting in 
retention of CIP after 6 hours.  
 
The release of CIP from the nanocomposite films and foams increased as the amount 
of drug within the composites increased. As could be expected, significantly (p < 0.05) 
more CIP was released from the composites containing 160 mg CIP compared to those 
containing 130 mg CIP. Laws of diffusion are thought to play a significant role in the 
release of drugs from phyllosilicate-polymer composites, with concentration gradient 
being of notable importance (Dziadkowiec et al., 2016; Pongjanyakul and Suksri, 2010). 
The concentration gradients within the nanocomposites containing 160 mg would have 
been higher than for the 130 mg containing composites, and been maintained for a 
longer period, therefore increasing the amount of CIP released.  
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After 4-hours significantly (p < 0.001) greater amounts of CIP were released from the 
nanocomposite foams containing 130 mg and 160 mg CIP compared to their film 
counterparts (figure 4.21). By examining the relative percentage CIP released over time 
(figure 4.22) it can also be seen that the nanocomposite foams containing 130 mg and 
160 mg CIP had less of a profound burst release and demonstrated a release profile 
that was more appropriate to a modified release preparation. These differences in 
release profiles may be directly related to the internal structure of the film and foam 
matrices. For example, the nanocomposite films were much thinner and had a denser 
structure when compared to the foams, which would have resulted in a greater 
concentration of CIP per unit volume of composite, therefore creating a greater 
concentration gradient that resulted in more rapid CIP release.  
 
While the zipping effect of the SWF cations on LXL21 is likely to be similar between the 
different formulation types, the effect of calcium ions on the alginate matrix may have 
differing effects on the release of CIP from these formulations.  When Gonçalves et al. 
(2013) investigated the release of doxorubicin from Laponite-alginate matrices they 
noted the effect of calcium bridging on rate of drug release; concluding that alginate 
matrix shrinkage made the release of drug more arduous. This effect may also explain 
some of the differences observed in the release of CIP whereby the formation of 
calcium-alginate bridges within the films resulted in a denser matrix structure 
(Davidovich-Pinhas and Bianco-Peled, 2010) and thus greater inhibition in CIP release 
compared to in the foams. This is supported by the ongoing, yet, slowed release of CIP 
from the nanocomposite foams after 6 hours in SWF.  
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Figure 4.22. Profiles of ciprofloxacin released (% relative to 100% released by each sample, mean 
average, n=3) from film formulations containing MVAlg-LXL21-GLY-20CIP (blue diamonds), MVAlg-
LXL21-GLY-130CIP (red crosses), and MVAlg-LXL21-GLY-160CIP (green triangles), alongside foams 
containing LVAlg-LXL21-GLY-20CIP (purple squares), LVAlg-LXL21-GLY-130CIP (grey crosses), LVAlg-
LXL21-GLY-160CIP (orange rings), and LXL21-CIP (black circles).  
 
(Gonçalves et al., 2013b) 
While this study is limited to a 24-hour window it can be seen that the incorporation of 
LXL21-CIP composites into an alginate matrix modifies and prolongs drug release. 
These data suggest that the nanocomposite foams containing 130 mg CIP or greater 
may be able to continue beyond the 24-hour period, which is a promising property for 
these candidate wound dressing materials. Further studies will be required to 
determine the release profiles of these materials over a 96-hour period and will also 
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need to consider alternative methodologies such as the utilisation of Franz-cells (Ito et 
al., 2001; Perkins and Heard, 1999; Thu et al., 2012) and animal models (Vijayan et al., 
2013) to fully determine dermis, subcutaneous and wound-bed penetration and 
systemic absorption.  
 
4.3.10. Antimicrobial properties 
These microbiological studies adapted the methods described in section 2.2.4, which 
impregnated the molten agar with bacterial cultures so that confluent growth occurs 
throughout the medium. Other research in this field applied the bacterial culture to 
the surface of the ready-set agar (Ambrogi et al., 2016; Das et al., 2014), which can 
result in uneven growth across the plate (Matuschek et al., 2014) but is also not 
representative of an infected wound environment where bacteria can grow within the 
deeper tissues (Siddiqui and Bernstein, 2010). Therefore, the methods used in this 
study are more representative of activity in an infected wound environment. 
 
The nanocomposite films and foams that did not contain CIP were not shown to 
generate clearance zones and it can therefore be assumed that these materials have 
no inherent activity on the bacterial species tested against (figures 4.23 and 4.24). This 
finding also supports the conclusion that any zones of inhibition observed was a result 
of CIP being released from the composites in an active form. 
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Figure 4.23. Zones of inhibition (mean ±SD, n=3) generated by CIP containing nanocomposite films 
against P. aeruginosa (blue), S. epidermidis (orange), and P. acnes (green). 
 
 
Through its unique mode of action of affecting bacterial DNA functionality, CIP was 
able to inhibit the growth of S. epidermidis, P. aeruginosa and P. acnes (Vance-Bryan et 
al., 1990; Wispelwey, 2005). The zones of inhibition extended beyond the dimensions 
of the composite samples placed onto the agar, demonstrating that CIP was able to 
diffuse away from the nanocomposite matrix and through the growth medium. These 
zones of inhibition, as demonstrated in chapters 2 and 3, grew in diameter as the 
concentration of CIP within the composite increased. A significant (p < 0.05) increase in 
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efficacy was observed between the composites containing the lowest concentration of 
CIP compared to those containing higher concentrations. However, while the efficacy 
was shown to increase as the concentration of CIP was increased from 2.42% to 2.96% 
w/w in nanocomposite films and 2.28% to 2.80% w/w in nanocomposite foams the 
difference was not statistically significant (p 0.078 – 0.465). 
 
It is worth noting that the zones of inhibition only demonstrate efficacy over a period 
less than 24 hours, due to the design of the test and the rapid proliferation of these 
bacterial strains (Matuschek et al., 2014). It should also be noted that CIP exhibits 
concentration-dependant killing; requiring high concentrations to be bactericidal (Silva 
et al., 2011). Therefore, when CIP induces bacteriostasis it halts cellular activities and 
proliferation to such an extent that the host’s immune system can destroy the bacteria. 
Given the prolonged release profiles observed in section 4.3.9, especially for the 
nanocomposite foams, it is likely that the data presented in figure 4.24 is an 
underestimation of the true efficacy of these materials. Coupled with ongoing drug 
release and wound-bed neutrophils, macrophages and leucocytes (Boateng et al., 2008) 
the true clearance of bacteria from the wound is likely to be greater. However, animal 
and human modelling will be needed to fully characterise this effect and also 
determine the role of absorption and clearance through the capillary bed. 
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Figure 4.24. Zones of inhibition (mean ±SD, n=3) generated by CIP containing nanocomposite foams 
against P. aeruginosa (blue), S. epidermidis (orange), and P. acnes (green). 
 
The results presented here prove that these nanocomposite materials are able to 
affect a broad spectrum of common wound pathogens, making them promising 
materials for wound care. The extended zones of inhibition are also a promising 
property of these materials as it may be possible to design targeted therapies for more 
localised infections, or design hybridised-dressings where the CIP-containing materials 
are in distinct domains that deliver adequate CIP to the wound but allow other 
beneficial wound care materials to be present concurrently.  
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4.3.11. Keratinocyte cell viability 
Determining the effect of new materials on cell viability is an important step before 
moving onto animal then human models (Rezvanain et al., 2017). By measuring the 
impact of a material on cell viability it is possible to determine whether the material is i) 
biocompatible and ii) able to support cell growth. Research into the effects of polymer-
phyllosilicate composites on cell function is in its infancy (Dawson and Oreffo, 2013) 
and as such there is currently scant evidence regarding the effects of these types of 
materials on keratinocytes. Ambrogi et al (2017) reported reduced cytotoxicity of 
keratinocyte and fibroblast cell lines when chlorhexidine was loaded into a 
montmorillonite-chitosan nanocomposite, compared to chlorhexidine alone.  
(Ambrogi et al., 2016) 
All the materials tested allowed for greater than 70% viability (figure 4.25) of the 
keratinocyte (HaCaT) cell-line and therefore acceptable biocompatibility as described 
in ISO 10993-5 (British Standards Institute, 2009; Rezvanain et al., 2017). LVAlg, MVAlg, 
and LXL21 powders were all shown to significantly reduce HaCaT viability over the time 
period tested, as did the nanocomposite film of LVAlg-LXL21-GLY and all of the 
nanocomposite foams. Glycerol and ciprofloxacin did not result in a reduction in cell 
viability, thus affirming the safety in this human cell line. While the safety of systemic 
CIP has been known for years, through its regular use in modern medicine (Wispelwey, 
2005), the data presented here may represent evidence of the safety of CIP when 
applied topically to the wound environment; vital information for this research. 
 
The CIP containing nanocomposite films did not cause a significant reduction in HaCaT 
cell viability (p = 0.077, 0.074, 0.375) and were found to support cell growth 
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significantly (p < 0.05) better than the nanocomposite foams. This is not necessarily a 
reflection of different toxicity/safety levels as no significant difference (p > 0.05) in cell 
viability between LVAlg and MVAlg was observed. This difference may be explained by 
the differences in formulating each type of composite (Ghadiri et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.25. HaCaT cell viability after 24 hours treatment with test materials (mean ±SD, n=3), relative to 
the cell viability of untreated HaCaT cells (grey zone; 100 ±9.9 %). * Indicates no significant difference 
between these components. ** Indicates no significant difference between these CIP samples. ◊ 
Indicates these samples have significantly (p < 0.05) reduced cell viability compared to the control. 
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Research investigating the effect of phyllosilicate-polymer composites has given 
particular attention to the role of phyllosilicates within these materials. A number of 
teams have shown that clay-mineral particles can increase cell adhesion by directly 
interacting with surface proteins, such as fibronectin, and even acting as a point of 
attachment for cells (Ghadiri et al., 2013; Schexnailder et al., 2010; Zheng et al., 2007). 
With regards to this latter point, microscopy undertaken by Ghadiri et al. (2013) and 
Gaharwar et al. (2011) showed how Laponite® within a formulation can promote cell 
adherence and increasing quantities can support cells to stretch across the surface of 
the nanocomposite films, assumedly attaching to Laponite® particles, which may be 
beneficial for the migratory phase of wound-healing. Similar work has also been 
undertaken on gelatine-montmorillonite-chitosan composites that encouraged stromal 
cell attachment via filopodia, which supported onward proliferation of the cells (Zheng 
et al., 2007). 
 
In the work presented here the nanocomposite films have a higher proportion of LXL21 
within their structure (18.48 to 18.97%) when compared to the foams (17.48 to 
17.91%). The internal structure of these materials may also play an important role in 
the availability of LXL21, which is likely to be reduced in the foams as their porous 
nature and thicker dimensions may result in a large proportion of the bound LXL21 not 
coming into contact with the cells. These derivations support the increased HaCaT cell 
viability observed for the CIP containing nanocomposite films.  
 
The results presented here prove good biocompatibility of the nanocomposite films 
and foams, and relative cytocompatibility of the individual components. It is also 
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promising that the nanocomposite films did not significantly reduce cell proliferation 
as promotion of keratinocyte migration and proliferation is vital in the migratory phase 
early in the wound healing process. Further work should investigate the behaviour of 
cell adherence and movement across these composites and move onto animal models 
(Emami-Razavi et al., 2006) to determine their behaviour in true wound environments. 
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4.4. Conclusions 
Through a series of pre-formulation and refinement studies a set of novel and unique 
materials have been created containing Laponite® XL21, alginate, glycerol and 
ciprofloxacin. Of these materials the nanocomposite films were shown to be most 
promising and were supported by the tissue viability nursing team at Liverpool and 
Broadgreen University Hospitals NHS Trust for their malleability, softness, and 
transparency that was confirmed spectrophotometrically. While the nanocomposite 
foam materials were deemed to require further work to increase their physical 
strength and integrity, they still bore some promising characteristics such as increased 
fluid absorption and prolonged drug release. 
 
Nanocomposite films and foams were able to reduce water vapour transmission rate in 
such a way that they would still allow gaseous exchange but could also prevent 
desiccation of the wound environment. Both types of material were also shown to 
have impressive fluid absorption capacities without losing their overall shape or 
integrity. The research described here is the first within clay-mineral studies to include 
commercially available products as comparisons. The nanocomposite films were 
shown to have greater wound-fluid adsorption potential and less surface adherence 
compared to Opsite®, whereas the nanocomposite foams were also shown to be more 
absorbent than Kaltostat®, equally as absorbent as Lyofoam®, and have similar surface 
adherence properties to Kaltostat®. This ability to absorb more fluid will be important 
for their application to infected wounds, which generally produce more exudate that 
can become purulent (Healy and Freedman, 2006; Stevens et al., 2014).  
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The incorporation of LXL21-CIP composites into alginate allowed for slower and 
controlled release of drug into the SWF, which was more pronounced in the 
nanocomposite foam samples. This ability to release CIP was also demonstrated 
against bacteria commonly found in infected wounds. When applied to a culture of 
keratinocytes these film and foam nanocomposites, and their individual components, 
where proven to have good biocompatibility with the film nanocomposites causing no 
adverse effect on cell proliferation.  
 
Overall, these nanocomposite materials warrant further investigation beyond the 
remit of this project to fully realise their potential. For the nanocomposite foams, a 
number of polymers of differing molecular weights such as chitosan, polyvinyl alcohol, 
and polyurethanes should be investigated to determine which provides the best 
mechanical and biological properties. To further characterise the structure of the 
nanocomposite films and foams, scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM) can be used. A number of additional, pharmaceutically 
relevant, techniques should also be utilised, such as texture analysis, tensile strength, 
deformation testing, and drug and formulation stability over time. Moreover, future 
work should use the knowledge developed within this thesis and move its application 
forward to animal and clinical studies.  
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Chapter 5 
Concluding remarks & future directions 
 
The management of infected wounds is often complex and can result in prolonged and 
repeated courses of antimicrobial agents alongside supportive therapies to promote 
wound healing. The current lack of appropriate wound-care materials that can 
sufficiently kill bacteria or inhibit bacterial growth results in patients receiving 
antimicrobial therapy systemically, which puts them at risk of adverse drug reactions 
(Tamma et al., 2017) and the development of secondary infections from organisms 
such as Clostridium difficile (Aldeyab et al., 2009). Repeated and prolonged 
antimicrobial therapy can also result in the development of antimicrobial resistance 
within the human microbiota (Jernberg et al., 2010; Price et al., 2009), which can 
ultimately result in infections that are more difficult to treat and may only respond to 
the most toxic and expensive agents available (Chatterjee et al., 2016; Grice and Segre, 
2011). 
 
Antimicrobial resistance has been identified as a world-wide-issue and impending crisis 
for human and animal health. Although there are many ways to prevent the 
development of antimicrobial resistance the World Health Organisation, the UK 
Department of Health, and the Royal Pharmaceutical Society have stressed the 
importance of developing new ways to utilise the available antimicrobial arsenal 
(Davies, 2013; Royal Pharmaceutical Society, 2014; World Health Organization, 2012). 
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The work presented in this thesis highlights the ability of clay-minerals to act as 
carriers for antimicrobial agents and potentially benefit the wound-healing process.  
 
By treating the infection at the source it may be possible to reduce selection pressures, 
for antimicrobial resistance, on the rest of the microbiota and also allow for smaller 
doses to be used; reducing the risk of adverse drug reactions. In turn these 
nanocomposite materials may reduce the burden on the patient and the healthcare 
system as patients may not require systemic antimicrobial therapy within the inpatient 
or outpatient setting. 
 
Tetracycline, doxycycline (chapter 2) and ciprofloxacin (chapter 3) were successfully 
adsorbed onto the surfaces of clay mineral layers. The chemistry and physical-
structure of the clay minerals examined was key to determining the amount of drug 
that could be adsorbed onto the mineral surfaces. Non-swelling 1:1 minerals with 
small surface areas and poor cation exchange capacities (i.e. kaolin) were shown to 
adsorb the least amount of drug onto their outer particle surfaces, whereas swelling 
2:1 minerals, which generally have much larger surface areas and significantly greater 
cation exchange capacities, where able to adsorb much more drug into the laminar 
space between mineral layers and onto positively charged edge-groups. The chemistry 
of the adsorbate also influenced the quantity of drug adsorbed onto the different clay 
mineral surfaces. A dispersion which favoured the zwitterionic state of each drug 
molecule was clearly shown to favour greater drug adsorption, possibly through tighter 
arrangement of drug molecules at the clay mineral surface.  
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These antibacterial agents were shown to be able to desorb from these the clay-drug 
composites in a series of microbiological experiments that were specially designed to 
better represent a chronically infected wound. Through these experiments the 
desorbed drugs were shown to inhibit the growth of Staphylococcus epidermidis, 
Propionibacterium acnes, and Pseudomonas aeruginosa; important skin, skin-
structure, and wound pathogens.  
 
Through a series of pre-formulation and formulation studies (chapter 4), ciprofloxacin 
clay-mineral composites were successfully incorporated into alginate polymer matrices 
to create films and foams. The alginate was shown to interact with the edge-sites of 
the clay mineral layers to form a nanocomposite that afforded increased thermal 
stability to the composite. Glycerol was shown to be a useful softener and plasticiser in 
these composite materials, whereas freezing parameters were an important factor in 
improving foam structure.  
 
Novel methods were developed, utilising synthetic wound fluid, to predict the 
behaviour of these nanocomposite materials on a suppurating wound, which not only 
demonstrated promising physical characteristics but also proved the release of 
ciprofloxacin from these materials was modified. Ciprofloxacin released from these 
nanocomposite materials was also shown to be effective at inhibiting the growth of a 
range of clinically important bacteria. Finally, these nanocomposite materials were 
shown to be biocompatible with keratinocytes and the findings within this work 
suggest the films may even be able to promote the wound-healing process.  
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While the nanocomposite materials developed in this research show a great deal of 
promise for a future role in healthcare, more work is needed to fully characterise their 
properties and understand their role within the management of infected wounds. The 
nanocomposite film formulations developed in this research showed the most promise 
for future use in clinical practice and were deemed to be acceptable materials by the 
tissue viability nurse. These nanocomposite films were sufficiently flexible, 
transparent, allowed for gaseous exchange, adsorbed significant quantities of wound 
exudate, and had low adherence to the wound surface.  
 
Although the nanocomposite foams were also able to adsorb large amounts of wound 
exudate and allow for gaseous exchange, significantly more research is required to 
obtain a formulation that is appropriate for clinical applications. In order to develop 
composite foams that are optimised for the management of infected wounds it will be 
necessary to investigate different polymers with differing properties. Polymers such as 
chitosan, polyvinyl alcohol, polyethylene glycol, and polyurethanes could be 
investigated initially as they have already been used in the development of clay-
polymer composites and are known to be biocompatible (Aguzzi et al., 2010; Da Silva 
et al., 2013; Kokabi et al., 2007; Sandri et al., 2016; Viseras et al., 2008; Zhu et al., 
2013). The possibility of using combinations of these polymers should not be ruled out 
if it could result in beneficial properties being utilised from each polymer. As well as 
investigating different polymers it will also be useful to examine the role of different 
additives to improve structure and mechanical properties, and it will also be necessary 
to examine different formulation techniques that can produce porous-foam materials 
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such as temperature-controlled and cycled lyophilisation, particulate leaching, phase 
separation, and gas foaming (Salerno and Nettis, 2014).  
 
It should be noted, however, that the pharmaceutical analysis of these nanocomposite 
films and foams was limited by the techniques available during the project. Future 
research into these materials will need to focus on quantitative analyses to fully 
characterise and quantify their behaviour. Texture analysis should be utilised to 
measure tensile strength, elongation properties, Young’s modulus and adhesion onto 
the wound surface (Matthews et al., 2005; Momoh et al., 2015; Zare et al., 2017). 
Additional thermal analysis with differential scanning calorimetry (DSC) and TGA-
evolved gas analysis (TGA-EGA) alongside more precise imaging techniques such as 
high-resolution transmission electron microscopy (HRTEM) or micro-computed 
tomography analysis (µ-CT) should allow the internal structure of these 
nanocomposites to be fully characterised (Aguzzi et al., 2013; Ghadiri et al., 2013; 
Mofokeng et al., 2016; Shikinaka et al., 2012). Utilisation of techniques such as magic 
angle scanning NMR (MAS-NMR), solid-state NMR, near infrared spectroscopy (NIR), 
and zeta-potential could also unveil new information about the specific interactions 
between drugs, clay minerals, and polymer molecules (Gil et al., 2011; Gonçalves et al., 
2013; Madejova, 2003; Ray and Okamoto, 2003; Shikinaka et al., 2012). 
 
Regardless of the development of this fundamental knowledge it will be vitally 
important to test these materials in line with international standards for healthcare 
products. The suitability of these nanocomposite materials for wound care will need to 
be tested in line with the ISO 10993 standards to characterise their interaction with 
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blood, determine their degradation products, and also predict their potential to cause 
local and systemic sensitivities and adverse effects. Such an approach will allow the 
work to be taken forward to animal and eventually human models. 
 
It should also be highlighted that whilst the tetracycline and quinolone classes remain 
useful options for the management of wound, skin, and skin-structure infections 
(Stevens et al., 2014), their widespread use for other infective indications, alongside 
poor antimicrobial stewardship, is resulting in increasing rates of wound and skin and 
skin structure infections that resist treatment with these drugs (Fraise, 2006; Stevens, 
2009). Flucloxacillin is still widely recommended for the management of skin and skin-
structure infections (National Institute of Health and Care Excellence, 2015) and could 
prove to be an interesting candidate for inclusion into the composite materials 
developed in this work. 
 
It would be particularly interesting for the knowledge developed in this thesis to be 
taken forward to examine the potential for clay-minerals to carry other, much larger 
and chemically complex, antimicrobials that are useful in the management of drug-
resistant skin, skin-structure, and wound infections such as daptomycin, dalbavancin, 
rifampicin and vancomycin (Enoch et al., 2007; Roberts et al., 2015; Unal, 2009). In 
addition to this, testing these composites against other clinically relevant bacterial 
species such as Streptococcus pyogenes, methicillin sensitive and methicillin resistant 
Staphylococcus aureus, and various Enterobacteriaceae will be important (Dryden, 
2009; Grice and Segre, 2011; Malik et al., 2013). It will also be important to consider 
utilising international standards for microbiological testing, such as the European 
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Society of Clinical Microbiology and Infectious Diseases (2017) antibacterial 
susceptibility testing methods. 
 
To fully realise the potential of these nanocomposite materials, future research 
projects will require significant investment in terms of time and resources, and will 
also require a multidisciplinary approach with collaborations between pharmaceutical 
scientists, biomedical scientists, specialist pharmacists, tissue viability nurses, and 
medics specialised in microbiology, infectious diseases, and dermatology. A 
multidisciplinary approach will also ensure the work remains clinically relevant and 
addresses the changing needs of modern healthcare and the ever evolving patterns to 
antimicrobial resistance. 
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treatment of infected wounds 
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The antimicrobial properties of clay composites containing tetracycline and 
ciprofloxacin,  
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Republic, 4th-9th September 2012. [This work won first prize in the poster 
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 Presented at PharmSci 2012, Nottingham, UK, 13th September 2012. 
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An investigation of ciprofloxacin adsorption onto clays for optimal drug release 
 Presented at the LJMU Faculty of Science Research Seminar, Liverpool John 
Moores University, UK, 9th May 2012. [This work won second prize in the 
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 Presented at the Salford Postgraduate Annual Research Conference, Salford 
University, UK, 30th-31st May 2012. 
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Utilising montmorillonite K-10 and Laponite® for delivery of ciprofloxacin.  
Presented at the UK & Ireland Controlled Release Society, Aston University, UK, 2nd 
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